US20040204638A1 - Signal processing apparatus and method - Google Patents
Signal processing apparatus and method Download PDFInfo
- Publication number
- US20040204638A1 US20040204638A1 US10/839,309 US83930904A US2004204638A1 US 20040204638 A1 US20040204638 A1 US 20040204638A1 US 83930904 A US83930904 A US 83930904A US 2004204638 A1 US2004204638 A1 US 2004204638A1
- Authority
- US
- United States
- Prior art keywords
- signal
- signals
- noise
- blood
- undesired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
- A61B5/7214—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using signal cancellation, e.g. based on input of two identical physiological sensors spaced apart, or based on two signals derived from the same sensor, for different optical wavelengths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7228—Signal modulation applied to the input signal sent to patient or subject; demodulation to recover the physiological signal
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B1/00—Details of transmission systems, not covered by a single one of groups H04B3/00 - H04B13/00; Details of transmission systems not characterised by the medium used for transmission
- H04B1/06—Receivers
- H04B1/10—Means associated with receiver for limiting or suppressing noise or interference
- H04B1/12—Neutralising, balancing, or compensation arrangements
- H04B1/123—Neutralising, balancing, or compensation arrangements using adaptive balancing or compensation means
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F2218/00—Aspects of pattern recognition specially adapted for signal processing
- G06F2218/02—Preprocessing
- G06F2218/04—Denoising
Definitions
- the present invention relates to the field of signal processing. More specifically, the present invention relates to the processing of measured signals to remove undesired portions when little is known about the undesired signal portion.
- Signal processors are typically employed to remove undesired portions from a composite measured signal including a desired signal portion and an undesired signal portion. If the undesired signal portion occupies a different frequency spectrum than the desired signal, then conventional filtering techniques such as low pass, band pass, and high pass filtering could be used to separate the desired portion from the total signal. Fixed single or multiple notch filters could also be employed if the undesired signal portions(s) exist at a fixed frequency(s).
- the noise reference signal is not necessarily a representation of the undesired signal portion, but has a frequency spectrum which is similar to that of the undesired signal. In many cases, it requires considerable ingenuity to determine a noise reference signal since nothing is a priori known about the undesired signal portion.
- Physiological monitoring apparatuses generally measure signals derived from a physiological system, such as the human body. Measurements which are typically taken with physiological monitoring systems include electron cardiographs, blood pressure, blood gas saturation (such as oxygen saturation), capnographs, heart rate, respiration rate, and depth of anesthesia, for example. Other types of measurements include those which measure the pressure and quantity of a substance within the body such as breathalizer testing, drug testing, cholesterol testing, glucose testing, arterial carbon dioxide testing, protein testing, and carbon monoxide testing, for example. The source of the undesired signal portion in these measurements is often due to motion of the patient, both external and internal (muscle movement, for example), during the measurement process.
- Energy is caused to be incident on a medium either derived from or contained within a patient and the amplitude of transmitted or reflected energy is then measured.
- the amount of attenuation of the incident energy caused by the medium is strongly dependent on the thickness and composition of the medium through which the energy must pass as well as the specific form of energy selected.
- Information about a physiological system can be derived from data taken from the attenuated signal of the incident energy transmitted through the medium if the noise can be removed.
- non-invasive measurements often do not afford the opportunity to selectively observe the interference causing the undesired signal portion, making it difficult to remove.
- the first undesired portion is an easily removed DC component caused by transmission of the energy through differing media which are of relatively constant thickness within the body, such as bone, tissue, skin, blood, etc.
- Traditional signal filtering techniques are frequently totally ineffective and grossly deficient in removing these motion induced effects from a signal.
- the erratic or unpredictable nature of motion induced undesired signal components is the major obstacle in removing them.
- physiological monitors generally become totally inoperative during time periods when the patient moves.
- a blood gas monitor is one example of a physiological monitoring system which is based upon the measurement of energy attenuated by biological tissues or substances. Blood gas monitors transmit light into the tissue and measure the attenuation of the light as a function of time.
- the output signal of a blood gas monitor which is sensitive to the arterial blood flow contains a component which is a waveform representative of the patient's arterial pulse. This type of signal, which contains a component related to the patient's pulse, is called a plethysmographic wave, and is shown in FIG. 1 as curve Y.
- Plethysmographic waveforms are used in blood pressure or blood gas saturation measurements, for example. As the heart beats the amount of blood in the arteries increases and decreases, causing increases and decreases in energy attenuation, illustrated, by the cyclic wave Y in FIG. 1.
- a digit such as a finger, an ear lobe, or other portion of the body where blood flows close to the skin
- the finger comprises skin, fat, bone, muscle, etc., shown schematically in FIG. 2, each of which attenuates energy incident on the finger in a generally predictable and constant manner.
- fleshy portions of the finger are compressed erratically, for example by motion of the finger, energy attenuation becomes erratic.
- FIG. 3 An example of a more realistic measured waveform S is shown in FIG. 3, illustrating the, effect of motion.
- the desired portion of the signal Y is the waveform representative of the pulse, corresponding to the sawtooth-like pattern wave in FIG. 1.
- the large, motion-induced excursions in signal amplitude hide the desired signal Y. It is easy to see how even small variations in amplitude make it difficult to distinguish the desired signal Y in the presence of a noise component n.
- a specific example of a blood gas monitoring apparatus is a pulse oximeter which measures the saturation of oxygen in the blood.
- the pumping of the heart forces freshly oxygenated blood into the arteries causing greater energy attenuation.
- the saturation of oxygenated blood may be determined from the depth of the valleys relative to the peaks of two plethysmographic waveforms measured at separate wavelengths.
- motion induced undesired signal portions, or motion artifacts must be removed from the measured signal for the oximeter to continue the measurement during periods when the patient moves.
- the present invention is a signal processor which acquires a first signal and a second signal that is correlated to the first signal.
- the first signal comprises a first desired signal portion and a first undesired signal portion.
- the second signal comprises a second desired signal portion and a second undesired signal portion.
- the signals may be acquired by propagating energy through a medium and measuring an attenuated signal after transmission or reflection. Alternatively, the signal may be acquired by measuring energy generated by the medium.
- the first and second measured signals are processed to generate a noise reference signal which does not contain the desired signal portions from either of the first or second measured signals.
- the remaining undesired signal portions from the first and second measured signals are combined to form a noise reference signal.
- This noise reference signal is correlated to the undesired signal portion of each of the first and second measured signals.
- the noise reference signal is then used to remove the undesired portion of each of the first and second measured signals via an adaptive noise canceler.
- An adaptive noise canceler can be described by analogy to a dynamic multiple notch filter which dynamically changes its transfer function in response to the noise reference signal and the measured signals to remove frequencies from the measured signals that are also present in the noise reference signal.
- a typical adaptive noise canceler receives the signal from which it is desired to remove noise and a noise reference signal.
- the output of the adaptive noise canceler is a good approximation to the desired signal with the noise removed.
- Physiological monitors can often advantageously employ signal processors of the present invention.
- a first signal comprising a first desired portion and a first undesired portion and a second signal comprising a second desired portion and a second undesired portion are acquired.
- the signals may be acquired by propagating energy through a patient's body (or a material which is derived from the body, such as breath, blood, or tissue, for example) and measuring an attenuated signal after transmission or reflection.
- the signal may be acquired by measuring energy generated by a patient's body, such as in electrocardiography.
- the signals are processed via the signal processor of the present invention to acquire a noise reference signal which is input to an adaptive noise canceler.
- One physiological monitoring apparatus which can advantageously incorporate the features of the present invention is a monitoring system which determines a signal which is representative of the arterial pulse, called a plethysmographic wave.
- This signal can be used in blood pressure calculations, blood gas saturation measurements, etc.
- a specific example of such a use is in pulse oximetry which determines the saturation of oxygen in the blood.
- the desired portion of the signal is the arterial blood contribution to attenuation of energy as it passes through a portion of the body where blood flows close to the skin.
- the pumping of the heart causes blood flow to increase and decrease in the arteries in a periodic fashion, causing periodic attenuation wherein the periodic waveform is the plethysmographic waveform representative of the pulse.
- a physiological monitor particularly adapted to pulse oximetry oxygen saturation measurement comprises two light emitting diodes (LED's) which emit light at different wavelengths to produce first and second signals.
- a detector registers the attenuation of the two different energy signals after each passes through an absorptive media, for example a digit such as a finger, or an earlobe.
- the attenuated signals generally comprise both desired and undesired signal portions.
- a static filtering system such as a band pass filter, removes a portion of the undesired signal which is static, or constant, or outside of a known bandwidth of interest, leaving an erratic or random undesired signal portion, often caused by motion and often difficult to remove, along with the desired signal portion.
- a processor of the present invention removes the desired signal portions from the measured signals yielding a noise reference signal which is a combination of the remaining undesired signal portions.
- the noise reference signal is correlated to both of the undesired signal portions.
- the noise reference signal and at least one of the measured signals are input to an adaptive noise canceler which removes the random or erratic portion of the undesired signal. This yields a good approximation to the desired plethysmographic signal as measured at one of the measured signal wavelengths.
- quantitative measurements of the amount of oxygenated blood in the body can be determined from the plethysmographic signal in a variety of ways.
- One aspect of the present invention is a signal processor comprising a detector for receiving a first signal which travels along a first propagation path and a second signal which travels along a second propagation path wherein a portion of the first and second propagation paths are located in a propagation medium.
- the first signal has a first desired signal portion and a first undesired signal portion and the second signal has a second desired signal portion and a second undesired signal portion.
- the first and second undesired signal portions are a result of a perturbation of the propagation medium.
- This aspect of the invention additionally comprises a reference processor having an input for receiving the first and second signals.
- the processor is adapted to combine the first and second signals to generate a reference signal having a primary component which is a function of the first and said second undesired signal portions.
- the above described aspect of the present invention may further comprise an adaptive signal processor for receiving the reference signal and the first signal and for deriving therefrom an output signal having a primary component which is a function of the first desired signal portion of the first signal.
- the above described aspect of the present invention my further comprise an adaptive signal processor for receiving the reference signal and the second signal and for deriving therefrom an output signal having a primary component which is a function of the second desired signal portion of the second signal.
- the adaptive signal processor may comprise an adaptive noise canceler.
- the adaptive noise canceler may be comprise a joint process estimator having a least-squares-lattice predictor and a regression filter.
- the detector in the aspect of the signal processor of the present invention described above may further comprise a sensor for sensing a physiological function.
- the sensor may comprises a light sensitive device.
- the present invention may further comprising a pulse oximeter for measuring oxygen saturation in a living organism.
- Another aspect of the present invention is a physiological monitoring apparatus comprising a detector for receiving a first physiological measurement signal which travels along a first propagation path and a second physiological measurement signal which travels along a second propagation path. A portion of the first and second propagation paths is located in a propagation medium.
- the first signal has a first desired signal portion and a first undesired signal portion and the second signal has a second desired signal portion and a second undesired signal portion.
- the physiological monitoring apparatus further comprises a reference processor having an input for receiving the first and second signals.
- the processor is adapted to combine the first and second signals to generate a reference signal having a primary component which is a function of the first and the second undesired signal portions.
- the physiological monitoring apparatus may further comprise an adaptive signal processor for receiving the reference signal and the first signal and for deriving therefrom an output signal having a primary component which is a function of the first desired signal portion of the first signal.
- the physiological monitoring apparatus may further comprise an adaptive signal processor for receiving the reference signal and the second signal and for deriving therefrom an output signal having a primary component which is a function of the second desired signal portion of the second signal.
- the physiological monitoring apparatus may further comprise a pulse oximeter.
- a further aspect of the present invention is an apparatus for measuring a blood constituent comprising an energy source for directing a plurality of predetermined wavelengths of electromagnetic energy upon a specimen and a detector for receiving the plurality of predetermined wavelengths of electromagnetic energy from the specimen.
- the detector produces electrical signals corresponding to the predetermined wavelengths in response to the electromagnetic energy. At least two of the electrical signals each has a desired signal portion and an undesired signal portion.
- the apparatus comprises a reference processor having an input for receiving the electrical signals.
- the processor is configured to combine said electrical signals to generate a reference signal having a primary component which is derived from the undesired signal portions.
- This aspect of the present invention may further comprise an adaptive signal processor for receiving the reference signal and one of the two electrical signals and for deriving therefrom an output signal having a primary component which is a function of the desired signal portion of the electrical signal.
- an adaptive noise canceler in the adaptive signal processor which may employ a joint process estimator having a least squares-lattice predictor and a regression filter.
- Yet another aspect of the present invention is a blood gas monitor for non-invasively measuring a blood constituent in a body
- a light source for directing at least two predetermined wavelengths of light upon a body and a detector for receiving the light from the body.
- the detector in response to the light from the body, produces at least two electrical signals corresponding to the at least two predetermined wavelengths of light.
- the at least two electrical signals each has a desired signal portion and an undesired signal portion.
- the blood oximeter further comprises a reference processor having an input for receiving the at least two electrical signals.
- the processor is adapted to combine the at least two electrical signals to generate a reference signal with a primary component which is derived from the undesired signal portions.
- the blood oximeter may further comprise an adaptive signal processor for receiving the reference signal and the two electrical signals and for deriving therefrom at least two output signals which are substantially equal, respectively, to the desired signal portions of the electrical signals.
- the present invention also includes a method of determining a noise reference signal from a first signal comprising a first desired signal portion and a first noise portion and a second signal comprising a second desired signal portion and a second noise portion.
- the method comprises the steps of selecting a signal coefficient which is proportional to a ratio of predetermined attributes of the first desired signal portion and predetermined attributes of the second desired signal portion.
- the first signal and the second signal coefficient are input into a signal multiplier wherein the first signal is multiplied by the signal coefficient thereby generating a first intermediate signal.
- the second signal and the first intermediate signal are input into a signal subtractor wherein the first intermediate signal is subtracted from the second signal.
- This generates a noise reference signal having a primary component which is derived from the first and second noise signal portions.
- the first and second signals in this method may be derived from light energy transmitted through an absorbing medium.
- the present invention further embodies a physiological monitoring apparatus comprising means for acquiring a first signal comprising a first desired signal portion and a first undesired signal portion and a second signal comprising a second desired signal portion and a second undesired signal portion.
- the physiological monitoring apparatus of the present invention also comprises means for determining from the first and second signals a noise reference signal.
- the monitoring apparatus comprises an adaptive noise canceler having a noise reference input for receiving the noise reference signal and a signal input for receiving the first signal wherein the adaptive noise canceler, in real or near real time, generates an output signal which approximates the first desired signal portion.
- the adaptive noise canceler may further comprise a joint process estimator.
- a further aspect of the present invention is an apparatus for processing an amplitude modulated signal having a signal amplitude complicating feature, the apparatus comprising an energy source for directing electromagnetic energy upon a specimen. Additionally, the apparatus comprises a detector for acquiring a first amplitude modulated signal and a second amplitude modulated signal. Each of the first and second signals has a component containing information about the attenuation of electromagnetic energy by the specimen and a signal amplitude complicating feature.
- the apparatus includes a reference processor for receiving the first and second amplitude modulated signals and deriving therefrom a noise reference signal which is correlated with the signal amplitude complicating feature.
- the apparatus incorporates an adaptive noise canceler having a signal input for receiving the first amplitude modulated signal, a noise reference input for receiving the noise reference signal, wherein the adaptive noise canceler produces an output signal having a primary component which is derived from the component containing information about the attenuation of electromagnetic energy by the specimen.
- Still another aspect of the present invention is an apparatus for extracting a plethysmographic waveform from an amplitude modulated signal having a signal amplitude complicating feature, the apparatus comprising a light source for transmitting light into an organism and a detector for monitoring light from the organism.
- the detector produces a first light attenuation signal and a second light attenuation signal, wherein each of the first and second light attenuation signals has a component which is representative of a plethysmographic waveform and a component which is representative of the signal amplitude complicating feature.
- the apparatus also includes a reference processor for receiving the first and second light attenuation signals and deriving therefrom a noise reference signal.
- the noise reference signal and the signal amplitude complicating feature each has a frequency spectrum.
- the frequency spectrum of the noise reference signal is correlated with the frequency spectrum of the signal amplitude complicating feature.
- an adaptive noise canceler having a signal input for receiving the first attenuation signal and a noise reference input for receiving the noise reference signal.
- the adaptive noise canceler produces an output signal having a primary component which is derived from the component which is representative of a plethysmographic waveform.
- the present invention also comprises a method of removing a motion artifact signal from a signal derived from a physiological measurement wherein a first signal having a physiological measurement component and a motion artifact component and a second signal having a physiological measurement component and a motion artifact component are acquired. From the first and second signals a motion artifact noise reference signal which is a primary function of the first and second signals motion artifact components is derived.
- This method of removing a motion artifact signal from a signal derived from a physiological measurement may also comprise the step of inputting the motion artifact noise reference signal into an adaptive noise canceler to produce an output signal which is a primary function of the first signal physiological measurement component.
- FIG. 1 illustrates an ideal plethysmographic waveform.
- FIG. 2 schematically illustrates the cross-sectional structure of a typical finger.
- FIG. 3 illustrates a plethysmographic waveform which includes a motion-induced undesired erratic signal portion.
- FIG. 4 illustrates a schematic diagram of a physiological monitor incorporating a processor of the present invention and an adaptive noise canceler.
- FIG. 4 a illustrates the transfer function of a multiple notch filter.
- FIG. 5 illustrates an example of an adaptive noise canceler which could be employed in a physiological monitor which also incorporates the processor of the present invention.
- FIG. 6 a illustrates a schematic absorbing material comprising N constituents within an absorbing material.
- FIG. 6 b illustrates another schematic absorbing material comprising N constituents within an absorbing material.
- FIG. 7 is a schematic model of a joint process estimator comprising a least-squares lattice predictor and a regression filter.
- FIG. 8 is a flowchart representing a subroutine capable of implementing a joint process estimator as modeled in FIG. 7.
- FIG. 9 is a schematic model of a joint process estimator with a least-squares lattice predictor and two regression filters.
- FIG. 10 is an example of a physiological monitor incorporating a processor of the present invention and an adaptive noise canceler within a microprocessor. This physiological monitor is specifically designed to measure a plethysmographic waveform and perform pulse oximetry measurements.
- FIG. 11 is a graph of oxygenated and deoxygenated absorption coefficients vs. wavelength.
- FIG. 12 is a graph of the ratio of the absorption coefficients of deoxygenated hemoglobin divided by oxygenated hemoglobin vs. wavelength.
- FIG. 13 is an expanded view of a portion of FIG. 11 marked by a circle labelled 13 .
- the measured signal comprises a desired portion Y ⁇ a (t) and an undesired portion n ⁇ a (t).
- the measured signal comprises a desired portion Y ⁇ b (t) and an undesired portion n ⁇ b (t).
- the measured signal comprises a desired portion Y ⁇ c (t) and an undesired portion n ⁇ c (t).
- FIG. 17 illustrates the noise reference signal n′(t) determined by a processor of the present invention using the ratiometric method.
- the measured signal comprises a desired portion Y ⁇ a (t) and an undesired portion n ⁇ a (t).
- the measured signal comprises a desired portion Y′ b (t) and an undesired portion n ⁇ b (t).
- FIG. 22 illustrates the noise reference signal n′(t) determined by a processor of the present invention using the constant saturation method.
- the present invention is a processor which determines a noise reference signal n′(t) for use in an adaptive noise canceler.
- the undesired portion n(t) may contain one or more of a constant portion, a predictable portion, an erratic portion, a random portion, etc. The approximation to the desired signal.
- Y′(t) is derived by removing as many of the undesired portions n(t) from the composite signal S(t) as possible.
- the constant portion and predictable portion are easily removed with traditional filtering techniques, such as simple subtraction, low pass, band pass, and high pass filtering.
- the erratic portion is more difficult to remove due to its unpredictable nature. If something is known about the erratic signal, even statistically, it could be removed from the measured signal via traditional filtering techniques. However, it is often the case that no information is known about the erratic portion of the noise. In this case, traditional filtering techniques are usually insufficient. Often no information about the erratic portion of the measured signal is known.
- an adaptive noise canceler is utilized in the present invention to remove the erratic portion.
- an adaptive noise canceler has two signal inputs and one output.
- One of the inputs is the noise reference signal n′(t) which is correlated to the erratic undesired signal portions n(t) present in the composite signal S(t).
- the other input is for the composite signal S(t).
- the output of the adaptive noise canceler Y′(t) corresponds to the desired signal portion Y(t) only.
- the most difficult task in the application of adaptive noise cancelers is determining the noise reference signal n′(t) which is correlated to the erratic undesired portion n(t) of the measured signal S(t) since, as discussed above, unpredictable signal portions are usually quite difficult to isolate from the measured signal S(t).
- a noise reference signal n′(t) is determined from two composite signals measured simultaneously, or nearly simultaneously, at two different wavelengths, ⁇ a and ⁇ b.
- the signal processor of the present invention can be advantageously used in a monitoring device, such a monitor being well suited for physiological monitoring.
- FIG. 4 A block diagram of a generic monitor incorporating a signal processor, or reference processor, according to the present invention and an adaptive noise canceler is shown in FIG. 4.
- Two measured signals, S ⁇ a (t) and S ⁇ b (t) are acquired by a detector 20 .
- Each signal is conditioned by a signal conditioner 22 a and 22 b . Conditioning includes, but is not limited to, such procedures as filtering the signals to remove constant portions and amplifying the signals for ease of manipulation.
- the signals are then converted to digital data by an analog-to-digital converter 24 a and 24 b .
- the first measured signal S ⁇ a (t) comprises a first desired signal portion, labelled herein Y ⁇ a (t), and a first undesired signal portion, labelled herein n ⁇ a (t).
- the second measured signal S ⁇ b (t) is at least partially correlated to the first measured signal S ⁇ a (t) and comprises a second desired signal portion, labelled herein Y ⁇ b (t), and a second undesired signal portion, labelled herein n ⁇ b (t).
- the first and second undesired signal portions, n ⁇ a (t) and n ⁇ b (t) are uncorrelated and/or erratic with respect to the desired signal portions Y ⁇ a (t) and Y ⁇ b (t).
- the undesired signal portions n ⁇ a (t) and n ⁇ b (t) are often caused by motion of a patient.
- the signals S ⁇ a (t) and S ⁇ b (t) are input to a reference processor 26 .
- the reference processor 26 multiplies the second measured signal S ⁇ b (t) by a factor ⁇ and then subtracts the second measured signal S ⁇ b (t) from the first measured signal S ⁇ a (t).
- the factor ⁇ is determined to cause the desired signal portions Y ⁇ a (t) and Y ⁇ b (t) to cancel when the two signals S ⁇ a (t) and S ⁇ b (t) are subtracted.
- the noise reference signal n′(t) is input, along with one of the measured signals S ⁇ a (t), to an adaptive noise canceler 27 which uses the noise reference signal n′(t) to remove the undesired signal portion n ⁇ a (t) or n ⁇ b (t) from the measured signal S ⁇ a (t).
- S ⁇ b (t) could have been input to the adaptive noise canceler 27 along with the noise reference signal n′(t) instead of S ⁇ a (t).
- the output of the adaptive noise canceler 27 is a good approximation Y′ ⁇ a (t) to the desired signal Y ⁇ a (t).
- the approximation Y ⁇ b (t) is displayed on the display 28 .
- An adaptive noise canceler 30 is employed to remove the erratic, undesired signal portions n ⁇ a (t) and n ⁇ b (t) from the measured signals S ⁇ a (t) and S ⁇ b (t).
- the adaptive noise canceler 30 in FIG. 5 has as one input a sample of the noise reference signal n′(t) which is correlated to the undesired signal portions n ⁇ a (t) and n ⁇ b (t).
- the noise reference signal n′(t) is determined from the two measured signals S ⁇ a (t) and S ⁇ b (t) by the processor 26 of the present invention as described herein.
- the adaptive noise canceler 30 functions to remove frequencies common to both the noise reference signal n′(t) and the measured signal S ⁇ a (t) or S ⁇ b (t). Since the noise reference signal n′(t) is correlated to the erratic undesired signal portions n ⁇ a (t) and n ⁇ b (t), the noise reference signal n′(t) is also erratic.
- the adaptive noise canceler acts in a manner which may be analogized to a dynamic multiple notch filter based on the spectral distribution of the noise reference signal n′(t).
- the transfer function of a multiple notch filter is shown.
- the notches, or dips in the amplitude of the transfer function, indicate frequencies which are attenuated or removed when a composite measured signal passes through the notch filter.
- the output of the notch filter is the composite signal having frequencies at which a notch was present removed.
- the frequencies at which notches are present change continuously based upon the inputs to the adaptive noise canceler.
- the adaptive noise canceler 30 shown in FIG. 5 produces an output signal, labelled herein Y′ ⁇ a (t) or Y′ ⁇ b (t), which is fed back to an internal processor 32 within the adaptive noise canceler 30 .
- the internal processor 32 automatically adjusts its own transfer function according to a predetermined algorithm such that the output of the internal processor 32 , labelled b(t), closely resembles the undesired signal portion n ⁇ a (t) or n ⁇ b (t).
- the output b(t) of the internal processor 32 is subtracted from the measured signal, S ⁇ a (t) or S ⁇ b (t), yielding a signal Y′ ⁇ a (t) ⁇ S ⁇ a (t)+n ⁇ a (t) ⁇ b ⁇ a (t) or Y′ ⁇ b (t) ⁇ S ⁇ b (t)+n ⁇ b (t) ⁇ b ⁇ b (t).
- the internal processor optimizes Y ⁇ a (t) or Y ⁇ b (t) such that Y′ ⁇ a (t) or Y′ ⁇ b (t) is approximately equal to the desired signal Y ⁇ a (t) or Y ⁇ b (t), respectively.
- One algorithm which may be used for the adjustment of the transfer function of the internal processor 32 is a least-squares algorithm, as described in Chapter 6 and Chapter 12 of the book Adaptive Signal Processing by Bernard Widrow and Samuel Stearns, published by Prentice Hall, copyright 1985. This entire book, including Chapters 6 and 12, is hereby incorporated herein by reference.
- Adaptive processors 30 have been successfully applied to a number of problems including antenna sidelobe canceling, pattern recognition, the elimination of periodic interference in general, and the elimination of echoes on long distance telephone transmission lines.
- considerable ingenuity is often required to find a suitable noise reference signal n′(t) for a given application since the random or erratic portions n ⁇ a (t) or n ⁇ b (t) cannot easily be separated from the measured signal S ⁇ a (t) or S ⁇ b (t). If the actual undesired signal portion n ⁇ a (t) or n ⁇ b (t) were a priori available, techniques such as adaptive noise canceling would not be necessary.
- the unique determination of a suitable noise reference signal n′(t) from measurements taken by a monitor incorporating a reference processor of the present invention is one aspect of the present invention.
- a first signal is measured at, for example, a wavelength ⁇ a, by a detector yielding a signal S ⁇ a (t):
- the measured signals S ⁇ a (t) and S ⁇ b (t) are transformed to eliminate the desired signal components.
- One way of doing this is to find a proportionality constant, ⁇ 1 , between the desired signals Y ⁇ a (t) and Y ⁇ b (t) such that:
- a non-zero signal which is correlated to each undesired signal portion n ⁇ a ( t ) and n ⁇ b (t) and can be used as the noise reference signal n′(t) in an adaptive noise canceler.
- Adaptive noise canceling is particularly useful in a large number of measurements generally described as absorption measurements.
- An example of an absorption type monitor which can advantageously employ adaptive noise canceling based upon a noise reference signal n′(t) determined by a processor of the present invention is one which determines the concentration of an energy absorbing constituent within an absorbing material when the material is subject to perturbation. Such perturbations can be caused by forces about which information is desired, or alternatively, by random or erratic forces such as a mechanical force on the material. Random or erratic interference, such as motion, generates undesired noise components in the measured signal. These undesired components can be removed by the adaptive noise canceler if a suitable noise reference signal n′(t) is known.
- a schematic N constituent absorbing material comprising a container 42 having N different absorbing constituents, labelled A 1 , A 2 , A 3 , . . . A N , is shown schematically in FIG. 6 a .
- the constituents A 1 through A N in FIG. 6 a are arranged in a generally orderly, layered fashion within the container 42 .
- An example of a particular type of absorptive system is one in which light energy passes through the container 42 and is absorbed according to the generalized Beer-Lambert Law of light absorption. For light of wavelength ⁇ a, this attenuation may be approximated by:
- I 0 is the incident light energy intensity
- I is the transmitted light energy intensity
- ⁇ i, ⁇ a is the absorption coefficient of the i th constituent at the wavelength ⁇ a
- x 1 (t) is the optical path length of i th layer, i.e., the thickness of material of the i th layer through which optical energy passes
- c i (t) is the concentration of the i th constituent in the volume associated with the thickness x i (t).
- the absorption coefficients ⁇ 1 through ⁇ N are known values which are constant at each wavelength. Most concentrations c 1 (t) through c N (t) are typically unknown, as are most of the optical path lengths x i (t) of each layer.
- the total optical path length is the sum of each of the individual optical path lengths x i (t) of each layer.
- the optical path length of each layer, x i (t) is generally constant. This results in generally constant attenuation of the optical energy and thus, a generally constant offset in the measured signal. Typically, this portion of the signal is of little interest since knowledge about a force which perturbs the material is usually desired. Any signal portion outside of a known bandwidth of interest, including the constant undesired signal portion resulting from the generally constant absorption of the constituents when not subject to perturbation, should be removed. This is easily accomplished by traditional band pass filtering techniques. However, when the material is subject to forces, each layer of constituents may be affected by the perturbation differently than each other layer.
- Some perturbations of the optical path lengths of each layer x i (t) may result in excursions in the measured signal which represent desired information.
- Other perturbations of the optical path length of each layer x i (t) cause undesired excursions which mask desired information in the measured signal.
- Undesired signal components associated with undesired excursions must also be removed to obtain desired information from the measured signal.
- the adaptive noise canceler removes from the composite signal, measured after being transmitted through or reflected from the absorbing material, the undesired signal components caused by forces which perturb the material differently from the forces which perturbed the material to cause the desired signal component.
- the portion of the measured signal which is deemed the desired signal Y ⁇ a (t) is the attenuation term ⁇ 5 c 5 x 5 (t) associated with a constituent of interest, namely A 5 , and that the layer of constituent A 5 is affected by perturbations differently than each of the layers of other constituents A 1 through A 4 and A 6 through A N .
- the undesired signal component n ⁇ a (t) can be removed via an adaptive noise canceler having as one input a noise reference signal n′(t) determined by a processor of the present invention as long as the perturbation on layers other than the layer of constituent A 5 is different than the perturbation on the layer of constituent A 5 .
- the adaptive noise canceler yields a good approximation to the desired signal Y′ ⁇ a (t). From this approximation, the concentration of the constituent of interest, C 5 (t), can often be determined since in some physiological measurements, the thickness of the desired signal component, x 5 (t) in this example, is known or can be determined.
- the adaptive noise canceler utilizes a sample of a noise reference signal n′(t) determined from two substantially simultaneously measured signals S ⁇ a (t) and S ⁇ b (t).
- S ⁇ a (t) is determined as above in equation (7).
- S ⁇ b (t) is determined similarly at a different wavelength ⁇ b.
- To find the noise reference signal n′(t), attenuated transmitted energy is measured at the two different wavelengths ⁇ a and ⁇ b and transformed via logarithmic conversion.
- a sample of this noise reference signal n′(t); and a sample of either measured signal S ⁇ a (t) or S ⁇ b (t), are input to an adaptive noise canceler, one model of which is shown in FIG. 5 and a preferred model of which is discussed herein under the heading PREFERRED ADAPTIVE NOISE CANCELER USING A JOINT PROCESS ESTIMATOR IMPLEMENTATION.
- the adaptive noise canceler removes the undesired portion of the measured signal n ⁇ a (t) or n ⁇ b (t), yielding a good approximation to the desired portion of signal Y′ ⁇ a (t) ⁇ 5, ⁇ a c 5 x 5 (t) or Y′ ⁇ a (t) ⁇ 5, ⁇ b c 5 x 5 (t)
- the concentration C 5 (t) may then be determined from the approximation to the desired signal Y′ ⁇ a (t) or Y′ ⁇ b (t) according to:
- the absorption coefficients are constant at each wavelength ⁇ a and ⁇ b and the thickness of the desired signal component, x 5 (t) in this example, is often known or can be determined as a function of time, thereby allowing calculation of the concentration c 5 (t) of constituent A 5 .
- FIG. 6 b another material having N different constituents arranged in layers is shown.
- a combination of layers such as the combination of layers of constituents A 5 and A 6 , is feasible when the two layers are under the same total forces which result in the same perturbation of the optical path lengths x 5 (t) and x 6 (t) of the layers.
- concentration or the saturation i.e., a percent concentration
- a determination of the concentration or the saturation of a constituent within a given volume may be made with any number of constituents in the volume subject to the same total forces and therefore under the same perturbation.
- To determine the saturation of one constituent in a volume comprising many constituents as many measured signals as there are constituents which absorb incident light energy are necessary. It will be understood that constituents which do not absorb light energy are not consequential in the determination of saturation.
- concentration as many signals as there are constituents which absorb incident light energy are necessary as well as information about the sum of concentrations.
- a thickness under unique motion contains only two constituents.
- the desired signals Y ⁇ a (t) and Y ⁇ b (t) comprise terms related to both A 5 and A 6 so that a determination of the concentration or saturation of A 5 or A 6 in the volume may be made.
- any signal portions outside of a known bandwidth of interest including the constant undesired signal portion resulting from the generally constant absorption of the constituents when not under perturbation, should be removed to determine an approximation to the desired signal. This is easily accomplished by traditional band pass filtering techniques. As in the previous example, it is often the case that the total perturbation affecting the layers associated with the undesired signal components is caused by random or erratic forces, causing the thickness of each layer, or the optical path length of each layer, x i (t), to change erratically, producing a random or erratic undesired signal component n ⁇ a (t).
- the undesired signal component n ⁇ a (t) can be removed via an adaptive noise canceler having as one input a noise reference signal n′(t) determined by a processor of the present invention as long as the perturbation in layers other than the layer of constituents A 5 and A 6 is different than the perturbation in the layer of constituents A 5 and A 6 .
- the erratic undesired signal components n ⁇ a (t) and n ⁇ b (t) may advantageously be removed from equations (18) and (20), or alternatively equations (19) and (21), by an adaptive noise canceler.
- the adaptive noise canceler again, requires a sample of a noise reference signal n′(t).
- Two methods which may be used by a processor of the present invention to determine the noise reference signal n′(t) are a ratiometric method and a constant saturation method.
- the preferred embodiment of a physiological monitor incorporating a processor of the present invention utilizes the ratiometric method wherein the two wavelengths ⁇ a and ⁇ b, at which the signals S ⁇ a (t) and S ⁇ b (t) are measured, are specifically chosen such that a relationship between the absorption coefficients ⁇ 5, ⁇ a , ⁇ 5, ⁇ b , ⁇ 6, ⁇ a and ⁇ 6, ⁇ b exists, i.e.:
- An alternative method for determining the noise reference signal from the measured signals S ⁇ a (t) and S ⁇ b (t) using a processor of the present invention is the constant saturation approach.
- Saturation ⁇ ⁇ ( A 5 ⁇ ( t ) ) c 5 ⁇ ( t ) / [ c 5 ⁇ ( t ) + c 6 ⁇ ( t ) ] ( 28 )
- ⁇ ⁇ 1 + [ c 6 ⁇ ( t ) / c 5 ⁇ ( t ) ] ⁇ - 1 ( 29 )
- the approximations to the desired signals Y′ ⁇ a (t) and Y′ ⁇ b (t) found by the adaptive noise canceler for a substantially immediately preceding set of samples of the measured signals S ⁇ a (t) and S ⁇ b (t) are used in a processor of the present: invention for calculating the proportionality constant, ⁇ 3 (t), for the next set of samples of the measured signals S ⁇ a (t) and S ⁇ b (t).
- n ′( t ) S ⁇ a ( t ) ⁇ 3 ( t )
- S ⁇ b ( t ) n ⁇ a ( t ) ⁇
- equation (21) could be multiplied by ⁇ 3 (t) and the resulting equation could be subtracted from equation (19) to yield the same noise reference signal n′(t) as given in equation (37).
- an adaptive noise canceler may be utilized with a noise reference signal n′(t) determined by the constant saturation method.
- the adaptive noise canceler can be implemented in either hardware or software.
- the least mean squares(LMS) implementation of the internal processor 32 described above in conjunction with the adaptive noise canceler of FIG. 5 is relatively easy to implement, but lacks the speed of adaptation desirable for most physiological monitoring applications of the present invention.
- a faster approach for adaptive noise canceling called a least-squares lattice joint process estimator model, is preferably used.
- a joint process estimator 60 is shown diagrammatically in FIG. 7 and is described in detail in Chapter 9 of Adaptive Filter Theory by Simon Haykin, published by Prentice-Hall, copyright 1986. This entire book, including Chapter 9, is hereby incorporated herein by reference.
- the function of the joint process estimator is to remove the undesired signal portions n ⁇ a (t) or n ⁇ b (t) from the measured signals, S ⁇ a (t) or S ⁇ b (t), yielding a signal Y′ ⁇ a (t) or Y ⁇ b (t) which is a good approximation to the desired signal Y ⁇ a (t) or Y ⁇ b (t).
- the joint process estimator estimates the value of, the desired signal Y ⁇ a (t) or Y ⁇ b (t).
- the inputs to the joint process estimator 60 are the noise reference signal n′(t) and the composite measured signal S ⁇ a (t) or S ⁇ b (t).
- the output is a good approximation to the signal S ⁇ a (t) or S ⁇ b (t) with the noise removed, i.e. a good approximation to Y ⁇ a (t) or Y ⁇ b (t).
- the joint process estimator 60 utilizes, in conjunction, a least square lattice predictor 70 and a regression filter 80 .
- the noise reference signal n′(t) is input to the least square lattice predictor 70 while the measured signal S ⁇ a (t) or S ⁇ b (t) is input to the regression filter 80 .
- S ⁇ a (t) will be the measured signal from which the desired portion Y ⁇ a (t) will be estimated by the joint process estimator 60 .
- S ⁇ b (t) could equally well be input to the regression filter 80 and the desired portion Y ⁇ b (t) of this signal could equally well be estimated.
- the joint process estimator 60 removes all frequencies that are present in both the noise reference signal n′(t) and the measured signal S ⁇ a (t).
- the undesired signal portion n ⁇ a (t) usually comprises frequencies unrelated to those of the desired signal portion Y ⁇ a (t). It is highly improbable that the undesired signal portion n ⁇ a (t) would be of exactly the same spectral content as the desired signal portion Y ⁇ a (t) However, in the unlikely event that the spectral content of S ⁇ a (t) and n′(t) are similar, this approach will not yield accurate results.
- the joint process estimator 60 compares input signal n′(t), which is correlated to the undesired signal portion n ⁇ a (t), and input signal S ⁇ a (t) and removes all frequencies which are identical.
- the joint process estimator 60 acts as a dynamic multiple notch filter to remove those frequencies in the undesired signal component n ⁇ a (t) as they change erratically with the motion of the patient. This yields a signal having substantially the same spectral content as the desired signal Y ⁇ a (t).
- the output of the joint process estimator 60 has substantially the same spectral content and amplitude as the desired signal Y ⁇ a (t).
- the output Y′ ⁇ a (t) of the joint process estimator 60 is a very good approximation to the desired signal Y ⁇ a (t).
- the joint process estimator 60 can be divided into stages, beginning with a zero-stage and terminating in an m th -stage, as shown in FIG. 7. Each stage, except for the zero-stage, is identical to every other stage.
- the zero-stage is an input stage for the joint process estimator 60 .
- the first stage through the m th -stage work on the signal produced in the immediately previous stage, i.e., the (m ⁇ 1) th -stage, such that a good approximation to the desired signal Y′ ⁇ a (t) is produced as output from th m th -stage.
- the least-squares lattice predictor 70 comprises registers 90 and 92 , summing elements 100 and 102 , and delay elements 110 .
- the registers 90 and 92 contain multiplicative values of a forward reflection coefficient ⁇ r,m (t) and a backward reflection coefficient ⁇ b,m (t) which multiply the noise reference signal n′(t) and signals derived from the noise reference signal n′(t).
- Each stage of the least-squares lattice predictor outputs a forward prediction error f m (t) and a backward prediction error b m (t).
- the subscript m is indicative of the stage.
- the sample of the noise reference signal n′(t) is input to the least-squares lattice predictor 70 .
- the zero-stage forward prediction error f 0 (t) and the zero-stage backward prediction error b 0 (t) are set equal to the noise reference signal n′(t).
- the backward prediction error b 0 (t) is delayed by one sample period by the delay element 110 in the first stage of the least-squares lattice predictor 70 .
- the immediately previous value of the noise reference signal n′(t) is used in calculations involving the first-stage delay element 110 .
- the zero-stage forward prediction error is added to the negative of the delayed zero-stage backward prediction error b 0 (t ⁇ 1) multiplied by the forward reflection coefficient value ⁇ f,1 (t) register 90 value, to produce a first-stage forward prediction error f 1 (t).
- the zero-stage forward prediction error f 0 (t) is multiplied by the backward reflection coefficient value ⁇ b,1 (t) register 92 value and added to the delayed zero-stage backward prediction error b 0 (t ⁇ 1) to produce a first-stage backward prediction error b 1 (t).
- each-subsequent stage, m, of the least square lattice predictor 70 the previous forward and backward prediction error values, f m ⁇ 1 (t) and b m ⁇ 1 (t ⁇ 1), the backward prediction error being delayed by one sample period, are used to produce values of the forward and backward prediction errors for the present stage, f m (t) and b m (t).
- the backward prediction error b m (t) is fed to the concurrent stage, m, of the regression filter 80 . There it is input to a register 96 , which contains a multiplicative regression coefficient value ⁇ m, ⁇ a (t).
- a register 96 which contains a multiplicative regression coefficient value ⁇ m, ⁇ a (t).
- the zero-stage backward prediction error b 0 (t) is multiplied by the zero-stage regression coefficient ⁇ 0, ⁇ a (t) register 96 value and subtracted from the measured value of the signal S ⁇ a (t) at a summing element 106 to produce a first stage estimation error signal e 1, ⁇ a (t).
- the first-stage estimation error signal e 1, ⁇ a (t) is a first approximation to the desired signal.
- This first-stage estimation error signal e 1, ⁇ a (t) is input to the first-stage of the regression filter 80 .
- the first-stage backward prediction error b 1 (t), multiplied by the first-stage regression coefficient ⁇ 1, ⁇ a register 96 value is subtracted from the first-stage estimation error signal e 1, ⁇ a (t) to produce the second-stage estimation error e 2, ⁇ a (t).
- the second-stage estimation error signal e 2, ⁇ a (t) is a second, somewhat better approximation to the desired signal Y ⁇ a (t).
- a number of intermediate variables are required to calculate the forward reflection coefficient ⁇ f,m (t)., the backward reflection coefficient ⁇ b,m (t) and the regression coefficient ⁇ m, ⁇ a (t) register 90 , 92 , and 96 values.
- Intermediate variables include a weighted sum of the forward prediction error squares m (t), a weighted sum of the backward prediction error squares ⁇ m (t), a scaler parameter ⁇ m (t), a conversion factor ⁇ (t), and another scaler parameter ⁇ m, ⁇ a (t).
- ⁇ without a wavelength identifier, a or b is a constant multiplicative value unrelated to wavelength and is typically less than or equal to one, i.e., ⁇ 1.
- ⁇ without a wavelength identifier, a or b is a constant multiplicative value unrelated to wavelength and is typically less than or equal to one, i.e., ⁇ 1.
- the operation of the joint process estimator 60 is as follows.
- the initial values of intermediate variable and signal including the parameter ⁇ m ⁇ 1 (t), the weighted sum of the forward prediction error signals m ⁇ 1 (t), the weighted sum of the backward prediction error signals ⁇ m ⁇ 1 (t), the parameter ⁇ m, ⁇ a (t), and the zero-stage estimation error e 0, ⁇ a (t) are initialized, some to zero and some to a small positive number ⁇ :
- a simultaneous sample of the measured signal S ⁇ a (t) and the noise reference signal n′(t) are input to the joint process estimator 60 , as shown in FIG. 7.
- the forward and backward prediction error signals f 0 (t) and b 0 (t), and intermediate variables including the weighted sums of the forward and backward error signals 0 (t) and ⁇ 0 (t), and the conversion factor ⁇ 0 (t) are calculated for the zero-stage according to:
- ⁇ without a wavelength identifier, a or b is a constant multiplicative value unrelated to wavelength.
- Forward reflection coefficient ⁇ f,m (t), backward reflection coefficient ⁇ b,m (t), and regression coefficient ⁇ m, ⁇ a (t) register 90 , 92 and 96 values in each stage thereafter are set according to the output of the previous stage.
- the forward reflection coefficient ⁇ r,1 (t), backward reflection coefficient ⁇ b,1 (t), and regression coefficient ⁇ 1, ⁇ a (t) register 90 , 92 and 96 values in the first stage are thus set according to algorithm using values in the zero-stage of the joint process estimator 60 .
- intermediate values and register values including the parameter ⁇ m ⁇ 1 (t); the forward reflection coefficient ⁇ f,m (t) register 90 value; the backward reflection coefficient ⁇ b,m (t) register 92 value; the forward and backward error signals f m (t) and b m (t); the weighted sum of squared forward prediction errors f,m (t), as manipulated in ⁇ 9.3 of the Haykin book; the weighted sum of squared backward prediction errors ⁇ b,m (t), as manipulated in ⁇ 9.3 of the Haykin book; the conversion factor ⁇ m (t); the parameter ⁇ m, ⁇ a (t); the regression coefficient ⁇ m, ⁇ a (t) register 96 value; and the estimation error e m+1, ⁇ a (t) value are set according to:
- ⁇ m ⁇ 1 ( t ) ⁇ m ⁇ 1 ( t ⁇ 1)+ ⁇ b m ⁇ 1 ( t ⁇ 1) f* m ⁇ 1 ( t )/ ⁇ m ⁇ 1 ( t ⁇ 1) ⁇ (48)
- ⁇ b,m ( t ) ⁇ * m ⁇ 1 (t)/ m ⁇ 1 ( t ) ⁇ (50)
- m ( t ) m ⁇ 1 ( t ) ⁇
- ⁇ m ( t ) ⁇ m ⁇ 1 ( t ⁇ 1) ⁇
- ⁇ m ( t ⁇ 1) ⁇ m ⁇ 1 ) ⁇
- ⁇ m, ⁇ a ( t ) ⁇ m, ⁇ a ( t ⁇ 1)+ ⁇ b m ( t ) e* m, ⁇ a ( t )/ ⁇ m ( t ) ⁇ (56)
- ⁇ m, ⁇ a ( t ) ⁇ m, ⁇ a ( t )/ ⁇ m ( t ) ⁇ (57)
- a next set of samples including a sample of the measured signal S ⁇ a (t) and a sample of the noise reference signal n′(t), are input to the joint process estimator 60 .
- the re-initialization process does not re-occur, such that the forward and backward reflection coefficient r f,m (t) and ⁇ b,m (t) register 90 , 92 values and the regression coefficient ⁇ m, ⁇ a (t) register 96 value reflect the multiplicative values required to estimate the desired portion Y ⁇ a (t) of the sample of S ⁇ a (t) input previously.
- information from previous samples is used to estimate the desired signal portion of a present set of samples in each stage.
- a joint process estimator 60 type adaptive noise canceler is generally implemented via a software program having an iterative loop.
- One iteration of the loop is analogous to a single stage of the joint process estimator as shown in FIG. 7.
- a loop is iterated m times, it is equivalent to an m stage joint process estimator 60 .
- a flow chart of a subroutine to estimate the desired signal portion Y ⁇ a (t) of a sample of a measured signal, S ⁇ a (t) is shown in FIG. 8.
- the flow chart describes how the action of a reference processor for determining the noise reference signal and the joint process estimator 60 would be implemented in software.
- a one-time only initialization is performed when the physiological monitor is turned on, as indicated by an “INITIALIZE NOISE CANCELER” box 120 .
- the initialization sets all registers 90 , 92 , and 96 and delay element variables 110 to the values described above in equations (40) through (44).
- a set of simultaneous samples of the measured signals S ⁇ a (t) and S ⁇ b (t) is input to the subroutine represented by the flowchart in FIG. 8. Then a time update of each of the delay element program variables occurs, as indicated in a “TIME UPDATE OF [Z ⁇ 1 ] ELEMENTS” box 130 , wherein the value stored in each of the delay element variables 110 is set to the value at the input of the delay element variable 110 .
- the zero-stage backward prediction error b 0 (t) is stored in the first-stage delay element variable
- the first-stage backward prediction error b 1 (t) is stored in the second-stage delay element variable, and so on.
- the noise reference signal is calculated according to the ratiometric or the constant saturation method described above. This is indicated by a “CALCULATE NOISE REFERENCE (n′(t)) FOR TWO MEASURED SIGNAL SAMPLES” box 140 .
- the ratiometric method is generally preferred since no assumptions about constant saturation values need be made.
- a zero-stage order update is performed next as indicated in a “ZERO-STAGE UPDATE” box 150 .
- the zero-stage backward prediction error b 0 (t), and the zero-stage forward prediction error f 0 (t) are set equal to the value of the noise reference signal n′(t).
- the weighted sum of the forward prediction errors m (t) and the weighted sum of backward prediction errors ⁇ m (t) are set equal to the value defined in equation (46).
- a maximum value of m defining the total number of stages to be used by the subroutine corresponding to the flowchart in FIG. 8, is also defined.
- the loop is constructed such that it stops iterating once a criterion for convergence upon a best approximation to the desired signal has been met by the joint process estimator 60 .
- the forward and backward reflection coefficient ⁇ f,m (t) and ⁇ b,m (t) register 90 and 92 values in the least-squares lattice filter are calculated first, as indicated by the “ORDER UPDATE NTH CELL OF LSL-LATTICE” box 170 in FIG. 8. This requires calculation of intermediate variable and signal values used in determining register 90 , 92 , and 96 values in the present stage, the next stage, and in the regression filter 80
- regression filter register 96 value ⁇ m, ⁇ a (t) is performed next, indicated by the “ORDER UPDATE MTH STAGE OF REGRESSION FILTER(S)” box 180 .
- convergence is determined by checking if the weighted sums of the forward and backward prediction errors m (t) and ⁇ m (t) are less than a small positive number.
- An output is calculated next, as indicated by a “CALCULATE OUTPUT” box 200 .
- the output is a good approximation to the desired signal, as determined by the reference processor and joint process estimator 60 subroutine corresponding to the flow chart of FIG. 8. This is displayed (or used in a calculation in another subroutine), as indicated by a “TO DISPLAY” box 210 .
- a new set of samples of the two measured signals S ⁇ a (t) and S ⁇ b (t) is input to the processor and joint process estimator 60 adaptive noise canceler subroutine corresponding to the flowchart of FIG. 8 and the process reiterates for these samples. Note, however, that the initialization process does not re-occur. New sets of measured signal samples S ⁇ a (t) and S ⁇ b (t) are continuously input to the reference processor and joint process estimator 60 adaptive noise canceler subroutine. The output forms a chain of samples which is representative of a continuous wave. This waveform is a good approximation to the desired signal waveform Y′ ⁇ a (t) at wavelength ⁇ a.
- Physiological monitors typically use the approximation of the desired signal Y′ ⁇ a (t) to calculate another quantity, such as the saturation of one constituent in a volume containing that constituent plus one or more other constituents.
- this wavelength is ⁇ b, the wavelength used in the calculation of the noise reference signal n′(t).
- the constant saturation method of determining the noise reference signal requires a good approximation of the desired signal portions Y′ ⁇ a (t) and Y ⁇ b (t) of both measured signals S ⁇ a and S ⁇ b (t). Then, the saturation is determined from the approximations to both signals, i.e. Y′ ⁇ a (t) and Y′ ⁇ b (t).
- the wavelength ⁇ c is chosen such that the desired portion Y ⁇ c (t) of the measured signal S ⁇ c (t) is not linearly dependent with the desired portions Y ⁇ a (t) and Y ⁇ b (t) of the measured signals S ⁇ a (t) and S ⁇ b (t).
- the noise reference signal n′(t) is correlated to the undesired signal portions n ⁇ a , n ⁇ b , and n ⁇ c of each of the measured signals S ⁇ a (t), S ⁇ b (t) 1 and S ⁇ c (t) and can be used to estimate approximations to the desired signal portions Y ⁇ a (t), Y ⁇ b (t), and Y ⁇ c (t) for all three measured signals S ⁇ a (t), S ⁇ b (t); and S ⁇ c (t) Using the ratiometric method, estimation of the desired signal portions Y ⁇ a (t) and Y ⁇ c (t) of two measured signals S ⁇ a (t) and S ⁇ c (t), chosen correctly, is usually satisfactory to determine most physiological data.
- a joint process estimator 60 having two regression filters 80 a and 80 b is shown in FIG. 9.
- a first regression filter 80 a accepts a measured signal S ⁇ a (t).
- a second regression filter 80 b accepts a measured signal S ⁇ b (t) or S ⁇ c (t), depending whether the constant saturation method or the ratiometric method is used to determine the noise reference signal n′(t).
- the first and second regression filters 80 a and 80 b are independent.
- the backward prediction error b m (t) is input to each regression filter 80 a and 80 b , the input for the second regression filter 80 b bypassing the first regression filter 80 a.
- the second regression filter 80 b comprises registers 98 , and summing elements 108 arranged similarly to those in the first regression filter 80 a .
- the second regression filter 80 b operates via an additional intermediate variable in conjunction with those defined by equations (48) through (58), i.e.:
- ⁇ m, ⁇ b ( t ) ⁇ m, ⁇ b ( t ⁇ 1)+ ⁇ b m ( t ) e* m, ⁇ b ( t )/ ⁇ m ( t ) ⁇ ; or (59)
- ⁇ m, ⁇ c ( t ) ⁇ m, ⁇ c ( t ⁇ 1)+ ⁇ b m ( t ) e* m, ⁇ c ( t )/ ⁇ m, ( t ) ⁇ ; and (60)
- the second regression filter 80 b has an error signal value defined similar to the first regression filter error signal values, e m+1, ⁇ s (t), i.e.:
- the second regression filter has a regression coefficient ⁇ m, ⁇ b (t) register 98 value defined similarly to the first regression filter error signal values, i.e.:
- S ⁇ c (t) is input to the second regression filter 80 b .
- the output of the, second regression filter 80 b is then a good approximation to the desired signal Y′ ⁇ c (t).
- S ⁇ b (t) is input to the second regression filter 80 b .
- the output is then a good approximation to the desired signal Y′ ⁇ b (t).
- the addition of the second regression filter 80 b does not substantially change the computer program subroutine represented by the flowchart of FIG. 8. Instead of an order update of the m th stage of only one regression filter, an order update of the m th stage of both regression filters 80 a and 80 b is performed. This is characterized by the plural designation in the “ORDER UPDATE OF m th STAGE OF REGRESSION FILTER(S)” box 180 in FIG. 8. Since the regression filters 80 a and 80 b operate independently, independent calculations can be performed in the reference processor and joint process estimator 60 adaptive noise canceler subroutine modeled by the flowchart of FIG. 8.
- Y′ ⁇ a (t) and Y′ ⁇ c (t) for the ratiometric method and Y′ ⁇ a (t) and Y′ ⁇ b (t) for the constant saturation method have been determined by the joint process estimator 60 , the saturation of A 5 in a volume containing A 5 and A 6 , for example, may be calculated according to various known methods.
- the approximations to the desired signals can be written:
- the saturation can be determined by acquiring approximations to the desired signal portions at two different, yet proximate times t 1 and t 2 over which the saturation of A 5 in the volume containing A 5 and A 6 does not change substantially. For example, for the desired signals estimated by the ratiometric method, at times t 1 and t 2 :
- difference signals may be determined which relate the signals of equation (73) through (76), i.e.:
- ⁇ Y ⁇ a Y′ ⁇ a ( t 1 ) ⁇ Y′ ⁇ a ( t 2 ) ⁇ 5, ⁇ a c 5 ⁇ x+ ⁇ 6, ⁇ a c 6 ⁇ x ; and (77)
- ⁇ Y ⁇ c Y′ ⁇ c ( t 1 ) ⁇ Y′ ⁇ c ( t 2 ) ⁇ 5, ⁇ c c 5 ⁇ x+ ⁇ 6, ⁇ c c 6 ⁇ x; (78)
- a specific example of a physiological monitor utilizing a processor of the present invention to determine a noise reference signal n′(t) for input to an adaptive noise canceler that removes erratic motion-induced undesired signal portions is a pulse oximeter.
- a pulse oximeter typically causes energy to propagate through a medium where blood flows close to the surface for example, an ear lobe, or a digit such as a finger, or a forehead.
- An attenuated signal is measured after propagation through or reflection from the medium.
- the pulse oximeter estimates the saturation of oxygenated blood available to the body for use.
- Freshly oxygenated blood is pumped at high pressure from the heart into the arteries for use by the body.
- the volume of blood in the arteries varies with the heartbeat, giving rise to a variation in absorption of energy at the rate of the heartbeat, or the pulse.
- Oxygen depleted, or deoxygenated, blood is returned to the heart by the veins along with unused oxygenated blood.
- the volume of blood in the veins varies with the rate of breathing, which is typically much slower than the heartbeat.
- venous blood causes a low frequency variation in absorption of energy.
- the low frequency variation in absorption is coupled with the erratic variation in absorption due to motion artifact.
- two light emitting diodes are positioned on one side of a portion of the body where blood flows close to the surface, such as a finger, and a photodetector is positioned on the opposite side of the finger.
- a visible wavelength preferably red
- the other LED emits an infrared wavelength.
- other wavelength combinations could be used.
- the finger comprises skin, tissue, muscle, both arterial blood and venous blood, fat, etc., each of which absorbs light energy differently due to different absorption coefficients, different concentrations, and different thicknesses.
- absorption is substantially constant except for the flow of blood. This constant attenuation can be determined and subtracted from the signal via traditional filtering techniques.
- the absorption becomes erratic. Erratic motion induced noise typically cannot be predetermined and subtracted from the measured signal via traditional filtering techniques. Thus, determining the saturation of oxygenated arterial blood becomes more difficult.
- FIG. 10 A schematic of a physiological monitor for pulse oximetry is shown in FIG. 10.
- Two LED's 300 and 302 one LED 300 emitting red wavelengths and another LED 302 emitting infrared wavelengths, are placed adjacent a finger 310 .
- a photodetector 320 which produces an electrical signal corresponding to the attenuated visible and infrared light energy signals is located opposite the LED's 300 and 302 .
- the photodetector 320 is connected to a single channel of common processing circuitry including an amplifier 330 which is in turn connected to a band pass filter 340 .
- the band pass filter 340 passes signal into a synchronized demodulator 350 which has a plurality of output channels.
- One output channel is for signals corresponding to visible wavelengths and another output channel is for signals corresponding to infrared wavelengths.
- the output channels of the synchronized demodulator for signals corresponding to both the visible and infrared wavelengths are each connected to separate paths, each path comprising further processing circuitry.
- Each path includes a DC offset removal element 360 and 362 , such as a differential amplifier, a programmable gain amplifier 370 and 372 and a low pass filter 380 and 382 .
- the output of each low pass filter 380 and 382 is amplified in a second programmable gain amplifier 390 and 392 and then input to a multiplexer 400 .
- the multiplexer 400 is connected to an analog-to-digital converter 410 which is in turn connected to a microprocessor 420 .
- Control lines between the microprocessor 420 and the multiplexer 400 , the microprocessor 420 and the analog-to-digital converter 410 , and the microprocessor 420 and each programmable gain amplifier 370 , 372 , 390 , and 392 are formed.
- the microprocessor 420 has additional control lines, one of which leads to a display 430 and the other of which leads to an LED driver 440 situated in a feedback loop with the two LED's 300 and 302 .
- the LED's 300 and 302 each emits energy which is absorbed by the finger 310 and received by the photodetector 320 .
- the photodetector 320 produces an electrical signal which corresponds to the intensity of the light energy striking the photodetector 320 surface.
- the amplifier 330 amplifies this electrical signal for ease of processing.
- the band pass filter 340 then removes unwanted high and low frequencies.
- the synchronized demodulator 350 separates the electrical signal into electrical signals corresponding to the red and infrared light energy components.
- a predetermined reference voltage, V ref is subtracted by the DC offset removal element 360 and 362 from each of the separate signals to remove substantially constant absorption which corresponds to absorption when there is no motion induced undesired signal component.
- the low pass filters 380 and 382 integrate each signal to remove unwanted high frequency components and the second programmable gain amplifiers 390 and 392 amplify each signal for further ease of processing.
- the multiplexer 400 acts as an analog switch between the electrical signals corresponding to the red and the infrared light energy, allowing first a signal corresponding to the red light to enter the analog-to-digital convertor 410 and then a signal corresponding to the infrared light to enter the analog-to-digital convertor 410 .
- the analog-to-digital convertor 410 inputs the data into the microprocessor 420 for calculation of a noise reference signal via the processing technique of the present invention and removal of undesired signal portions via an adaptive noise canceler.
- the microprocessor 420 centrally controls the multiplexer 400 , the analog-to-digital convertor 410 , and the first and second programmable gain amplifiers 370 and 390 for both the red and the infrared channels. Additionally, the microprocessor 420 controls the intensity of the LED's 302 and 304 through the LED driver 440 in a servo loop to keep the average intensity received at the photodetector 320 within an appropriate range.
- a noise reference signal n′(t) is calculated via either the constant saturation method or the ratiometric method, as described above, the ratiometric method being generally preferred. This signal is used in an adaptive noise canceler of the joint process estimator type 60 , described above.
- the multiplexer 400 time multiplexes, or sequentially switches between, the electrical signals corresponding to the red and the infrared light energy. This allows a single channel to be used to detect and begin processing the electrical signals. For example, the red LED 300 is energized first and the attenuated signal is measured at the photodetector 320 . An electrical signal corresponding to the intensity of the attenuated red light energy is passed to the common processing circuitry. The infrared LED 302 is energized next and the attenuated signal is measured at the photodetector 320 . An electrical signal corresponding to the intensity of the attenuated infrared light energy is passed to the common processing circuitry. Then, the red LED 30 . 0 is energized again and the corresponding electrical signal is passed to the common processing circuitry. The sequential energization of LED's 300 and 302 occurs continuously while the pulse oximeter is operating.
- the processing circuitry is divided into distinct paths after the synchronized demodulator 350 to ease time constraints generated by time multiplexing.
- a sample rate, or LED energization rate of 1000 Hz is advantageously employed.
- electrical signals reach the synchronized demodulator 350 at a rate of 1000 Hz.
- Time multiplexing is not used in place of the separate paths due to settling time constraints of the low pass filters 380 , 382 , and 384 .
- a third LED 304 is shown adjacent the finger, located near the LED's 300 and 302 .
- the third LED 304 is used to measure a third signal S ⁇ c (t) to be used to determine saturation using the ratiometric method.
- the third LED 304 is time multiplexed with the red and infrared LED's 300 and 302 .
- a third signal is input to the common processing circuitry in sequence with the signals from the red and infrared LED's 300 and 302 .
- the third electrical signal corresponding to light energy at wavelength ⁇ c is input to a separate path including a DC offset removal element 364 , a first programmable gain amplifier 374 , a low pass filter 384 , and a second programmable gain amplifier 394 .
- the third signal is then input to the multiplexer 400 .
- the dashed line connection for the third, LED 304 indicates that this third LED 304 is incorporated into the pulse oximeter when the ratiometric method is used; it is unnecessary for the constant saturation method.
- the multiplexer 400 acts as an analog switch between all three LED 300 , 302 , and 304 signals. If the third LED 304 is utilized, feedback loops between the microprocessor 420 and the first and second programmable gain amplifier 374 and 394 in the ⁇ c wavelength path are also formed.
- the signals (logarithm converted) transmitted through the finger 310 at each wavelength ⁇ a, ⁇ b, and ⁇ c are:
- x A (t) is the lump-sum thickness of the arterial blood in the finger
- x V (t) is the lump-sum thickness of venous blood in the finger
- ⁇ HbO2, ⁇ a ⁇ HbO2, ⁇ b , ⁇ HbO2, ⁇ c , ⁇ Hb, ⁇ a , ⁇ Hb, ⁇ b , and ⁇ Hb, ⁇ c are the absorption coefficients of the oxygenated and non-oxygenated hemoglobin, at each wavelength measured
- c HbO2 (t) and c Hb (t) with the superscript designations A and V are the concentrations of the oxygenated and non-oxygenated arterial blood and venous blood, respectively.
- the wavelengths chosen are typically two in the visible red range, i.e., ⁇ a and ⁇ b, and one in the infrared range, i.e., ⁇ c.
- the measurement wavelengths ⁇ a and ⁇ b are advantageously chosen to satisfy a proportionality relationship which removes the desired signal portion Y ⁇ a (t): and Y ⁇ b (t), yielding a noise reference signal n′(t).
- the ratiometric method is used to determine the noise reference signal n′(t) by picking two wavelengths that cause the desired portions Y ⁇ a (t) and Y′ ⁇ b (t) of the measured signals S ⁇ a (t) and S ⁇ b (t) to become linearly dependent similarly to equation (22); i.e. wavelengths ⁇ a and ⁇ b which satisfy:
- ⁇ r4 ⁇ Hb, ⁇ a / ⁇ Hb, ⁇ b ;
- FIG. 11 is a graph of the absorption coefficients of oxygenated and deoxygenated hemoglobin ( ⁇ HbO2 and ⁇ Hb ) vs. wavelength ( ⁇ ).
- FIG. 12 is a graph of the ratio of absorption coefficients vs. wavelength, i.e., ⁇ Hb / ⁇ HbO2 VS. ⁇ over the range of wavelength within circle 13 in FIG. 11. Anywhere a horizontal line touches the curve of FIG. 12 twice, a does line 400, the condition of equation ( 84 ) is satisfied.
- FIG. 13 shows an exploded view of the area of FIG. 11 within the circle 13 . Values of ⁇ HbO2 and ⁇ Hb at the wavelengths where a horizontal line touches the curve of FIG. 12 twice can then be determined from the data in FIG. 13 to solve for the proportionality relationship of equation (85).
- a special case of the ratiometric method is when the absorption coefficients ⁇ HbO2 and ⁇ Hb are equal at a wavelength.
- Arrow 410 in FIG. 11 indicates one such location, called an isobestic point.
- FIG. 13 shows an exploded view of the isobestic point.
- isobestic points two wavelengths at isobestic points are determined to satisfy equation (84).
- n ′( t ) S ⁇ a ( t ) ⁇ r4
- S ⁇ b ( t ) n ⁇ a ( t ) ⁇ r4 n ⁇ b .
- This noise reference signal n′(t) has spectral content corresponding to the erratic, motion-induced noise.
- the adaptive noise canceler will function much like an adaptive multiple notch filter and remove frequency components present in both the noise reference signal n′(t) and the measured signals from the measured signals S ⁇ a (t) and S ⁇ c (t) or S ⁇ b (t) and S ⁇ c (t).
- the adaptive noise canceler is able to remove erratic noise caused in the venous portion of the measured signals S ⁇ a (t), S ⁇ b (t), and S ⁇ c (t) even though the venous portion of the measured signals S ⁇ a (t) and S ⁇ b (t) was not incorporated in the noise reference signal n′(t).
- the low frequency absorption caused by venous blood moving through the veins is generally not one of the frequencies incorporated into the noise reference signal n′(t).
- the adaptive noise canceler generally will not remove this portion of the undesired signal.
- a band pass filter applied to the approximations to the desired signals Y′ ⁇ a (t) and Y′ ⁇ c (t) or Y′ ⁇ b (t) and Y′ ⁇ c (t) can remove this portion of the undesired signal corresponding to the low frequency venous absorption.
- the wavelengths chosen are typically one in the visible red range, i.e., ⁇ a, and one in the infrared range, i.e., ⁇ b.
- ⁇ s4 ⁇ ( t ) ⁇ Hb02 , ⁇ ⁇ ⁇ a ⁇ c Hb02 ⁇ x ⁇ ( t ) + ⁇ Hb , ⁇ ⁇ ⁇ a ⁇ c Hb ⁇ x ⁇ ( t ) ⁇ Hb02 , ⁇ ⁇ ⁇ b ⁇ c Hb02 ⁇ x ⁇ ( t ) + ⁇ Hb , ⁇ ⁇ ⁇ b ⁇ c Hb ⁇ x ⁇ ( t ) ( 90 ) ⁇ ⁇ Y ⁇ ⁇ ⁇ a ′ ⁇ ( t ) / Y ⁇ ⁇ ⁇ b ′ ⁇ ( t ) ; where ( 91 ) n ⁇ a (t) ⁇ s4 ( t ) n ⁇ b ( t ). (92)
- a noise reference signal n′(t) is determined by the processor of the present invention for use in an adaptive noise canceler which is defined by software in the microprocessor.
- the preferred adaptive noise canceler is the joint process estimator 60 described above.
- a first segment 14 a , 15 a , and 16 a of each of the signals is relatively undisturbed by motion artifact, i.e., the patient did not move substantially during the time period in which these segments were measured.
- segments 14 a , 15 a , and 16 a are thus generally representative of the desired plethysmographic waveform at each of the measured wavelengths.
- a second segment 14 b , 15 b , and 16 b of each of the signals is affected by motion artifact, i.e., the patient did move during the time period in which these segments were measured.
- Each of these segments 14 b , 15 b , and 16 b shows large motion induced excursions in the measured signal.
- a third segment 14 c , 15 c , and 16 c of each of the signals is again relatively unaffected by motion artifact and is thus generally representative of the desired plethysmographic waveform at each of the measured wavelengths.
- the noise reference signal n′(t) is correlated to the undesired signal portions n ⁇ a , n ⁇ b , and n ⁇ c .
- a first segment 17 a of the noise reference signal n′(t) is generally flat, corresponding to the fact that there is very little motion induced noise in the first segments 14 a , 15 a , and 16 a of each signal.
- a second segment 17 b of the noise reference signal n′(t) exhibits large excursions, corresponding to the large motion induced excursions in each of the measured signals.
- a third segment 17 c of the noise reference signal n′(t) is generally flat, again corresponding to the lack of motion artifact in the third segments 14 a , 14 b , and 14 c of each measured signal.
- FIGS. 18 and 19 show the approximations Y′ ⁇ a (t) and Y′ ⁇ c (t) to the desired signals Y ⁇ a (t) and Y ⁇ c (t) as estimated by the joint process estimator 60 using a noise reference signal n′(t) determined by the ratiometric method. Note that the scale of FIGS. 14 through 19 is not the same for each figure to better illustrate changes in each signal. FIGS. 18 and 19 illustrate the effect of the joint process estimator adaptive noise canceler using the noise reference signal n′(t) as determined by the reference processor of the present invention using the ratiometric method.
- Segments 18 b and 19 b are not dominated by motion induced noise as were segments 14 b , 15 b ; and 16 b of the measured signals. Additionally, segments 18 a , 19 a , 18 c , and 19 c have not been substantially changed from the measured signal segments 14 a , 15 a , 16 a , 14 c , 15 c , and 16 c where there was no motion induced noise.
- a first segment 20 a and 21 a of each of the signals is relatively undisturbed by motion artifact, i.e., the patient did not move substantially during the time period in which these segments were measured.
- These segments 20 a and 21 a are thus generally representative of the desired plethysmographic waveform at each of the measured wavelengths.
- a second segment 20 b and 21 b of each of the signals is affected by motion artifact, i.e., the patient did move during the time period in which these segments were measured. Each of these segments 20 b and 21 b shows large motion induced excursions in the measured signal.
- a third segment 20 c and 21 c of each of the signals is again relatively unaffected by motion artifact and is thus generally representative of the desired plethysmographic waveform at each of the measured wavelengths.
- the noise reference signal n′(t) is correlated to the undesired signal portions n ⁇ a and n ⁇ b .
- a first segment 22 a of the noise reference signal n′(t) is generally flat, corresponding to the fact that there is very little motion induced noise in the first segments 20 a and 21 a of each signal.
- a second segment 22 b of the noise reference signal n′(t) exhibits large excursions, corresponding to the large motion induced excursions in each of the measured signals.
- a third segment 22 c of the noise reference signal n′(t) is generally flat, again corresponding to the lack of motion artifact in the third segments 20 b and 21 c of each measured signal.
- FIGS. 23 and 24 show the approximations Y′ ⁇ a (t) and Y′ ⁇ b (t) to the desired signals Y a (t) and Y ⁇ b (t) as estimated by the joint process estimator 60 using a noise reference signal n′(t) determined by the constant saturation method. Note that the scale of FIGS. 20 through 24 is not the same for each figure to better illustrate changes in each signal. FIGS. 23 and 24 illustrate the effect of the joint process estimator adaptive noise canceler using the noise reference signal n′(t) as determined by a reference processor of the present invention utilizing the constant saturation method. Segments 23 b and 24 b are not dominated by motion induced noise as were segments 20 b and 21 b of the measured signals. Additionally, segments 23 a , 24 a , 23 c , and 24 c have not been substantially changed from the measured signal segments 20 a , 21 a , 20 c , and 21 c where there was nomotion induced noise.
- This subroutine is one way to implement the steps illustrated in the flowchart of FIG. 8 for a monitor particularly adapted for pulse oximetry.
- the program estimates the desired signal portions of two light energy signals, one preferably corresponding to lighted in the visible red range and the other preferably corresponding to light in the infrared range such that a determination of the amount of oxygen availiable to the body, or the saturation of oxygen in the arterial blood, may be made.
- the calculation of the saturation is performed in a separate subroutine.
- Various methods for calculation of the oxygen saturation are known to those skilled in the art. One such calculation is described in the articles by G. A. Mook, et al, and Michael R. Neuman cited above.
- the value of the saturation is determined similarly to equations (73) through (80) wherein measurements at times t 1 and t 2 are made at different, yet proximate times over which the saturation is relatively constant.
- the wavelengths of light at which S ⁇ a (t) and S ⁇ b (t) are measured are chosen to satisfy the relationship of equation (84).
- the noise reference signal n′(t) is determined, the desired signal portions Y ⁇ a (t) and Y ⁇ c (t) of the measured signals S ⁇ a (t) and S ⁇ c (t) are estimated for use in calculation of the oxygen saturation.
- a first portion of the program performs the initialization of the registers 90 , 92 , 96 , and 98 and intermediate variable values as in the “INITIALIZE NOISE CANCELER” box 120 and equations (40) through (44) and equations (61), (62), (65), and (66).
- a second portion of the program performs the time updates of the delay element variables 110 where the value at the input of each delay element variable 110 is stored in the delay element variable 110 as in the “TIME>UPDATE OF [Z ⁇ 1 ]ELEMENTS” box 130 .
- a third portion of the program calculates the noise reference signal, as in the “CALCULATE NOISE REFERENCE (n′(t)) FOR TWO MEASURED SIGNAL SAMPLES” box 140 using the proportionality constant ⁇ r4 determined by the ratiometric method as in equation (85).
- a fourth portion of the program performs the zero-stage update as in the “ZERO-STAGE UPDATE” box 150 where the zero-stage forward prediction error f o (t) and the zero-stage backward prediction error b o (t) are set equal to the value of the noise reference signal n′(t) just calculated. Additionally, zero-stage values of intermediate variables 0 (t) and ⁇ 0 (t) (nc[ ].Fswsqr and nc[ ].Bswsgr in the program) are calculated for use in setting register 90 , 92 , 96 , and 98 values in the least-squares lattice predictor 70 and the regression filters 80 a and 80 b.
- NC_CELLS is a predetermined maximum value of iterations for the loop.
- the test for conversion is whether or not the sum of the weighted sum of forward prediction errors plus the weighted sum of backward prediction errors is less than a small number, typically 0.00001 (i.e, m (t)+ ⁇ m (t) ⁇ 0.00001).
- a sixth portion of the program calculates the forward and backward reflection coefficient ⁇ m,f (t) and ⁇ m,b (t) register 90 and 92 values (nc[ ].fref and nc[ ].bref in the program) as in the “ORDER UPDATE m th -STAGE OF LSL-PREDICTOR” box 170 and equations (49) and (50). Then forward and backward prediction errors f m (t) and b m (t) (nc[ ].ferr and nc[ ].berr in the program) are calculated as in equations (51) and (52).
- intermediate variables m (t), ⁇ m (t) and ⁇ m (t) are calculated, as in equations (53), (54), and (55).
- the first cycle of the loop uses the values for nc[0].Fswsgr and n[0].Bswsqr calculated in the ZERO-STAGE UPDATE portion of the program.
- a seventh portion of the program calculates the regression coefficient ⁇ m, ⁇ a (t) and ⁇ m, ⁇ c (t) register 96 and 98 values (nc[ ].K_a and nc[ ].K_c in the program) in both regression filters, as in the “ORDER UPDATE m th STAGE OF REGRESSION FILTER(S)” box 180 and equations (57) through (68).
- an eighth portion of the program calculates the output of the joint process estimator 60 adaptive noise canceler as in the “CALCULATE OUTPUT” box 200 .
- This output is a good approximation to both of the desired signals Y′ ⁇ a (t) and Y′ ⁇ c (t) for the set of samples S ⁇ a (t), S ⁇ a (t) and S ⁇ c (t) input to the program.
- a compilation of the outputs provides output waves which are good approximations to the plethysmographic wave at each wavelength, ⁇ a and ⁇ c.
- the two signals are measured at two different wavelengths ⁇ a and ⁇ b, where ⁇ a is typically in the visible region and ⁇ b is typically in the infrared region.
- ⁇ a is typically in the visible region
- ⁇ b is typically in the infrared region.
- First and second portions of the subroutine are the same as the first and second portions of the above described subroutine tailored for the ratiometric method of determining the noise reference signal n′(t).
- a third portion of the subroutine calculates the noise reference signal, as in the “CALCULATE NOISE REFERENCE (n′(t)) FOR TWO MEASURED SIGNAL SAMPLES” box 140 for the signals S ⁇ a (t) and S ⁇ b (t) using the a proportionality constant ⁇ s4 (t) determined by the constant saturation method as in equations (90) and (91).
- the saturation is calculated in a separate subroutine and a value of w s4 (t) is imported to the present subroutine for estimating the desired portions Y ⁇ a (t) and Y ⁇ b (t) of the composite measured signals S ⁇ a (t) and S ⁇ b (t).
- Fourth, fifth, and sixth portions of the subroutine are similar to the fourth, fifth, and sixth portions of the above described program tailored for the ratiometric method.
- the signals being used to estimate the desired signal portions Y′ ⁇ a (t) and Y ⁇ b (t) in the present subroutine tailored for the constant saturation method are S ⁇ a (t) and, S ⁇ b (t), the same signals that were used to calculate the noise reference signal n′(t).
- a seventh portion of the program calculates the regression coefficient register 96 and 98 values ⁇ m, ⁇ a (t) and ⁇ m, ⁇ b (t) (nc[.].K_a and nc[ ].K_b in the program) in both regression filters, as in the “ORDER UPDATE m th STAGE OF REGRESSION FILTER(S)” box 180 and equations (57) through (67).
- the loop iterates until the test for convergence is passed, the test being the same as described above for the subroutine tailored for the ratiometric method.
- the output of the present subroutine is a good approximation to the desired signals Y′ ⁇ a (t) and Y′ ⁇ b (t) for the set of samples S ⁇ a (t) and S ⁇ b (t) input to the program.
- a compilation of the outputs provides waves which are good approximations to the plethysmographic wave at each wavelength, ⁇ a and ⁇ b.
- the estimating process of the iterative loop is the same in either subroutine, only the sample values S ⁇ a (t) and S ⁇ c (t) or S ⁇ a (t) and S ⁇ b (t) input to the subroutine for use in estimation of the desired signal portions Y ⁇ a (t) and Y ⁇ c (t) or Y′ ⁇ a (t) and Y ⁇ b (t) and how the noise reference signal n′(t) is calculated are different for the ratiometric method and the constant saturation methods.
- the concentration of oxygenated arterial blood can be found from the approximations to the desired signal values since the desired signals are made up of terms comprising x(t), the thickness of arterial blood in the finger; absorption coefficients of oxygenated and de-oxygenated hemoglobin, at each measured wavelength; and C HbO2 (t) and C Hb (t), the concentrations of oxygenated and de-oxygenated hemoglobin, respectively.
- the saturation is a ratio of the concentration of one constituent, A 5 , with respect to the total concentration of constituents in the volume containing A 5 and A 6 .
- the thickness, x(t) is divided out of the saturation calculation and need not be predetermined.
- the absorption coefficients are constant at each wavelength. The saturation of oxygenated arterial blood is then determined as in equations (95) and (96).
- any portion of a patient or a material derived from a patient may be used to take measurements for a physiological monitor incorporating a processor of the present invention and an adaptive noise canceler.
- Such areas include a digit such as a finger, but are not limited to a finger.
- physiological monitors may employ a signal processor of the present invention in conjunction with an adaptive noise canceler.
- Other types of physiological monitors include, but are in not limited to, electron cardiographs, blood pressure monitors, blood gas saturation (other than oxygen saturation) monitors, capnographs, heart rate monitors, respiration monitors, or depth of anesthesia monitors.
- monitors which measure the pressure and quantity of a substance within the body such as a breathalizer, a drug monitor, a cholesterol monitor, a glucose monitor, a carbon dioxide monitor, a glucose monitor, or a carbon monoxide monitor may also employ the above described techniques for removal of undesired signal portions.
- the present invention has been described in terms of a physiological monitor, one skilled in the art will realize that the signal processing techniques of the present invention can be applied in many areas, including but not limited to the processing of a physiological signal.
- the present invention may be applied in any situation where a signal processor comprising a detector receives a first signal which includes a first desired signal portion and a first undesired signal portion and a second signal which includes a second desired signal portion and a second undesired signal portion.
- the first and second signals propagate through a common medium and the first and second desired signal portions are correlated with one another.
- the processor receives the first and second signals and combines the first and second signals to generate a noise reference signal in which the primary component is derived from the first and second undesired signal portions.
- the signal processor of the present invention is readily applicable to numerous signal processing areas.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Signal Processing (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Artificial Intelligence (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Communication Control (AREA)
- Radar Systems Or Details Thereof (AREA)
- Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
- Indication And Recording Devices For Special Purposes And Tariff Metering Devices (AREA)
- Complex Calculations (AREA)
- Transforming Light Signals Into Electric Signals (AREA)
- Variable-Direction Aerials And Aerial Arrays (AREA)
- Noise Elimination (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
A signal processor which acquires a first signal, including a first desired signal portion and a first undesired signal portion, and a second signal, including a second desired signal portion and a second undesired signal portion, wherein the first and second desired signal portions are correlated. The signals may be acquired by propagating energy through a medium and measuring an attenuated signal after transmission or reflection. Alternatively, the signals may be acquired by measuring energy generated by the medium. A processor of the present invention generates a noise reference signal that is a combination of the undesired signal portions and is correlated to both the first and second undesired signal portions. The noise reference signal is then used to remove the undesired portion of each of the first and second measured signals. The processor of the present invention may be employed in physiological monitors wherein the known properties of energy attenuation through a medium are used to determine physiological characteristics of the medium. Many physiological conditions, such as the pulse of a patient or the concentration of a constituent in a medium, can be determined from the desired portion of the signal after undesired signal portions, such as those caused by erratic motion, are removed.
Description
- The present invention relates to the field of signal processing. More specifically, the present invention relates to the processing of measured signals to remove undesired portions when little is known about the undesired signal portion.
- Signal processors are typically employed to remove undesired portions from a composite measured signal including a desired signal portion and an undesired signal portion. If the undesired signal portion occupies a different frequency spectrum than the desired signal, then conventional filtering techniques such as low pass, band pass, and high pass filtering could be used to separate the desired portion from the total signal. Fixed single or multiple notch filters could also be employed if the undesired signal portions(s) exist at a fixed frequency(s).
- However, it is often the case that an overlap in frequency spectrum between the desired and undesired signal portions does exist and the statistical properties of both signal portions change with time. In such cases, conventional filtering techniques are totally ineffective in extracting the desired signal. If, however, a description of the undesired portion can be made available, adaptive noise canceling can be employed to remove the undesired portion of the signal leaving the desired portion available for measurement. Adaptive noise cancelers dynamically change their transfer function to adapt to and remove the undesired signal portions of a composite signal. Adaptive noise cancelers require a noise reference signal which is correlated to the undesired signal portion. The noise reference signal is not necessarily a representation of the undesired signal portion, but has a frequency spectrum which is similar to that of the undesired signal. In many cases, it requires considerable ingenuity to determine a noise reference signal since nothing is a priori known about the undesired signal portion.
- One area where composite measured signals comprise a desired signal portion and an undesired signal portion about which no information can easily be determined is physiological monitoring. Physiological monitoring apparatuses generally measure signals derived from a physiological system, such as the human body. Measurements which are typically taken with physiological monitoring systems include electron cardiographs, blood pressure, blood gas saturation (such as oxygen saturation), capnographs, heart rate, respiration rate, and depth of anesthesia, for example. Other types of measurements include those which measure the pressure and quantity of a substance within the body such as breathalizer testing, drug testing, cholesterol testing, glucose testing, arterial carbon dioxide testing, protein testing, and carbon monoxide testing, for example. The source of the undesired signal portion in these measurements is often due to motion of the patient, both external and internal (muscle movement, for example), during the measurement process.
- Knowledge of physiological systems, such as the amount of oxygen in a patient's blood, can be critical, for example during surgery. Data can be determined by a lengthy invasive procedure of extracting and testing matter, such as blood, from a patient, or by more expedient, non-invasive measures. Many types of non-invasive measurements can be made by using the known properties of energy attenuation as a selected form of energy passes through a medium.
- Energy is caused to be incident on a medium either derived from or contained within a patient and the amplitude of transmitted or reflected energy is then measured. The amount of attenuation of the incident energy caused by the medium is strongly dependent on the thickness and composition of the medium through which the energy must pass as well as the specific form of energy selected. Information about a physiological system can be derived from data taken from the attenuated signal of the incident energy transmitted through the medium if the noise can be removed. However, non-invasive measurements often do not afford the opportunity to selectively observe the interference causing the undesired signal portion, making it difficult to remove.
- These undesired signal portions often originate from both AC and DC sources. The first undesired portion is an easily removed DC component caused by transmission of the energy through differing media which are of relatively constant thickness within the body, such as bone, tissue, skin, blood, etc. Second, is an erratic AC component caused when differing media being measured are perturbed and thus, change in thickness while the measurement is being made. Since most materials in and derived from the body are easily compressed, the thickness of such matter changes if the patient moves during a non-invasive physiological measurement. Patient movement can cause the properties of energy attenuation to vary erratically. Traditional signal filtering techniques are frequently totally ineffective and grossly deficient in removing these motion induced effects from a signal. The erratic or unpredictable nature of motion induced undesired signal components is the major obstacle in removing them. Thus, presently available physiological monitors generally become totally inoperative during time periods when the patient moves.
- A blood gas monitor is one example of a physiological monitoring system which is based upon the measurement of energy attenuated by biological tissues or substances. Blood gas monitors transmit light into the tissue and measure the attenuation of the light as a function of time. The output signal of a blood gas monitor which is sensitive to the arterial blood flow contains a component which is a waveform representative of the patient's arterial pulse. This type of signal, which contains a component related to the patient's pulse, is called a plethysmographic wave, and is shown in FIG. 1 as curve Y. Plethysmographic waveforms are used in blood pressure or blood gas saturation measurements, for example. As the heart beats the amount of blood in the arteries increases and decreases, causing increases and decreases in energy attenuation, illustrated, by the cyclic wave Y in FIG. 1.
- Typically, a digit such as a finger, an ear lobe, or other portion of the body where blood flows close to the skin, is employed as the medium through which light energy is transmitted for blood gas attenuation measurements. The finger comprises skin, fat, bone, muscle, etc., shown schematically in FIG. 2, each of which attenuates energy incident on the finger in a generally predictable and constant manner. However, when fleshy portions of the finger are compressed erratically, for example by motion of the finger, energy attenuation becomes erratic.
- An example of a more realistic measured waveform S is shown in FIG. 3, illustrating the, effect of motion. The desired portion of the signal Y is the waveform representative of the pulse, corresponding to the sawtooth-like pattern wave in FIG. 1. The large, motion-induced excursions in signal amplitude hide the desired signal Y. It is easy to see how even small variations in amplitude make it difficult to distinguish the desired signal Y in the presence of a noise component n.
- A specific example of a blood gas monitoring apparatus is a pulse oximeter which measures the saturation of oxygen in the blood. The pumping of the heart forces freshly oxygenated blood into the arteries causing greater energy attenuation. The saturation of oxygenated blood may be determined from the depth of the valleys relative to the peaks of two plethysmographic waveforms measured at separate wavelengths. However, motion induced undesired signal portions, or motion artifacts, must be removed from the measured signal for the oximeter to continue the measurement during periods when the patient moves.
- The present invention is a signal processor which acquires a first signal and a second signal that is correlated to the first signal. The first signal comprises a first desired signal portion and a first undesired signal portion. The second signal comprises a second desired signal portion and a second undesired signal portion. The signals may be acquired by propagating energy through a medium and measuring an attenuated signal after transmission or reflection. Alternatively, the signal may be acquired by measuring energy generated by the medium.
- The first and second measured signals are processed to generate a noise reference signal which does not contain the desired signal portions from either of the first or second measured signals. The remaining undesired signal portions from the first and second measured signals are combined to form a noise reference signal. This noise reference signal is correlated to the undesired signal portion of each of the first and second measured signals.
- The noise reference signal is then used to remove the undesired portion of each of the first and second measured signals via an adaptive noise canceler. An adaptive noise canceler can be described by analogy to a dynamic multiple notch filter which dynamically changes its transfer function in response to the noise reference signal and the measured signals to remove frequencies from the measured signals that are also present in the noise reference signal. Thus, a typical adaptive noise canceler receives the signal from which it is desired to remove noise and a noise reference signal. The output of the adaptive noise canceler is a good approximation to the desired signal with the noise removed.
- Physiological monitors can often advantageously employ signal processors of the present invention. Often in physiological measurements a first signal comprising a first desired portion and a first undesired portion and a second signal comprising a second desired portion and a second undesired portion are acquired. The signals may be acquired by propagating energy through a patient's body (or a material which is derived from the body, such as breath, blood, or tissue, for example) and measuring an attenuated signal after transmission or reflection. Alternatively, the signal may be acquired by measuring energy generated by a patient's body, such as in electrocardiography. The signals are processed via the signal processor of the present invention to acquire a noise reference signal which is input to an adaptive noise canceler.
- One physiological monitoring apparatus which can advantageously incorporate the features of the present invention is a monitoring system which determines a signal which is representative of the arterial pulse, called a plethysmographic wave. This signal can be used in blood pressure calculations, blood gas saturation measurements, etc. A specific example of such a use is in pulse oximetry which determines the saturation of oxygen in the blood. In this configuration, the desired portion of the signal is the arterial blood contribution to attenuation of energy as it passes through a portion of the body where blood flows close to the skin. The pumping of the heart causes blood flow to increase and decrease in the arteries in a periodic fashion, causing periodic attenuation wherein the periodic waveform is the plethysmographic waveform representative of the pulse.
- A physiological monitor particularly adapted to pulse oximetry oxygen saturation measurement comprises two light emitting diodes (LED's) which emit light at different wavelengths to produce first and second signals. A detector registers the attenuation of the two different energy signals after each passes through an absorptive media, for example a digit such as a finger, or an earlobe. The attenuated signals generally comprise both desired and undesired signal portions. A static filtering system, such as a band pass filter, removes a portion of the undesired signal which is static, or constant, or outside of a known bandwidth of interest, leaving an erratic or random undesired signal portion, often caused by motion and often difficult to remove, along with the desired signal portion.
- Next, a processor of the present invention removes the desired signal portions from the measured signals yielding a noise reference signal which is a combination of the remaining undesired signal portions. The noise reference signal is correlated to both of the undesired signal portions. The noise reference signal and at least one of the measured signals are input to an adaptive noise canceler which removes the random or erratic portion of the undesired signal. This yields a good approximation to the desired plethysmographic signal as measured at one of the measured signal wavelengths. As is known in the art, quantitative measurements of the amount of oxygenated blood in the body can be determined from the plethysmographic signal in a variety of ways.
- One aspect of the present invention is a signal processor comprising a detector for receiving a first signal which travels along a first propagation path and a second signal which travels along a second propagation path wherein a portion of the first and second propagation paths are located in a propagation medium. The first signal has a first desired signal portion and a first undesired signal portion and the second signal has a second desired signal portion and a second undesired signal portion. The first and second undesired signal portions are a result of a perturbation of the propagation medium. This aspect of the invention additionally comprises a reference processor having an input for receiving the first and second signals. The processor is adapted to combine the first and second signals to generate a reference signal having a primary component which is a function of the first and said second undesired signal portions.
- The above described aspect of the present invention may further comprise an adaptive signal processor for receiving the reference signal and the first signal and for deriving therefrom an output signal having a primary component which is a function of the first desired signal portion of the first signal. Alternatively, the above described aspect of the present invention my further comprise an adaptive signal processor for receiving the reference signal and the second signal and for deriving therefrom an output signal having a primary component which is a function of the second desired signal portion of the second signal. The adaptive signal processor may comprise an adaptive noise canceler. The adaptive noise canceler may be comprise a joint process estimator having a least-squares-lattice predictor and a regression filter.
- The detector in the aspect of the signal processor of the present invention described above may further comprise a sensor for sensing a physiological function. The sensor may comprises a light sensitive device. Additionally, the present invention may further comprising a pulse oximeter for measuring oxygen saturation in a living organism.
- Another aspect of the present invention is a physiological monitoring apparatus comprising a detector for receiving a first physiological measurement signal which travels along a first propagation path and a second physiological measurement signal which travels along a second propagation path. A portion of the first and second propagation paths is located in a propagation medium. The first signal has a first desired signal portion and a first undesired signal portion and the second signal has a second desired signal portion and a second undesired signal portion. The physiological monitoring apparatus further comprises a reference processor having an input for receiving the first and second signals. The processor is adapted to combine the first and second signals to generate a reference signal having a primary component which is a function of the first and the second undesired signal portions.
- The physiological monitoring apparatus may further comprise an adaptive signal processor for receiving the reference signal and the first signal and for deriving therefrom an output signal having a primary component which is a function of the first desired signal portion of the first signal. Alternatively, the physiological monitoring apparatus may further comprise an adaptive signal processor for receiving the reference signal and the second signal and for deriving therefrom an output signal having a primary component which is a function of the second desired signal portion of the second signal. The physiological monitoring apparatus may further comprise a pulse oximeter.
- A further aspect of the present invention is an apparatus for measuring a blood constituent comprising an energy source for directing a plurality of predetermined wavelengths of electromagnetic energy upon a specimen and a detector for receiving the plurality of predetermined wavelengths of electromagnetic energy from the specimen. The detector produces electrical signals corresponding to the predetermined wavelengths in response to the electromagnetic energy. At least two of the electrical signals each has a desired signal portion and an undesired signal portion. Additionally, the apparatus comprises a reference processor having an input for receiving the electrical signals. The processor is configured to combine said electrical signals to generate a reference signal having a primary component which is derived from the undesired signal portions.
- This aspect of the present invention may further comprise an adaptive signal processor for receiving the reference signal and one of the two electrical signals and for deriving therefrom an output signal having a primary component which is a function of the desired signal portion of the electrical signal. This may be accomplished by use of an adaptive noise canceler in the adaptive signal processor which may employ a joint process estimator having a least squares-lattice predictor and a regression filter.
- Yet another aspect of the present invention is a blood gas monitor for non-invasively measuring a blood constituent in a body comprising a light source for directing at least two predetermined wavelengths of light upon a body and a detector for receiving the light from the body. The detector, in response to the light from the body, produces at least two electrical signals corresponding to the at least two predetermined wavelengths of light. The at least two electrical signals each has a desired signal portion and an undesired signal portion. The blood oximeter further comprises a reference processor having an input for receiving the at least two electrical signals. The processor is adapted to combine the at least two electrical signals to generate a reference signal with a primary component which is derived from the undesired signal portions. The blood oximeter may further comprise an adaptive signal processor for receiving the reference signal and the two electrical signals and for deriving therefrom at least two output signals which are substantially equal, respectively, to the desired signal portions of the electrical signals.
- The present invention also includes a method of determining a noise reference signal from a first signal comprising a first desired signal portion and a first noise portion and a second signal comprising a second desired signal portion and a second noise portion. The method comprises the steps of selecting a signal coefficient which is proportional to a ratio of predetermined attributes of the first desired signal portion and predetermined attributes of the second desired signal portion. The first signal and the second signal coefficient are input into a signal multiplier wherein the first signal is multiplied by the signal coefficient thereby generating a first intermediate signal. The second signal and the first intermediate signal are input into a signal subtractor wherein the first intermediate signal is subtracted from the second signal. This generates a noise reference signal having a primary component which is derived from the first and second noise signal portions. The first and second signals in this method may be derived from light energy transmitted through an absorbing medium.
- The present invention further embodies a physiological monitoring apparatus comprising means for acquiring a first signal comprising a first desired signal portion and a first undesired signal portion and a second signal comprising a second desired signal portion and a second undesired signal portion. The physiological monitoring apparatus of the present invention also comprises means for determining from the first and second signals a noise reference signal.
- Additionally, the monitoring apparatus comprises an adaptive noise canceler having a noise reference input for receiving the noise reference signal and a signal input for receiving the first signal wherein the adaptive noise canceler, in real or near real time, generates an output signal which approximates the first desired signal portion. The adaptive noise canceler may further comprise a joint process estimator.
- A further aspect of the present invention is an apparatus for processing an amplitude modulated signal having a signal amplitude complicating feature, the apparatus comprising an energy source for directing electromagnetic energy upon a specimen. Additionally, the apparatus comprises a detector for acquiring a first amplitude modulated signal and a second amplitude modulated signal. Each of the first and second signals has a component containing information about the attenuation of electromagnetic energy by the specimen and a signal amplitude complicating feature. The apparatus includes a reference processor for receiving the first and second amplitude modulated signals and deriving therefrom a noise reference signal which is correlated with the signal amplitude complicating feature. Further, the apparatus incorporates an adaptive noise canceler having a signal input for receiving the first amplitude modulated signal, a noise reference input for receiving the noise reference signal, wherein the adaptive noise canceler produces an output signal having a primary component which is derived from the component containing information about the attenuation of electromagnetic energy by the specimen.
- Still another aspect of the present invention is an apparatus for extracting a plethysmographic waveform from an amplitude modulated signal having a signal amplitude complicating feature, the apparatus comprising a light source for transmitting light into an organism and a detector for monitoring light from the organism. The detector produces a first light attenuation signal and a second light attenuation signal, wherein each of the first and second light attenuation signals has a component which is representative of a plethysmographic waveform and a component which is representative of the signal amplitude complicating feature. The apparatus also includes a reference processor for receiving the first and second light attenuation signals and deriving therefrom a noise reference signal. The noise reference signal and the signal amplitude complicating feature each has a frequency spectrum. The frequency spectrum of the noise reference signal is correlated with the frequency spectrum of the signal amplitude complicating feature. Additionally incorporated into this embodiment of the present invention is an adaptive noise canceler having a signal input for receiving the first attenuation signal and a noise reference input for receiving the noise reference signal. The adaptive noise canceler produces an output signal having a primary component which is derived from the component which is representative of a plethysmographic waveform.
- The present invention also comprises a method of removing a motion artifact signal from a signal derived from a physiological measurement wherein a first signal having a physiological measurement component and a motion artifact component and a second signal having a physiological measurement component and a motion artifact component are acquired. From the first and second signals a motion artifact noise reference signal which is a primary function of the first and second signals motion artifact components is derived. This method of removing a motion artifact signal from a signal derived from a physiological measurement may also comprise the step of inputting the motion artifact noise reference signal into an adaptive noise canceler to produce an output signal which is a primary function of the first signal physiological measurement component.
- FIG. 1 illustrates an ideal plethysmographic waveform.
- FIG. 2 schematically illustrates the cross-sectional structure of a typical finger.
- FIG. 3 illustrates a plethysmographic waveform which includes a motion-induced undesired erratic signal portion.
- FIG. 4 illustrates a schematic diagram of a physiological monitor incorporating a processor of the present invention and an adaptive noise canceler.
- FIG. 4a illustrates the transfer function of a multiple notch filter.
- FIG. 5 illustrates an example of an adaptive noise canceler which could be employed in a physiological monitor which also incorporates the processor of the present invention.
- FIG. 6a illustrates a schematic absorbing material comprising N constituents within an absorbing material.
- FIG. 6b illustrates another schematic absorbing material comprising N constituents within an absorbing material.
- FIG. 7 is a schematic model of a joint process estimator comprising a least-squares lattice predictor and a regression filter.
- FIG. 8 is a flowchart representing a subroutine capable of implementing a joint process estimator as modeled in FIG. 7.
- FIG. 9 is a schematic model of a joint process estimator with a least-squares lattice predictor and two regression filters.
- FIG. 10 is an example of a physiological monitor incorporating a processor of the present invention and an adaptive noise canceler within a microprocessor. This physiological monitor is specifically designed to measure a plethysmographic waveform and perform pulse oximetry measurements.
- FIG. 11 is a graph of oxygenated and deoxygenated absorption coefficients vs. wavelength.
- FIG. 12 is a graph of the ratio of the absorption coefficients of deoxygenated hemoglobin divided by oxygenated hemoglobin vs. wavelength.
- FIG. 13 is an expanded view of a portion of FIG. 11 marked by a circle labelled13.
- FIG. 14 illustrates a signal measured at a first red wavelength λa=λred1=650 nm for use in a processor of the present invention employing the ratiometric method for determining the noise reference signal n′(t) and for use in a joint process estimator. The measured signal comprises a desired portion Yλa(t) and an undesired portion nλa(t).
- FIG. 15 illustrates a signal measured at a second red wavelength λb=λred2=685 nm for use in a processor of the present invention employing the ratiometric method for determining the noise reference signal n′(t). The measured signal comprises a desired portion Yλb(t) and an undesired portion nλb(t).
- FIG. 16 illustrates a signal measured at an infrared wavelength λc=λIR=940 nm for use in a joint process estimator. The measured signal comprises a desired portion Yλc(t) and an undesired portion nλc(t).
- FIG. 17 illustrates the noise reference signal n′(t) determined by a processor of the present invention using the ratiometric method.
- FIG. 18 illustrates a good approximation Y′λa(t) to the desired portion Yλa(t) of the signal Sλa(t) measured at λa=λred1=650 nm estimated with a noise reference signal n′(t) determined by the ratiometric method.
- FIG. 19 illustrates a good approximation Y′λc(t) to the desired portion Yλc(t) of the signal Sλc(t) measured at λc=λIR=940 nm estimated with a noise reference signal n′(t) determined by the ratiometric method.
- FIG. 20 illustrates a signal measured at a red wavelength λa=λred=660 nm for use in a processor of the present invention employing the constant saturation method for determining the noise reference signal n′(t) and for use in a joint process estimator. The measured signal comprises a desired portion Yλa(t) and an undesired portion nλa(t).
- FIG. 21 illustrates a signal measured at an infrared wavelength λb=λIR=940 nm for use in a processor of the present invention employing the constant saturation method for determining the noise reference signal n′(t) and for use in a joint process estimator. The measured signal comprises a desired portion Y′b(t) and an undesired portion nλb(t).
- FIG. 22 illustrates the noise reference signal n′(t) determined by a processor of the present invention using the constant saturation method.
- FIG. 23 illustrates a good approximation Y′λa(t) to the desired portion Yλa(t) of the signal Sλa(t) measured at λa=λred=660 nm estimated with a noise reference signal n′(t) determined by the constant saturation method.
- FIG. 24 illustrates a good approximation Y*(t) to the desired portion Yλb(t) of the signal Sλb(t) measured at λb=λIR=940 nm estimated with a noise reference signal n′(t) determined by the constant saturation method.
- The present invention is a processor which determines a noise reference signal n′(t) for use in an adaptive noise canceler. An adaptive noise canceler estimates a good approximation Y′(t) to a desired signal Y(t) from a composite signal S(t)=Y(t)+n(t) which, in addition to the desired portion Y(t) comprises an undesired portion n(t). The undesired portion n(t) may contain one or more of a constant portion, a predictable portion, an erratic portion, a random portion, etc. The approximation to the desired signal. Y′(t) is derived by removing as many of the undesired portions n(t) from the composite signal S(t) as possible. The constant portion and predictable portion are easily removed with traditional filtering techniques, such as simple subtraction, low pass, band pass, and high pass filtering. The erratic portion is more difficult to remove due to its unpredictable nature. If something is known about the erratic signal, even statistically, it could be removed from the measured signal via traditional filtering techniques. However, it is often the case that no information is known about the erratic portion of the noise. In this case, traditional filtering techniques are usually insufficient. Often no information about the erratic portion of the measured signal is known. Thus, an adaptive noise canceler is utilized in the present invention to remove the erratic portion.
- Generally, an adaptive noise canceler has two signal inputs and one output. One of the inputs is the noise reference signal n′(t) which is correlated to the erratic undesired signal portions n(t) present in the composite signal S(t). The other input is for the composite signal S(t). Ideally, the output of the adaptive noise canceler Y′(t) corresponds to the desired signal portion Y(t) only. Often, the most difficult task in the application of adaptive noise cancelers is determining the noise reference signal n′(t) which is correlated to the erratic undesired portion n(t) of the measured signal S(t) since, as discussed above, unpredictable signal portions are usually quite difficult to isolate from the measured signal S(t). In the signal processor of the present invention, a noise reference signal n′(t) is determined from two composite signals measured simultaneously, or nearly simultaneously, at two different wavelengths, λa and λb. The signal processor of the present invention can be advantageously used in a monitoring device, such a monitor being well suited for physiological monitoring.
- A block diagram of a generic monitor incorporating a signal processor, or reference processor, according to the present invention and an adaptive noise canceler is shown in FIG. 4. Two measured signals, Sλa(t) and Sλb(t), are acquired by a
detector 20. One skilled in the art will realize that for some physiological measurements, more than one detector may be advantageous. Each signal is conditioned by asignal conditioner digital converter 24 a and 24 b. The first measured signal Sλa(t) comprises a first desired signal portion, labelled herein Yλa(t), and a first undesired signal portion, labelled herein nλa(t). The second measured signal Sλb(t) is at least partially correlated to the first measured signal Sλa(t) and comprises a second desired signal portion, labelled herein Yλb(t), and a second undesired signal portion, labelled herein nλb(t). Typically the first and second undesired signal portions, nλa(t) and nλb(t), are uncorrelated and/or erratic with respect to the desired signal portions Yλa(t) and Yλb(t). The undesired signal portions nλa(t) and nλb(t) are often caused by motion of a patient. The signals Sλa(t) and Sλb(t) are input to areference processor 26. Thereference processor 26 multiplies the second measured signal Sλb(t) by a factor Ω and then subtracts the second measured signal Sλb(t) from the first measured signal Sλa(t). The factor Ω is determined to cause the desired signal portions Yλa(t) and Yλb(t) to cancel when the two signals Sλa(t) and Sλb(t) are subtracted. Thus, the output of thereference processor 26 is a noise reference signal n′(t)=nλa(t)−Ωnλb(t) which is correlated to both of the erratic undesired signal portions nλa(t) and nλb(t). The noise reference signal n′(t) is input, along with one of the measured signals Sλa(t), to anadaptive noise canceler 27 which uses the noise reference signal n′(t) to remove the undesired signal portion nλa(t) or nλb(t) from the measured signal Sλa(t). It will be understood that Sλb(t) could have been input to theadaptive noise canceler 27 along with the noise reference signal n′(t) instead of Sλa(t). The output of theadaptive noise canceler 27 is a good approximation Y′λa(t) to the desired signal Yλa(t). The approximation Yλb(t) is displayed on thedisplay 28. - An
adaptive noise canceler 30, an example of which is shown in block diagram in FIG. 5, is employed to remove the erratic, undesired signal portions nλa(t) and nλb(t) from the measured signals Sλa(t) and Sλb(t). Theadaptive noise canceler 30 in FIG. 5 has as one input a sample of the noise reference signal n′(t) which is correlated to the undesired signal portions nλa(t) and nλb(t). The noise reference signal n′(t) is determined from the two measured signals Sλa(t) and Sλb(t) by theprocessor 26 of the present invention as described herein. A second input to the adaptive noise canceler is a sample of either the first or second measured signal Sλa(t)=Yλa(t)+nλa(t) or Sλb(t)=Yλb(t)+nλb(t). - The
adaptive noise canceler 30 functions to remove frequencies common to both the noise reference signal n′(t) and the measured signal Sλa(t) or Sλb(t). Since the noise reference signal n′(t) is correlated to the erratic undesired signal portions nλa(t) and nλb(t), the noise reference signal n′(t) is also erratic. The adaptive noise canceler acts in a manner which may be analogized to a dynamic multiple notch filter based on the spectral distribution of the noise reference signal n′(t). - Referring to FIG. 4a, the transfer function of a multiple notch filter is shown. The notches, or dips in the amplitude of the transfer function, indicate frequencies which are attenuated or removed when a composite measured signal passes through the notch filter. The output of the notch filter is the composite signal having frequencies at which a notch was present removed. In the analogy to an adaptive noise canceler, the frequencies at which notches are present change continuously based upon the inputs to the adaptive noise canceler.
- The
adaptive noise canceler 30 shown in FIG. 5 produces an output signal, labelled herein Y′λa(t) or Y′λb(t), which is fed back to aninternal processor 32 within theadaptive noise canceler 30. Theinternal processor 32 automatically adjusts its own transfer function according to a predetermined algorithm such that the output of theinternal processor 32, labelled b(t), closely resembles the undesired signal portion nλa(t) or nλb(t). The output b(t) of theinternal processor 32 is subtracted from the measured signal, Sλa(t) or Sλb(t), yielding a signal Y′λa(t)≈Sλa(t)+nλa(t)−bλa(t) or Y′λb(t)≈Sλb(t)+nλb(t)−bλb(t). The internal processor optimizes Yλa(t) or Yλb(t) such that Y′λa(t) or Y′λb(t) is approximately equal to the desired signal Yλa(t) or Yλb(t), respectively. - One algorithm which may be used for the adjustment of the transfer function of the
internal processor 32 is a least-squares algorithm, as described in Chapter 6 and Chapter 12 of the book Adaptive Signal Processing by Bernard Widrow and Samuel Stearns, published by Prentice Hall, copyright 1985. This entire book, including Chapters 6 and 12, is hereby incorporated herein by reference. -
Adaptive processors 30, have been successfully applied to a number of problems including antenna sidelobe canceling, pattern recognition, the elimination of periodic interference in general, and the elimination of echoes on long distance telephone transmission lines. However, considerable ingenuity is often required to find a suitable noise reference signal n′(t) for a given application since the random or erratic portions nλa(t) or nλb(t) cannot easily be separated from the measured signal Sλa(t) or Sλb(t). If the actual undesired signal portion nλa(t) or nλb(t) were a priori available, techniques such as adaptive noise canceling would not be necessary. The unique determination of a suitable noise reference signal n′(t) from measurements taken by a monitor incorporating a reference processor of the present invention is one aspect of the present invention. - An explanation which describes how the noise reference signal n′(t) may be determined as follows. A first signal is measured at, for example, a wavelength λa, by a detector yielding a signal Sλa(t):
- S λa(t)=Y λa(t)+n λa(t); (1)
- where Yλa(t) is the desired signal and nλa(t) is the noise component.
- A similar measurement is taken simultaneously, or nearly simultaneously, at a different wavelength, λb, yielding:
- S λb(t)=Y λb(t)+n λb. (2)
- Note that as long as the measurements, Sλa(t) and Sλb(t), are taken substantially simultaneously, the undesired signal components, nλa(t) and nλb(t), will be correlated because any random or erratic functions will affect each measurement in nearly the same fashion.
- To obtain the noise reference signal n′(t), the measured signals Sλa(t) and Sλb(t) are transformed to eliminate the desired signal components. One way of doing this is to find a proportionality constant, ω1, between the desired signals Yλa(t) and Yλb(t) such that:
- Y λa(t) ω1 Y′ λb(t). (3)
- This proportionality relationship can be satisfied in many measurements, including but not limited to absorption measurements and physiological measurements. Additionally, in most measurements, the proportionality constant ω1 can be determined such that:
- n λa(t)≈ω1 n λb(t). (4)
- Multiplying equation (2) by ω1 and then subtracting equation (2) from equation (1) results in a single equation wherein the desired signal terms Yλa(t) and Sλb(t) cancel, leaving:
- n′(t)=Sλa(t)−ω1 S λb(t)=n λa(t)−ω1nλb(t); (5)
- a non-zero signal which is correlated to each undesired signal portion nλa(t) and nλb(t) and can be used as the noise reference signal n′(t) in an adaptive noise canceler.
- Adaptive noise canceling is particularly useful in a large number of measurements generally described as absorption measurements. An example of an absorption type monitor which can advantageously employ adaptive noise canceling based upon a noise reference signal n′(t) determined by a processor of the present invention is one which determines the concentration of an energy absorbing constituent within an absorbing material when the material is subject to perturbation. Such perturbations can be caused by forces about which information is desired, or alternatively, by random or erratic forces such as a mechanical force on the material. Random or erratic interference, such as motion, generates undesired noise components in the measured signal. These undesired components can be removed by the adaptive noise canceler if a suitable noise reference signal n′(t) is known.
- A schematic N constituent absorbing material comprising a
container 42 having N different absorbing constituents, labelled A1, A2, A3, . . . AN, is shown schematically in FIG. 6a. The constituents A1 through AN in FIG. 6a are arranged in a generally orderly, layered fashion within thecontainer 42. An example of a particular type of absorptive system is one in which light energy passes through thecontainer 42 and is absorbed according to the generalized Beer-Lambert Law of light absorption. For light of wavelength λa, this attenuation may be approximated by: - I=I 0 e −Σ i N =o ε i, λa c i x i (6)
- Initially transforming the signal by taking the natural log of both sides and manipulating terms, the signal is transformed such that the signal components are combined by addition rather than multiplication, i.e.:
- S λa =ln(I 0 /I)=Σi N =o ε i, λa c i x i (7)
- where I0 is the incident light energy intensity; I is the transmitted light energy intensity; εi,λa is the absorption coefficient of the ith constituent at the wavelength λa; x1(t) is the optical path length of ith layer, i.e., the thickness of material of the ith layer through which optical energy passes; and ci(t) is the concentration of the ith constituent in the volume associated with the thickness xi(t). The absorption coefficients ε1 through εN are known values which are constant at each wavelength. Most concentrations c1(t) through cN(t) are typically unknown, as are most of the optical path lengths xi(t) of each layer. The total optical path length is the sum of each of the individual optical path lengths xi(t) of each layer.
- When the material is not subject to any forces which cause perturbation in the thicknesses of the layers, the optical path length of each layer, xi(t), is generally constant. This results in generally constant attenuation of the optical energy and thus, a generally constant offset in the measured signal. Typically, this portion of the signal is of little interest since knowledge about a force which perturbs the material is usually desired. Any signal portion outside of a known bandwidth of interest, including the constant undesired signal portion resulting from the generally constant absorption of the constituents when not subject to perturbation, should be removed. This is easily accomplished by traditional band pass filtering techniques. However, when the material is subject to forces, each layer of constituents may be affected by the perturbation differently than each other layer. Some perturbations of the optical path lengths of each layer xi(t) may result in excursions in the measured signal which represent desired information. Other perturbations of the optical path length of each layer xi(t) cause undesired excursions which mask desired information in the measured signal. Undesired signal components associated with undesired excursions must also be removed to obtain desired information from the measured signal.
- The adaptive noise canceler removes from the composite signal, measured after being transmitted through or reflected from the absorbing material, the undesired signal components caused by forces which perturb the material differently from the forces which perturbed the material to cause the desired signal component. For the purposes of illustration, it will be assumed that the portion of the measured signal which is deemed the desired signal Yλa(t) is the attenuation term ε5c5x5(t) associated with a constituent of interest, namely A5, and that the layer of constituent A5 is affected by perturbations differently than each of the layers of other constituents A1 through A4 and A6 through AN. An example of such a situation is when layer n is subject to forces about which information is desired and, additionally, the entire material is subject to forces which affect each of the layers. In this case, since the total force affecting the layer of constituents A5 is different than the total forces affecting each of the other layers and information is desired about the forces and resultant perturbation of the layer of constituents A5, attenuation terms due to constituents A1 through A4 and A6 through AN make up the undesired signal nλa(t). Even if the additional forces which affect the entire material cause the same perturbation in each layer, including the layer of A5, the total forces on the layer of constituent A5 cause it to have different total perturbation than each of the other layers of constituents A1 through A4 and A6 through AN,
- It is often the case that the total perturbation affecting the layers associated with the undesired signal components is caused by random or erratic forces. This causes the thickness of layers to change erratically and the optical path length of each layer, xi(t), to change erratically, thereby producing a random or erratic undesired signal component nλa(t). However, regardless of whether or not the undesired signal portion nλa(t) is erratic, the undesired signal component nλa(t) can be removed via an adaptive noise canceler having as one input a noise reference signal n′(t) determined by a processor of the present invention as long as the perturbation on layers other than the layer of constituent A5 is different than the perturbation on the layer of constituent A5. The adaptive noise canceler yields a good approximation to the desired signal Y′λa(t). From this approximation, the concentration of the constituent of interest, C5(t), can often be determined since in some physiological measurements, the thickness of the desired signal component, x5(t) in this example, is known or can be determined.
-
- A further transformation of the signals is the proportionality relationship defining ω2, similarly to equation (3), which allows determination of a noise reference signal n′(t), is:
- ε5,λa=ω2ε5,λb; where (12)
-
-
- A sample of this noise reference signal n′(t); and a sample of either measured signal Sλa(t) or Sλb(t), are input to an adaptive noise canceler, one model of which is shown in FIG. 5 and a preferred model of which is discussed herein under the heading PREFERRED ADAPTIVE NOISE CANCELER USING A JOINT PROCESS ESTIMATOR IMPLEMENTATION. The adaptive noise canceler removes the undesired portion of the measured signal nλa(t) or nλb(t), yielding a good approximation to the desired portion of signal Y′λa(t)≈ε5,λac5x5(t) or Y′λa(t)≈ε5,λbc5x5(t) The concentration C5(t) may then be determined from the approximation to the desired signal Y′λa(t) or Y′λb(t) according to:
- c 5(t)≈Y′λa(t)/ε5,λax5(t)≈Y′λb(t)/ε5,λbx5(t) (17)
- As discussed previously, the absorption coefficients are constant at each wavelength λa and λb and the thickness of the desired signal component, x5(t) in this example, is often known or can be determined as a function of time, thereby allowing calculation of the concentration c5(t) of constituent A5.
- Referring to FIG. 6b, another material having N different constituents arranged in layers is shown. In this material, two constituents A5 and A6 are found within one layer having thickness X5,6(t)=x5(t)+x6(t), located generally randomly within the layer. This is analogous to combining the layers of constituents A5 and A6 in FIG. 6a.
- A combination of layers, such as the combination of layers of constituents A5 and A6, is feasible when the two layers are under the same total forces which result in the same perturbation of the optical path lengths x5(t) and x6(t) of the layers.
- Often it is desirable to find the concentration or the saturation, i.e., a percent concentration, of one constituent within a given thickness which contains more than one constituent and is subject to unique forces A determination of the concentration or the saturation of a constituent within a given volume may be made with any number of constituents in the volume subject to the same total forces and therefore under the same perturbation. To determine the saturation of one constituent in a volume comprising many constituents, as many measured signals as there are constituents which absorb incident light energy are necessary. It will be understood that constituents which do not absorb light energy are not consequential in the determination of saturation. To determine the concentration, as many signals as there are constituents which absorb incident light energy are necessary as well as information about the sum of concentrations.
-
- Any signal portions outside of a known bandwidth of interest, including the constant undesired signal portion resulting from the generally constant absorption of the constituents when not under perturbation, should be removed to determine an approximation to the desired signal. This is easily accomplished by traditional band pass filtering techniques. As in the previous example, it is often the case that the total perturbation affecting the layers associated with the undesired signal components is caused by random or erratic forces, causing the thickness of each layer, or the optical path length of each layer, xi(t), to change erratically, producing a random or erratic undesired signal component nλa(t). Regardless of whether or not the undesired signal portion nλa(t) is erratic, the undesired signal component nλa(t) can be removed via an adaptive noise canceler having as one input a noise reference signal n′(t) determined by a processor of the present invention as long as the perturbation in layers other than the layer of constituents A5 and A6 is different than the perturbation in the layer of constituents A5 and A6. The erratic undesired signal components nλa(t) and nλb(t) may advantageously be removed from equations (18) and (20), or alternatively equations (19) and (21), by an adaptive noise canceler. The adaptive noise canceler, again, requires a sample of a noise reference signal n′(t).
- Two methods which may be used by a processor of the present invention to determine the noise reference signal n′(t) are a ratiometric method and a constant saturation method. The preferred embodiment of a physiological monitor incorporating a processor of the present invention utilizes the ratiometric method wherein the two wavelengths λa and λb, at which the signals Sλa(t) and Sλb(t) are measured, are specifically chosen such that a relationship between the absorption coefficients ε5,λa, ε5,λb, ε6,λa and ε6,λb exists, i.e.:
- ε5,λa/ε6,λa=ε5,λb/ε6,λb (22)
- The measured signals Sλa(t) and Sλb(t) can be factored and written as:
- Sλ a(t)=ε6,λa[(ε5,λa/ε6,λa)c5x(t)+c 6 x(t)]+n λa(t) (23)
- S λb(t)=ε6,λb[(ε5,λb/ε6,λb)c 5 x(t)+c 6 x(t)]+n λb(t). (24)
- The wavelengths λa and λb, chosen to satisfy-equation (22), cause the terms within the square brackets to be equal, thereby causing the desired signal portions Y′λa(t) and Y′λb(t) to be linearly dependent. Then, a proportionality constant ωr3 which causes the desired signal portions Y′λa(t) and Y′λb(t) to be equal and allows determination of a non-zero noise reference signal n′(t) is:
- ε6,λa=ωr3ε6,λb; where (25)
- n λa≈ωr3 n λb. (26)
- It is often the case that both equations (25) and (26) can be simultaneously satisfied. Additionally, since absorption coefficients of each constituent are constant with respect to wavelength, the proportionality constant ωr3 can be easily determined. Furthermore, absorption coefficients of other constituents A1 through A4 and A7 through AN are generally unequal to the absorption coefficients of A5 and A6. Thus, the undesired noise components nλa and nλb are generally not made linearly dependent by the relationships of equations (22) and (25).
- Multiplying equation (24) by ωr3 and subtracting the resulting equation from equation (23), a non-zero noise reference signal is determined by:
- n′(t)=S λa(t)=ωr3 S λb(t)=n λa(t)=ωr3 n λb(t). (27)
-
- is substantially constant over many samples of the measured signals Sλa and Sλb. This assumption is accurate over many samples since saturation generally changes relatively slowly in physiological systems.
- The constant saturation assumption is equivalent to assuming that:
- c 5(t)/c 6(t)=constant (30)
- since the only other term in equation (29) is a constant, namely the
numeral 1. -
- n λa(t)≢ωs3(t)nλb(t). (36)
- It is often the case that both equations (35) and (36) can be simultaneously satisfied to determine the proportionality constant ωs3(t). Additionally, the absorption coefficients at each wavelength ε5,λa, ε6,λa, ε5,λb, and ε6,λb are constant and the central assumption of the constant saturation method is that c5(t)/c6 (t) is constant over many sample periods. Thus, a new proportionality constant ωa3(t) may be determined every few samples from new approximations to the desired signal as output from the adaptive noise canceler. Thus, the approximations to the desired signals Y′λa(t) and Y′λb(t) found by the adaptive noise canceler for a substantially immediately preceding set of samples of the measured signals Sλa(t) and Sλb(t) are used in a processor of the present: invention for calculating the proportionality constant, ω3(t), for the next set of samples of the measured signals Sλa(t) and Sλb(t).
- Multiplying equation (20) by w3(t) and subtracting the resulting equation from equation (18) yields a non-zero noise reference signal:
- n′(t)=S λa(t)−ω3(t)S λb(t)=n λa(t)−ω
- It will be understood that equation (21) could be multiplied by ω3(t) and the resulting equation could be subtracted from equation (19) to yield the same noise reference signal n′(t) as given in equation (37).
- When using the constant saturation method, it is necessary for the patient to remain motionless for a short period of time such that an accurate initial saturation value can be determined by known methods other than adaptive noise canceling on which all other calculations will be based. With no erratic, motion-induced undesired signal portions, a physiological monitor can very quickly produce an initial value of the saturation of A5 in the volume containing A5 and A6. An example of a saturation calculation is given in the article “SPECTROPHOTOMETRIC DETERMINATION OF OXYGEN SATURATION OF BLOOD INDEPENDENT OF THE PRESENT OF INDOCYANINE GREEN” by G. A. Mook, et al., wherein determination of oxygen saturation in arterial blood is discussed. Another article discussing the calculation of oxygen saturation is “PULSE OXIMETRY: PHYSICAL PRINCIPLES, TECHNICAL REALIZATION AND PRESENT LIMITATIONS” by Michael R. Neuman. Then, with values for Y′λa(t) and Y′λb(t) determined, an adaptive noise canceler may be utilized with a noise reference signal n′(t) determined by the constant saturation method.
- Once the noise reference signal n′(t) is determined by the processor of the present invention using either the above described ratio metric or constant saturation methods, the adaptive noise canceler can be implemented in either hardware or software.
- The least mean squares(LMS) implementation of the
internal processor 32 described above in conjunction with the adaptive noise canceler of FIG. 5 is relatively easy to implement, but lacks the speed of adaptation desirable for most physiological monitoring applications of the present invention. Thus, a faster approach for adaptive noise canceling, called a least-squares lattice joint process estimator model, is preferably used. Ajoint process estimator 60 is shown diagrammatically in FIG. 7 and is described in detail in Chapter 9 of Adaptive Filter Theory by Simon Haykin, published by Prentice-Hall, copyright 1986. This entire book, including Chapter 9, is hereby incorporated herein by reference. The function of the joint process estimator is to remove the undesired signal portions nλa(t) or nλb(t) from the measured signals, Sλa(t) or Sλb(t), yielding a signal Y′λa(t) or Yλb(t) which is a good approximation to the desired signal Yλa(t) or Yλb(t). Thus, the joint process estimator estimates the value of, the desired signal Yλa(t) or Yλb(t). The inputs to thejoint process estimator 60 are the noise reference signal n′(t) and the composite measured signal Sλa(t) or Sλb(t). The output is a good approximation to the signal Sλa(t) or Sλb(t) with the noise removed, i.e. a good approximation to Yλa(t) or Yλb(t). - The
joint process estimator 60 utilizes, in conjunction, a leastsquare lattice predictor 70 and aregression filter 80. The noise reference signal n′(t) is input to the leastsquare lattice predictor 70 while the measured signal Sλa(t) or Sλb(t) is input to theregression filter 80. For simplicity in the following description, Sλa(t) will be the measured signal from which the desired portion Yλa(t) will be estimated by thejoint process estimator 60. However, it will be noted that Sλb(t) could equally well be input to theregression filter 80 and the desired portion Yλb(t) of this signal could equally well be estimated. - The
joint process estimator 60 removes all frequencies that are present in both the noise reference signal n′(t) and the measured signal Sλa(t). The undesired signal portion nλa(t) usually comprises frequencies unrelated to those of the desired signal portion Yλa(t). It is highly improbable that the undesired signal portion nλa(t) would be of exactly the same spectral content as the desired signal portion Yλa(t) However, in the unlikely event that the spectral content of Sλa(t) and n′(t) are similar, this approach will not yield accurate results. Functionally, thejoint process estimator 60 compares input signal n′(t), which is correlated to the undesired signal portion nλa(t), and input signal Sλa(t) and removes all frequencies which are identical. Thus, thejoint process estimator 60 acts as a dynamic multiple notch filter to remove those frequencies in the undesired signal component nλa(t) as they change erratically with the motion of the patient. This yields a signal having substantially the same spectral content as the desired signal Yλa(t). The output of thejoint process estimator 60 has substantially the same spectral content and amplitude as the desired signal Yλa(t). - Thus, the output Y′λa(t) of the
joint process estimator 60 is a very good approximation to the desired signal Yλa(t). - The
joint process estimator 60 can be divided into stages, beginning with a zero-stage and terminating in an mth-stage, as shown in FIG. 7. Each stage, except for the zero-stage, is identical to every other stage. The zero-stage is an input stage for thejoint process estimator 60. The first stage through the mth-stage work on the signal produced in the immediately previous stage, i.e., the (m−1)th-stage, such that a good approximation to the desired signal Y′λa(t) is produced as output from th mth-stage. - The least-
squares lattice predictor 70 comprisesregisters elements elements 110. Theregisters - For each set of samples, i.e. one sample of the noise reference signal n′(t) derived substantially simultaneously with one sample of the measured signal n′(t), the sample of the noise reference signal n′(t) is input to the least-
squares lattice predictor 70. The zero-stage forward prediction error f0(t) and the zero-stage backward prediction error b0(t) are set equal to the noise reference signal n′(t). The backward prediction error b0(t) is delayed by one sample period by thedelay element 110 in the first stage of the least-squares lattice predictor 70. Thus, the immediately previous value of the noise reference signal n′(t) is used in calculations involving the first-stage delay element 110. The zero-stage forward prediction error is added to the negative of the delayed zero-stage backward prediction error b0(t−1) multiplied by the forward reflection coefficient value Γf,1(t) register 90 value, to produce a first-stage forward prediction error f1(t). Additionally, the zero-stage forward prediction error f0(t) is multiplied by the backward reflection coefficient value Γb,1(t) register 92 value and added to the delayed zero-stage backward prediction error b0(t−1) to produce a first-stage backward prediction error b1(t). In each-subsequent stage, m, of the leastsquare lattice predictor 70, the previous forward and backward prediction error values, fm−1(t) and bm−1(t−1), the backward prediction error being delayed by one sample period, are used to produce values of the forward and backward prediction errors for the present stage, fm(t) and bm(t). - The backward prediction error bm(t) is fed to the concurrent stage, m, of the
regression filter 80. There it is input to aregister 96, which contains a multiplicative regression coefficient value κm,λa(t). For example, in the zero-stage of theregression filter 80, the zero-stage backward prediction error b0(t) is multiplied by the zero-stage regression coefficient κ0,λa(t) register 96 value and subtracted from the measured value of the signal Sλa(t) at a summingelement 106 to produce a first stage estimation error signal e1,λa(t). The first-stage estimation error signal e1,λa(t) is a first approximation to the desired signal. This first-stage estimation error signal e1,λa(t) is input to the first-stage of theregression filter 80. The first-stage backward prediction error b1(t), multiplied by the first-stage regression coefficient κ1,λa register 96 value is subtracted from the first-stage estimation error signal e1,λa(t) to produce the second-stage estimation error e2,λa(t). The second-stage estimation error signal e2,λa(t) is a second, somewhat better approximation to the desired signal Yλa(t). - The same processes are repeated in the least-
squares lattice predictor 70 and theregression filter 80 for each stage until a good approximation to the desired signal Yλa(t)=em,λa(t) is determined. Each of the signals discussed above, including the forward prediction error fm(t), the backward prediction error bm(t), the estimation error signal em,λa(t), is necessary to calculate the forward reflection coefficient Γf,m(t), the backward reflection coefficient Γb,m(t), and the regression coefficient κm,λa(t)register register -
-
- where, again, λ without a wavelength identifier, a or b, is a constant multiplicative value unrelated to wavelength and is typically less than or equal to one, i.e., λ≦1. These weighted sum intermediate error signals can be manipulated such that they are more easily solved for, as described in Chapter 9, § 9.3 and defined hereinafter in equations (53) and (54).
- The operation of the
joint process estimator 60 is as follows. When thejoint process estimator 60 is turned on, the initial values of intermediate variable and signal including the parameter Δm−1 (t), the weighted sum of the forward prediction error signals m−1(t), the weighted sum of the backward prediction error signals βm−1(t), the parameter ρm,λa(t), and the zero-stage estimation error e0,λa(t) are initialized, some to zero and some to a small positive number δ: - Δm−1(0)=0; (40)
- m−1(0)=δ; (41)
- βm−1(0)=δ; (42)
- ρm,λa(0)=0; (43)
- e 0,λa(t)S λb(t) for t≧0. (44)
- After initialization, a simultaneous sample of the measured signal Sλa(t) and the noise reference signal n′(t) are input to the
joint process estimator 60, as shown in FIG. 7. The forward and backward prediction error signals f0(t) and b0(t), and intermediate variables including the weighted sums of the forward and backward error signals 0(t) and β0(t), and the conversion factor γ0(t) are calculated for the zero-stage according to: - f 0(t)=b0(t)=n′(t). (45)
- 0(t)=β0(t)=λ0(t−1)+|n′(t)|2 (46)
- γ0(t−1)=1 (47)
- where, again, λ without a wavelength identifier, a or b, is a constant multiplicative value unrelated to wavelength.
- Forward reflection coefficient Γf,m(t), backward reflection coefficient Γb,m(t), and regression coefficient κm,λa(t)
register register joint process estimator 60. In each stage, m≧1, intermediate values and register values including the parameter Δm−1(t); the forward reflection coefficient Γf,m(t) register 90 value; the backward reflection coefficient Γb,m(t) register 92 value; the forward and backward error signals fm(t) and bm(t); the weighted sum of squared forward prediction errors f,m(t), as manipulated in § 9.3 of the Haykin book; the weighted sum of squared backward prediction errors βb,m(t), as manipulated in § 9.3 of the Haykin book; the conversion factor γm(t); the parameter ρm,λa(t); the regression coefficient κm,λa(t) register 96 value; and the estimation error em+1,λa(t) value are set according to: - Δm−1(t)=λΔm−1(t−1)+{b m−1(t−1)f* m−1(t)/γm−1(t−1)} (48)
- Γf,m(t)=−{Δm−1(t)/βm−1(t−1)} (49)
- Γb,m(t)=−{Δ*m−1(t)/m−1(t)} (50)
- f m(t)=f m−1(t)+Γ*f,m(t)b m−1(t−1) (51)
- b m(t)=f m−1(t−1)+Γ*b,m(t)f m−1(t) (52)
- m(t)=m−1(t)−{|Δm−1(t)|2/βm−1(t−1)} (
- βm(t)=βm−1(t−1)−{|Δm−1(t)|2/m−1(t)} (
- γm(t−1)=γm−1)−{|b m−1(t−1)|2/βm−1(t−1)} (55)
- ρm,λa(t)=λρm,λa(t−1)+{b m(t)e* m,λa(t)/γm(t)} (56)
- κm,λa(t)={ρm,λa(t)/βm(t)} (57)
- e m+1,λa(t)=e m,λa(t)−κ*m(t)b m(t) (58)
- where a (*) denotes a complex conjugate.
- These equations cause the error signals fm(t), bm(t), em,λa(t) to be squared or to be multiplied by one another., in effect squaring the errors, and creating new intermediate error values, such as Δm−1(t). The error signals and the intermediate error values are recursively tied together, as shown in the above equations (48) through (58). They interact to minimize the error signals in the next stage.
- After a good approximation to the desired signal Y′λa(t) has been determined by the
joint process estimator 60, a next set of samples, including a sample of the measured signal Sλa(t) and a sample of the noise reference signal n′(t), are input to thejoint process estimator 60. The re-initialization process does not re-occur, such that the forward and backward reflection coefficient rf,m(t) and γb,m(t)register - In a signal processor, such as a physiological monitor, incorporating a reference processor of the present invention to determine a noise reference signal n′(t) for input to an adaptive noise canceler, a
joint process estimator 60 type adaptive noise canceler is generally implemented via a software program having an iterative loop. One iteration of the loop is analogous to a single stage of the joint process estimator as shown in FIG. 7. Thus, if a loop is iterated m times, it is equivalent to an m stagejoint process estimator 60. - A flow chart of a subroutine to estimate the desired signal portion Yλa(t) of a sample of a measured signal, Sλa(t) is shown in FIG. 8. The flow chart describes how the action of a reference processor for determining the noise reference signal and the
joint process estimator 60 would be implemented in software. - A one-time only initialization is performed when the physiological monitor is turned on, as indicated by an “INITIALIZE NOISE CANCELER”
box 120. The initialization sets allregisters element variables 110 to the values described above in equations (40) through (44). - Next, a set of simultaneous samples of the measured signals Sλa(t) and Sλb(t) is input to the subroutine represented by the flowchart in FIG. 8. Then a time update of each of the delay element program variables occurs, as indicated in a “TIME UPDATE OF [Z−1] ELEMENTS”
box 130, wherein the value stored in each of thedelay element variables 110 is set to the value at the input of thedelay element variable 110. Thus, the zero-stage backward prediction error b0(t) is stored in the first-stage delay element variable, the first-stage backward prediction error b1 (t) is stored in the second-stage delay element variable, and so on. - Then, using the set of measured signal samples Sλa(t) and Sλb(t), the noise reference signal is calculated according to the ratiometric or the constant saturation method described above. This is indicated by a “CALCULATE NOISE REFERENCE (n′(t)) FOR TWO MEASURED SIGNAL SAMPLES”
box 140. The ratiometric method is generally preferred since no assumptions about constant saturation values need be made. - A zero-stage order update is performed next as indicated in a “ZERO-STAGE UPDATE”
box 150. The zero-stage backward prediction error b0(t), and the zero-stage forward prediction error f0(t) are set equal to the value of the noise reference signal n′(t). Additionally, the weighted sum of the forward prediction errors m(t) and the weighted sum of backward prediction errors βm(t) are set equal to the value defined in equation (46). - Next, a loop counter, m, is initialized as indicated in a “m=0”
box 160. A maximum value of m, defining the total number of stages to be used by the subroutine corresponding to the flowchart in FIG. 8, is also defined. Typically, the loop is constructed such that it stops iterating once a criterion for convergence upon a best approximation to the desired signal has been met by thejoint process estimator 60. Additionally, a maximum number of loop iterations may be chosen at which the loop stops iteration. In a preferred embodiment of a physiological monitor of the present invention, a maximum number of iterations, m=60 to m=80, is advantageously chosen. - Within the loop, the forward and backward reflection coefficient γf,m(t) and Γb,m(t) register 90 and 92 values in the least-squares lattice filter are calculated first, as indicated by the “ORDER UPDATE NTH CELL OF LSL-LATTICE”
box 170 in FIG. 8. This requires calculation of intermediate variable and signal values used in determiningregister regression filter 80 - The calculation of regression filter register96 value κm,λa(t) is performed next, indicated by the “ORDER UPDATE MTH STAGE OF REGRESSION FILTER(S)”
box 180. The twoorder update boxes decision box 190. In a computer subroutine, convergence is determined by checking if the weighted sums of the forward and backward prediction errors m(t) and βm(t) are less than a small positive number. An output is calculated next, as indicated by a “CALCULATE OUTPUT”box 200. The output is a good approximation to the desired signal, as determined by the reference processor andjoint process estimator 60 subroutine corresponding to the flow chart of FIG. 8. This is displayed (or used in a calculation in another subroutine), as indicated by a “TO DISPLAY”box 210. - A new set of samples of the two measured signals Sλa(t) and Sλb(t) is input to the processor and
joint process estimator 60 adaptive noise canceler subroutine corresponding to the flowchart of FIG. 8 and the process reiterates for these samples. Note, however, that the initialization process does not re-occur. New sets of measured signal samples Sλa(t) and Sλb(t) are continuously input to the reference processor andjoint process estimator 60 adaptive noise canceler subroutine. The output forms a chain of samples which is representative of a continuous wave. This waveform is a good approximation to the desired signal waveform Y′λa(t) at wavelength λa. - Physiological monitors typically use the approximation of the desired signal Y′λa(t) to calculate another quantity, such as the saturation of one constituent in a volume containing that constituent plus one or more other constituents. Generally, such calculations require information about a desired signal at two wavelengths. In some measurements, this wavelength is λb, the wavelength used in the calculation of the noise reference signal n′(t). For example, the constant saturation method of determining the noise reference signal requires a good approximation of the desired signal portions Y′λa(t) and Yλb(t) of both measured signals Sλa and Sλb(t). Then, the saturation is determined from the approximations to both signals, i.e. Y′λa(t) and Y′λb(t).
- In other physiological measurements, information about a signal at a third wavelength is necessary. For example, to find the saturation using the ratiometric method, signals Sλa(t) and Sλb(t) are used to find the noise reference signal n′(t). But as discussed previously, λa and λb were chosen to satisfy a proportionality relationship like that of equation (22). This proportionality relationship forces the two desired signal portions Yλa(t) and Yλb(t) to be linearly dependant. Generally, linearly dependent mathematical equations cannot be solved for the unknowns. Analogously, some desirable information cannot be derived from two linearly dependent signals. Thus, to determine the saturation using the ratiometric method, a third signal is simultaneously measured at wavelength λc. The wavelength λc is chosen such that the desired portion Yλc(t) of the measured signal Sλc(t) is not linearly dependent with the desired portions Yλa(t) and Yλb(t) of the measured signals Sλa(t) and Sλb(t). Since all measurements are taken substantially simultaneously, the noise reference signal n′(t) is correlated to the undesired signal portions nλa, nλb, and nλc of each of the measured signals Sλa(t), Sλb(t)1 and Sλc(t) and can be used to estimate approximations to the desired signal portions Yλa(t), Yλb(t), and Yλc(t) for all three measured signals Sλa(t), Sλb(t); and Sλc(t) Using the ratiometric method, estimation of the desired signal portions Yλa(t) and Yλc(t) of two measured signals Sλa(t) and Sλc(t), chosen correctly, is usually satisfactory to determine most physiological data.
- A
joint process estimator 60 having two regression filters 80 a and 80 b is shown in FIG. 9. A first regression filter 80 a accepts a measured signal Sλa(t). A second regression filter 80 b accepts a measured signal Sλb(t) or Sλc(t), depending whether the constant saturation method or the ratiometric method is used to determine the noise reference signal n′(t). The first and second regression filters 80 a and 80 b are independent. The backward prediction error bm(t) is input to each regression filter 80 a and 80 b, the input for the second regression filter 80 b bypassing the first regression filter 80 a. - The second regression filter80 b comprises
registers 98, and summingelements 108 arranged similarly to those in the first regression filter 80 a. The second regression filter 80 b operates via an additional intermediate variable in conjunction with those defined by equations (48) through (58), i.e.: - ρm,λb(t)=λρm,λb(t−1)+{b m(t)e* m,λb(t)/γm(t)}; or (59)
- ρm,λc(t)=λρm,λc(t−1)+{b m(t)e* m,λc(t)/γm,(t)}; and (60)
- ρ0,λb(0)=0; or (61)
- ρ0,λc(0)=0. (62)
- The second regression filter80 b has an error signal value defined similar to the first regression filter error signal values, em+1,λs(t), i.e.:
- e m+1,λb(t)=e m,λb(t)−κ*m,λb(t)bm(t); or (63)
- e m+1,λc(t)=mm,λc(t)−κ*m,λb(t)bm(t); and (64)
- e 0,λb(t)=S λb(t) for t≧0; or (65)
- e 0,λc(t)=S λc(t) for t≧0. (66)
- The second regression filter has a regression coefficient κm,λb(t) register 98 value defined similarly to the first regression filter error signal values, i.e.:
- κm,λb(t)={ρm,λb(t)/βm(t)}; or (67)
- These values are used in conjunction with those intermediate variable values, signal values, register and register values defined in equations (40) through (58). These signals are calculated in an order defined by placing the additional signals immediately adjacent a similar signal for the wavelength λa.
- For the ratiometric method, Sλc(t) is input to the second regression filter 80 b. The output of the, second regression filter 80 b is then a good approximation to the desired signal Y′λc(t). For the constant saturation method, Sλb(t) is input to the second regression filter 80 b. The output is then a good approximation to the desired signal Y′λb(t).
- The addition of the second regression filter80 b does not substantially change the computer program subroutine represented by the flowchart of FIG. 8. Instead of an order update of the mth stage of only one regression filter, an order update of the mth stage of both regression filters 80 a and 80 b is performed. This is characterized by the plural designation in the “ORDER UPDATE OF mth STAGE OF REGRESSION FILTER(S)”
box 180 in FIG. 8. Since the regression filters 80 a and 80 b operate independently, independent calculations can be performed in the reference processor andjoint process estimator 60 adaptive noise canceler subroutine modeled by the flowchart of FIG. 8. - Once good approximations to the desired signals, Y′λa(t) and Y′λc(t) for the ratiometric method and Y′λa(t) and Y′λb(t) for the constant saturation method, have been determined by the
joint process estimator 60, the saturation of A5 in a volume containing A5 and A6, for example, may be calculated according to various known methods. Mathematically, the approximations to the desired signals can be written: - Y′ λa(t)≈ε5,λa c 5 x 5,6(t); and (69)
- Y′ λc(t)≈ε5,λc c 5 x 5,6(t). (70)
- for the ratiometric method using wavelengths λa and λc. For the constant saturation method, the approximations to the desired signals can be written in terms of λa and λb as:
- Y′ λa(t)≈ε5,λa c 5 x 5,6(t)+ε6,λa c 6 x 5,6(t); and (71)
- Y′ λb(t)≈ε5,λb c 5 x 5,6(t)+ε6,λb c 5 x 5,6(t). (72)
- This is equivalent to two equations having three unknowns, namely c5(t), c6(t) and x5,6(t). In both the ratiometric and the constant saturation cases, the saturation can be determined by acquiring approximations to the desired signal portions at two different, yet proximate times t1 and t2 over which the saturation of A5 in the volume containing A5 and A6 does not change substantially. For example, for the desired signals estimated by the ratiometric method, at times t1 and t2:
- Y′ λa(t 1)≈ε5,λa c 5 x 5,6(t 1)+ε6,λa c 6 x 5,6(t 1) (73)
- Y′ λc(t 1)≈ε5,λc c 5 x 5,6(t 1)+ε6,λc c 6 x 5,6(t 1) (74)
- Y′ λa(t 2)≈ε5,λa c 5 x 5,6(t 2)+ε6,λa c 6 x 5,6(t 2) (75)
- Y′ λc(t2)≈ε5,λc c 5 x 5,6(t 2)+ε6,λc c 6 x 5,6(t 2) (76)
- Then, difference signals may be determined which relate the signals of equation (73) through (76), i.e.:
- ΔY λa =Y′ λa(t 1)−Y′ λa(t 2)≈ε5,λa c 5 Δx+ε 6,λa c 6 Δx; and (77)
- ΔY λc =Y′ λc(t 1)−Y′ λc(t 2)≈ε5,λc c 5 Δx+ε 6,λc c 6 Δx; (78)
-
- It will be understood that the ax term drops out from the saturation calculation because of the division Thus, knowledge of the thickness of the desired constituents is not required to calculate saturation.
- A specific example of a physiological monitor utilizing a processor of the present invention to determine a noise reference signal n′(t) for input to an adaptive noise canceler that removes erratic motion-induced undesired signal portions is a pulse oximeter. A pulse oximeter typically causes energy to propagate through a medium where blood flows close to the surface for example, an ear lobe, or a digit such as a finger, or a forehead. An attenuated signal is measured after propagation through or reflection from the medium. The pulse oximeter estimates the saturation of oxygenated blood available to the body for use.
- Freshly oxygenated blood is pumped at high pressure from the heart into the arteries for use by the body. The volume of blood in the arteries varies with the heartbeat, giving rise to a variation in absorption of energy at the rate of the heartbeat, or the pulse.
- Oxygen depleted, or deoxygenated, blood is returned to the heart by the veins along with unused oxygenated blood. The volume of blood in the veins varies with the rate of breathing, which is typically much slower than the heartbeat. Thus, when there is no motion induced variation in the thickness of the veins, venous blood causes a low frequency variation in absorption of energy. When there is motion induced variation in the thickness of the veins, the low frequency variation in absorption is coupled with the erratic variation in absorption due to motion artifact.
- In absorption measurements using the transmission of energy through a medium, two light emitting diodes (LED's) are positioned on one side of a portion of the body where blood flows close to the surface, such as a finger, and a photodetector is positioned on the opposite side of the finger. Typically, in pulse oximetry measurements, one LED emits a visible wavelength, preferably red, and the other LED emits an infrared wavelength. However, one skilled in the art will realize that other wavelength combinations could be used.
- The finger comprises skin, tissue, muscle, both arterial blood and venous blood, fat, etc., each of which absorbs light energy differently due to different absorption coefficients, different concentrations, and different thicknesses. When the patient is not moving, absorption is substantially constant except for the flow of blood. This constant attenuation can be determined and subtracted from the signal via traditional filtering techniques. When the patient moves, the absorption becomes erratic. Erratic motion induced noise typically cannot be predetermined and subtracted from the measured signal via traditional filtering techniques. Thus, determining the saturation of oxygenated arterial blood becomes more difficult.
- A schematic of a physiological monitor for pulse oximetry is shown in FIG. 10. Two LED's300 and 302, one
LED 300 emitting red wavelengths and anotherLED 302 emitting infrared wavelengths, are placed adjacent afinger 310. Aphotodetector 320, which produces an electrical signal corresponding to the attenuated visible and infrared light energy signals is located opposite the LED's 300 and 302. Thephotodetector 320 is connected to a single channel of common processing circuitry including anamplifier 330 which is in turn connected to aband pass filter 340. Theband pass filter 340 passes signal into asynchronized demodulator 350 which has a plurality of output channels. One output channel is for signals corresponding to visible wavelengths and another output channel is for signals corresponding to infrared wavelengths. - The output channels of the synchronized demodulator for signals corresponding to both the visible and infrared wavelengths are each connected to separate paths, each path comprising further processing circuitry. Each path includes a DC offset
removal element programmable gain amplifier low pass filter low pass filter programmable gain amplifier multiplexer 400. - The
multiplexer 400 is connected to an analog-to-digital converter 410 which is in turn connected to amicroprocessor 420. Control lines between themicroprocessor 420 and themultiplexer 400, themicroprocessor 420 and the analog-to-digital converter 410, and themicroprocessor 420 and eachprogrammable gain amplifier microprocessor 420 has additional control lines, one of which leads to adisplay 430 and the other of which leads to anLED driver 440 situated in a feedback loop with the two LED's 300 and 302. - The LED's300 and 302 each emits energy which is absorbed by the
finger 310 and received by thephotodetector 320. Thephotodetector 320 produces an electrical signal which corresponds to the intensity of the light energy striking thephotodetector 320 surface. Theamplifier 330 amplifies this electrical signal for ease of processing. Theband pass filter 340 then removes unwanted high and low frequencies. Thesynchronized demodulator 350 separates the electrical signal into electrical signals corresponding to the red and infrared light energy components. A predetermined reference voltage, Vref is subtracted by the DC offsetremoval element programmable gain amplifiers programmable gain amplifiers - The
multiplexer 400 acts as an analog switch between the electrical signals corresponding to the red and the infrared light energy, allowing first a signal corresponding to the red light to enter the analog-to-digital convertor 410 and then a signal corresponding to the infrared light to enter the analog-to-digital convertor 410. This eliminates the need for multiple analog-to-digital convertors 410. The analog-to-digital convertor 410 inputs the data into themicroprocessor 420 for calculation of a noise reference signal via the processing technique of the present invention and removal of undesired signal portions via an adaptive noise canceler. Themicroprocessor 420 centrally controls themultiplexer 400, the analog-to-digital convertor 410, and the first and secondprogrammable gain amplifiers microprocessor 420 controls the intensity of the LED's 302 and 304 through theLED driver 440 in a servo loop to keep the average intensity received at thephotodetector 320 within an appropriate range. Within the microprocessor 420 a noise reference signal n′(t) is calculated via either the constant saturation method or the ratiometric method, as described above, the ratiometric method being generally preferred. This signal is used in an adaptive noise canceler of the jointprocess estimator type 60, described above. - The
multiplexer 400 time multiplexes, or sequentially switches between, the electrical signals corresponding to the red and the infrared light energy. This allows a single channel to be used to detect and begin processing the electrical signals. For example, thered LED 300 is energized first and the attenuated signal is measured at thephotodetector 320. An electrical signal corresponding to the intensity of the attenuated red light energy is passed to the common processing circuitry. Theinfrared LED 302 is energized next and the attenuated signal is measured at thephotodetector 320. An electrical signal corresponding to the intensity of the attenuated infrared light energy is passed to the common processing circuitry. Then, the red LED 30.0 is energized again and the corresponding electrical signal is passed to the common processing circuitry. The sequential energization of LED's 300 and 302 occurs continuously while the pulse oximeter is operating. - The processing circuitry is divided into distinct paths after the
synchronized demodulator 350 to ease time constraints generated by time multiplexing. In the preferred embodiment of the pulse oximeter shown in FIG. 10, a sample rate, or LED energization rate, of 1000 Hz is advantageously employed. Thus, electrical signals reach thesynchronized demodulator 350 at a rate of 1000 Hz. Time multiplexing is not used in place of the separate paths due to settling time constraints of the low pass filters 380, 382, and 384. - In FIG. 10, a third LED304 is shown adjacent the finger, located near the LED's 300 and 302. The third LED 304 is used to measure a third signal Sλc(t) to be used to determine saturation using the ratiometric method. The third LED 304 is time multiplexed with the red and infrared LED's 300 and 302. Thus, a third signal is input to the common processing circuitry in sequence with the signals from the red and infrared LED's 300 and 302. After passing through and being processed by the
operational amplifier 330, theband pass filter 340, and thesynchronized demodulator 350, the third electrical signal corresponding to light energy at wavelength λc is input to a separate path including a DC offsetremoval element 364, a firstprogrammable gain amplifier 374, alow pass filter 384, and a secondprogrammable gain amplifier 394. The third signal is then input to themultiplexer 400. - The dashed line connection for the third, LED304 indicates that this third LED 304 is incorporated into the pulse oximeter when the ratiometric method is used; it is unnecessary for the constant saturation method. When the third LED 304 is used, the
multiplexer 400 acts as an analog switch between all threeLED microprocessor 420 and the first and secondprogrammable gain amplifier - For pulse oximetry measurements using the ratiometric method, the signals (logarithm converted) transmitted through the
finger 310 at each wavelength λa, λb, and λc are: - S λa(t)=S λred1(t)=εHbO2,λa c HbO2 A x A(t)+εHb,λa c Hb A x A(t)+εHbO2,λa c HbO2 v x v(t)+nλa(t) (81)
- S λc(t)=S λIR(t)=εHbO2,λb c HbO2 A x A(t)+εHbO2,λb c HbO2 v x v(t)+εHb,λb c Hb v x v(t)+n λb(t). (82)
- S λc(t)=S λIR(t)=εHbO2,λc c HbO2 v x v(t)+εHb,λc c Hb v x v +n λc(t). (83)
- In equations (81) through (83), xA(t) is the lump-sum thickness of the arterial blood in the finger; xV(t) is the lump-sum thickness of venous blood in the finger; εHbO2,λa εHbO2,λb, εHbO2,λc, εHb,λa, εHb,λb, and εHb,λc are the absorption coefficients of the oxygenated and non-oxygenated hemoglobin, at each wavelength measured and cHbO2(t) and cHb(t) with the superscript designations A and V are the concentrations of the oxygenated and non-oxygenated arterial blood and venous blood, respectively.
- For the ratiometric method, the wavelengths chosen are typically two in the visible red range, i.e., λa and λb, and one in the infrared range, i.e., λc. As described above, the measurement wavelengths λa and λb are advantageously chosen to satisfy a proportionality relationship which removes the desired signal portion Yλa(t): and Yλb(t), yielding a noise reference signal n′(t). In the preferred embodiment, the ratiometric method is used to determine the noise reference signal n′(t) by picking two wavelengths that cause the desired portions Yλa(t) and Y′λb(t) of the measured signals Sλa(t) and Sλb(t) to become linearly dependent similarly to equation (22); i.e. wavelengths λa and λb which satisfy:
- εHbO2,λa/εHb,λa=εHbO2,λb/εHb,λb (84)
- Typical wavelength values chosen are λa=650 nm and λb=685 nm. Additionally a typical wavelength value for λc is λc=940 nm. By picking wavelengths λa and λb to satisfy equation (84) the venous portion of the measured signal is also caused to become linearly dependent even though it is not a portion of the desired signal. Thus, the venous portion of the signal is removed with the desired portion. The proportionality relationship between equations (81) and (82) which allows determination of a non-zero noise reference signal n′(t), similarly to equation (25) is:
- ωr4=εHb,λa/εHb,λb; where (85)
- n λa(t)≠ωr4 nλb(t). (86)
- In pulse oximetry, both equations (85) and (86) can typically be satisfied simultaneously.
- FIG. 11 is a graph of the absorption coefficients of oxygenated and deoxygenated hemoglobin (εHbO2 and εHb) vs. wavelength (λ). FIG. 12 is a graph of the ratio of absorption coefficients vs. wavelength, i.e., εHb/εHbO2 VS. λ over the range of wavelength within
circle 13 in FIG. 11. Anywhere a horizontal line touches the curve of FIG. 12 twice, a doesline 400, the condition of equation (84) is satisfied. FIG. 13 shows an exploded view of the area of FIG. 11 within thecircle 13. Values of εHbO2 and εHb at the wavelengths where a horizontal line touches the curve of FIG. 12 twice can then be determined from the data in FIG. 13 to solve for the proportionality relationship of equation (85). - A special case of the ratiometric method is when the absorption coefficients εHbO2 and εHb are equal at a wavelength.
Arrow 410 in FIG. 11 indicates one such location, called an isobestic point. FIG. 13 shows an exploded view of the isobestic point. To use isobestic points with the ratiometric method, two wavelengths at isobestic points are determined to satisfy equation (84). - Multiplying equation (82) by ωr4 and then subtracting equation (82) from equation (81), a non-zero noise reference signal n′(t) is determined by:
- n′(t)=S λa(t)−ωr4 S λb(t)=n λa(t)−ωr4 n λb. (87)
- This noise reference signal n′(t) has spectral content corresponding to the erratic, motion-induced noise. When it is input to an adaptive noise canceler, with either the signals Sλa(t) and Sλc(t) or Sλb(t) and Sλc(t) input to two regression filters 80 a and 80 b, the adaptive noise canceler will function much like an adaptive multiple notch filter and remove frequency components present in both the noise reference signal n′(t) and the measured signals from the measured signals Sλa(t) and Sλc(t) or Sλb(t) and Sλc(t). Thus, the adaptive noise canceler is able to remove erratic noise caused in the venous portion of the measured signals Sλa(t), Sλb(t), and Sλc(t) even though the venous portion of the measured signals Sλa(t) and Sλb(t) was not incorporated in the noise reference signal n′(t). However, the low frequency absorption caused by venous blood moving through the veins is generally not one of the frequencies incorporated into the noise reference signal n′(t). Thus, the adaptive noise canceler generally will not remove this portion of the undesired signal. However, a band pass filter applied to the approximations to the desired signals Y′λa(t) and Y′λc(t) or Y′λb(t) and Y′λc(t) can remove this portion of the undesired signal corresponding to the low frequency venous absorption.
- For pulse oximetry measurements using the constant saturation method, the signals (logarithm converted) transmitted through the
finger 310 at each wavelength λa and λb are: - S λa(t)=S λred1(t)=εHbO2,λa c HbO2 A x A(t)+εHb,λa c Hb A x A(t)+εHbO2,λa c HbO2 x v(t)+εHb,λa c Hb,λa c Hb v x v(t)+n λa(t). (88)
- S λb(t)=S λIR(t)=εHbO2,λb c HbO2 A x A(t)+εHb,λb c Hb A x A(t)+εHbO2,λb c HbO2 v x v(t)+εHb,λb c Hb v x v(t)+n λb(t). (89)
- For the constant saturation method, the wavelengths chosen are typically one in the visible red range, i.e., λa, and one in the infrared range, i.e., λb. Typical wavelength values chosen are λa=660 nm and λb=940 nm. Using the constant saturation method, it is assumed that CHb02(t)/CHb(t)=constant. The saturation of oxygenated arterial blood changes slowly, if at all, with respect to the sample rate, making this a valid assumption. The proportionality factor between equation (88) and (89) can then be written as:
- In pulse oximetry, it is typically the case that both equations (91) and (92) can be satisfied simultaneously.
-
- The constant saturation assumption does not cause the venous contribution to the absorption to be canceled along with the desired signal portions Yλa(t) and Y′λb(t), as did the relationship of equation (84) used in the ratiometric method. Thus, frequencies associated with both the low frequency modulated absorption due to venous absorption when the patient is still and the erratically modulated absorption due to venous absorption when the patient is moving are represented in the noise reference signal n′(t). Thus, the adaptive canceler can remove both erratically modulated absorption due to venous blood in the finger under motion and the constant low frequency cyclic absorption of venous blood.
- Using either method, a noise reference signal n′(t) is determined by the processor of the present invention for use in an adaptive noise canceler which is defined by software in the microprocessor. The preferred adaptive noise canceler is the
joint process estimator 60 described above. - Illustrating the operation of the ratiometric method of the present invention, FIGS. 14, 15 and16 show signals measured for use in determining the saturation of oxygenated arterial blood using a reference processor of the present invention which employs the ratiometric method, i.e., the signals Sλa(t)=Sλred1(t), Sλb(t)=Sλred2(t), and Sλc(t)=SλIR(t). A first segment 14 a, 15 a, and 16 a of each of the signals is relatively undisturbed by motion artifact, i.e., the patient did not move substantially during the time period in which these segments were measured. These segments 14 a, 15 a, and 16 a are thus generally representative of the desired plethysmographic waveform at each of the measured wavelengths. A
second segment segments third segment - FIG. 17 shows the noise reference signal n′(t)=nλa−ωr4nλb(t), as determined by a reference processor of the present invention utilizing the ratiometric method. As discussed previously, the noise reference signal n′(t) is correlated to the undesired signal portions nλa, nλb, and nλc. Thus, a first segment 17 a of the noise reference signal n′(t) is generally flat, corresponding to the fact that there is very little motion induced noise in the first segments 14 a, 15 a, and 16 a of each signal. A
second segment 17 b of the noise reference signal n′(t) exhibits large excursions, corresponding to the large motion induced excursions in each of the measured signals. Athird segment 17 c of the noise reference signal n′(t) is generally flat, again corresponding to the lack of motion artifact in thethird segments 14 a, 14 b, and 14 c of each measured signal. - FIGS. 18 and 19 show the approximations Y′λa(t) and Y′λc(t) to the desired signals Yλa(t) and Yλc(t) as estimated by the
joint process estimator 60 using a noise reference signal n′(t) determined by the ratiometric method. Note that the scale of FIGS. 14 through 19 is not the same for each figure to better illustrate changes in each signal. FIGS. 18 and 19 illustrate the effect of the joint process estimator adaptive noise canceler using the noise reference signal n′(t) as determined by the reference processor of the present invention using the ratiometric method.Segments segments 14 b, 15 b; and 16 b of the measured signals. Additionally,segments signal segments - Illustrating the operation of the constant saturation method of the present invention, FIGS. 20 and 21 show signals measured for input to a reference processor of the present invention which employs the constant saturation method, i.e., the signals Sλa(t)=Sλred(t) and Sλb(t)=SλIR(t). A first segment 20 a and 21 a of each of the signals is relatively undisturbed by motion artifact, i.e., the patient did not move substantially during the time period in which these segments were measured. These segments 20 a and 21 a are thus generally representative of the desired plethysmographic waveform at each of the measured wavelengths. A
second segment segments third segment - FIG. 22 shows the noise reference signal n′(t)=nλa(t)−ωs4nλb(t), as determined by a reference processor of the present invention utilizing the constant saturation method. Again, the noise reference signal n′(t) is correlated to the undesired signal portions nλa and nλb. Thus, a
first segment 22 a of the noise reference signal n′(t) is generally flat, corresponding to the fact that there is very little motion induced noise in the first segments 20 a and 21 a of each signal. Asecond segment 22 b of the noise reference signal n′(t) exhibits large excursions, corresponding to the large motion induced excursions in each of the measured signals. Athird segment 22 c of the noise reference signal n′(t) is generally flat, again corresponding to the lack of motion artifact in thethird segments - FIGS. 23 and 24 show the approximations Y′λa(t) and Y′λb(t) to the desired signals Ya(t) and Yλb(t) as estimated by the
joint process estimator 60 using a noise reference signal n′(t) determined by the constant saturation method. Note that the scale of FIGS. 20 through 24 is not the same for each figure to better illustrate changes in each signal. FIGS. 23 and 24 illustrate the effect of the joint process estimator adaptive noise canceler using the noise reference signal n′(t) as determined by a reference processor of the present invention utilizing the constant saturation method.Segments 23 b and 24 b are not dominated by motion induced noise as weresegments segments signal segments - A copy of a computer program subroutine, written in the C programming language, calculates a noise reference signal n′(t) using the ratiometric method and, using a
joint process estimator 60, estimates the desired signal portions of two measured signals, each having an undesired portion which is correlated to the noise reference signal n′(t) and one of which was not used to calculate the noise reference signal n′(t), is appended in Appendix A. For example, Sλa(t)=Sλred1(t) Sλ650 nm(t) and Sλc(t)=SλIR(t)=Sλ940 nm(t) can be input to the computer subroutine. One skilled in the art will realize that Sλa(t)=Sλred2(t)=Sλ685 nm(t) and Sλc(t)=SλIR(t)=Sλ940 nm(t) will also work. This subroutine is one way to implement the steps illustrated in the flowchart of FIG. 8 for a monitor particularly adapted for pulse oximetry. - The program estimates the desired signal portions of two light energy signals, one preferably corresponding to lighted in the visible red range and the other preferably corresponding to light in the infrared range such that a determination of the amount of oxygen availiable to the body, or the saturation of oxygen in the arterial blood, may be made. The calculation of the saturation is performed in a separate subroutine. Various methods for calculation of the oxygen saturation are known to those skilled in the art. One such calculation is described in the articles by G. A. Mook, et al, and Michael R. Neuman cited above. Once the concentration of oxygenated hemoglobin and deoxygenated hemoglobin are determined, the value of the saturation is determined similarly to equations (73) through (80) wherein measurements at times t1 and t2 are made at different, yet proximate times over which the saturation is relatively constant. For pulse oximetry, the average saturation at time t=(t1+t2)/2 is then determined by:
- Using the ratiometric method, three signals Sλa(t), Sλb(t), and Sλc(t) are input to the subroutine. Sλa(t) and Sλb(t) are used to calculate the noise reference signal n′(t).
- As described above, the wavelengths of light at which Sλa(t) and Sλb(t) are measured are chosen to satisfy the relationship of equation (84). Once the noise reference signal n′(t) is determined, the desired signal portions Yλa(t) and Yλc(t) of the measured signals Sλa(t) and Sλc(t) are estimated for use in calculation of the oxygen saturation.
- The correspondence of the program variables to the variables defined in the discussion of the joint process estimator is as follows:
- Δm(t)=nc [ ].Delta
- Γf,m(t)=nc [ ].fref
- Γb,m(t)=nc [ ].berf
- fm(t)=nc [ ].ferr
- bm(t)=nc [ ].berr
-
- βm(t)=nc[ ].Bswsqr
- γm(t)=nc [ ].Gamma
- ρm,λa(t)=nc [ ].Roh_a
- ρmλc(t)=nc [ ].Roh_c
- em,λa(t)=nc [ ].err_a
- em,λc(t)=nc [ ].err_c
- κm,λa(t)=nc [ ].K_a
- κm,λc(t)=nc [ ].K_c
- A first portion of the program performs the initialization of the
registers box 120 and equations (40) through (44) and equations (61), (62), (65), and (66). A second portion of the program performs the time updates of thedelay element variables 110 where the value at the input of eachdelay element variable 110 is stored in the delay element variable 110 as in the “TIME>UPDATE OF [Z−1]ELEMENTS”box 130. - A third portion of the program calculates the noise reference signal, as in the “CALCULATE NOISE REFERENCE (n′(t)) FOR TWO MEASURED SIGNAL SAMPLES”
box 140 using the proportionality constant ωr4 determined by the ratiometric method as in equation (85). - A fourth portion of the program performs the zero-stage update as in the “ZERO-STAGE UPDATE”
box 150 where the zero-stage forward prediction error fo(t) and the zero-stage backward prediction error bo(t) are set equal to the value of the noise reference signal n′(t) just calculated. Additionally, zero-stage values of intermediate variables 0(t) and β0(t) (nc[ ].Fswsqr and nc[ ].Bswsgr in the program) are calculated for use in settingregister squares lattice predictor 70 and the regression filters 80 a and 80 b. - A fifth portion of the program is an iterative loop wherein the loop counter, m, is reset to zero with a maximum of m=NC_CELLS, as in the “m=0”
box 160 in FIG. 8. NC_CELLS is a predetermined maximum value of iterations for the loop. A typical value of NC_CELS is between 60 and 80, for example. The conditions of the loop are set such that the loop iterates a minimum of five times and continues to iterate until a test for conversion is met or m=NC_CELLS. The test for conversion is whether or not the sum of the weighted sum of forward prediction errors plus the weighted sum of backward prediction errors is less than a small number, typically 0.00001 (i.e, m(t)+βm(t)≦0.00001). - A sixth portion of the program calculates the forward and backward reflection coefficient Γm,f(t) and Γm,b(t) register 90 and 92 values (nc[ ].fref and nc[ ].bref in the program) as in the “ORDER UPDATE mth-STAGE OF LSL-PREDICTOR”
box 170 and equations (49) and (50). Then forward and backward prediction errors fm(t) and bm(t) (nc[ ].ferr and nc[ ].berr in the program) are calculated as in equations (51) and (52). Additionally, intermediate variables m(t), βm(t) and γm(t) (nc[ ].Fswsqr, nc[ ].Bswsqr, nc.[ ].Gamma in the program) are calculated, as in equations (53), (54), and (55). The first cycle of the loop uses the values for nc[0].Fswsgr and n[0].Bswsqr calculated in the ZERO-STAGE UPDATE portion of the program. - A seventh portion of the program, still within the loop, calculates the regression coefficient κm,λa(t) and κm,λc(t) register 96 and 98 values (nc[ ].K_a and nc[ ].K_c in the program) in both regression filters, as in the “ORDER UPDATE mth STAGE OF REGRESSION FILTER(S)”
box 180 and equations (57) through (68). Intermediate error signals and variables em,λa(t), em,λc(t), ρm,λa(t), and ρm,λc(t) (nc[ ].err_a and nc[ ].err_c, nc[ ].roh_a, and nc[ ].roh_c in the subroutine) are also calculated as in equations (58), (64), (56), and (60), respectively. - The test for convergence of the joint process estimator is performed each time the loop iterates, analogously to the “DONE”
box 190. If the sum of the weighted sums of the forward and backward prediction errors m(t)+βm(t) is less than or equal to 0.00001, the loop terminates. Otherwise, the sixth and seventh portions of the program repeat. - When either the convergence test is passed or m=NC_CELLS, an eighth portion of the program calculates the output of the
joint process estimator 60 adaptive noise canceler as in the “CALCULATE OUTPUT”box 200. This output is a good approximation to both of the desired signals Y′λa(t) and Y′λc(t) for the set of samples Sλa(t), Sλa(t) and Sλc(t) input to the program. After many sets of samples are processed by the joint process estimator, a compilation of the outputs provides output waves which are good approximations to the plethysmographic wave at each wavelength, λa and λc. - Another copy of a computer program subroutine, written in the C programming language, which calculates a noise reference signal n′(t) using the constant saturation method and, using a
joint process estimator 60, estimates a good approximation to the desired signal portions of two measured signals, each having an undesired portion which is correlated to the noise reference signal n′(t) and each having been used to calculate the noise reference signal n′(t), is appended in Appendix B. This. Subroutine is another way to implement the steps illustrated in the flowchart of FIG. 8 for a monitor particularly adapted for pulse oximetry. The two signals are measured at two different wavelengths λa and λb, where λa is typically in the visible region and λb is typically in the infrared region. For example, in one embodiment of the present invention, tailored specifically to perform pulse oximetry using the constant saturation method, λa 660 nm and λb=940 nm. - The correspondence of the program variables to the variables defined in the discussion of the joint process estimator is as follows:
- Δm(t)=nc[ ].Delta
- rf,m(t)=nc[ ].fref
- rb,m(t)=nc[ ].bref
- fm(t)=nc[ ].ferr
- bm(t)=nc[ ].berr
-
- βm(t) nc[ ].Bswsqr
- γ(t)=nc[ ].Gamma
- pm,λa(t) nc[ ].Roh_a
- pmλb(t)=nc[ ].Roh_b
- em,λa(t)=nc[ ].err_a
- em,λb(t)=nc[ ].err_b
- κm,λa(t)=nc[ ].K_a
- κm,λb(t)=nc[ ].K_b
- First and second portions of the subroutine are the same as the first and second portions of the above described subroutine tailored for the ratiometric method of determining the noise reference signal n′(t).
- A third portion of the subroutine calculates the noise reference signal, as in the “CALCULATE NOISE REFERENCE (n′(t)) FOR TWO MEASURED SIGNAL SAMPLES”
box 140 for the signals Sλa(t) and Sλb(t) using the a proportionality constant ωs4(t) determined by the constant saturation method as in equations (90) and (91). The saturation is calculated in a separate subroutine and a value of ws4(t) is imported to the present subroutine for estimating the desired portions Yλa(t) and Yλb(t) of the composite measured signals Sλa(t) and Sλb(t). - Fourth, fifth, and sixth portions of the subroutine are similar to the fourth, fifth, and sixth portions of the above described program tailored for the ratiometric method. However, the signals being used to estimate the desired signal portions Y′λa(t) and Yλb(t) in the present subroutine tailored for the constant saturation method, are Sλa(t) and, Sλb(t), the same signals that were used to calculate the noise reference signal n′(t).
- A seventh portion of the program, still within the loop begun in the fifth portion of the program, calculates the
regression coefficient register box 180 and equations (57) through (67). Intermediate error signals and variables em,λa(t), rm,λb(t), ρm,λa(t), and ρm,λb(t) (nc.[ ]err_a and nc[ ].err_b, .nc[ ].roh_a, and nc[ ].roh_b in the subroutine) are also calculated as in equations (58), (63), (56), and (59), respectively. - The loop iterates until the test for convergence is passed, the test being the same as described above for the subroutine tailored for the ratiometric method. The output of the present subroutine is a good approximation to the desired signals Y′λa(t) and Y′λb(t) for the set of samples Sλa(t) and Sλb(t) input to the program. After approximations to the desired signal portions of many sets of measured signal samples are estimated by the joint process estimator, a compilation of the outputs provides waves which are good approximations to the plethysmographic wave at each wavelength, λa and λb. The estimating process of the iterative loop is the same in either subroutine, only the sample values Sλa(t) and Sλc(t) or Sλa(t) and Sλb(t) input to the subroutine for use in estimation of the desired signal portions Yλa(t) and Yλc(t) or Y′λa(t) and Yλb(t) and how the noise reference signal n′(t) is calculated are different for the ratiometric method and the constant saturation methods.
- Independent of the method used, ratiometric or constant saturation, the approximations to the desired signal values Y′λa(t) and Y′λc(t) or Yλa(t) and Y′λb(t) are input to a separate subroutine in which the saturation of oxygen in the arterial blood is calculated. If the constant saturation method is used, the saturation calculation subroutine also determines a value for the proportionality constant ωs4(t) as defined in equations (90) and (91) and discussed above. The concentration of oxygenated arterial blood can be found from the approximations to the desired signal values since the desired signals are made up of terms comprising x(t), the thickness of arterial blood in the finger; absorption coefficients of oxygenated and de-oxygenated hemoglobin, at each measured wavelength; and CHbO2(t) and CHb(t), the concentrations of oxygenated and de-oxygenated hemoglobin, respectively. The saturation is a ratio of the concentration of one constituent, A5, with respect to the total concentration of constituents in the volume containing A5 and A6. Thus, the thickness, x(t), is divided out of the saturation calculation and need not be predetermined. Additionally, the absorption coefficients are constant at each wavelength. The saturation of oxygenated arterial blood is then determined as in equations (95) and (96).
- While one embodiment of a physiological monitor incorporating a processor of the present invention for determining a noise reference signal for use in an adaptive noise canceler to remove erratic noise components from a physiological measurement has been described in the form of a pulse oximeter, it will be obvious to one skilled in the art that other types of physiological monitors may also employ the above described techniques for noise reduction on a composite measured signal in the presence of noise.
- Furthermore, it will be understood that transformations of measured signals other than logarithmic conversion and determination of a proportionality factor which allows removal of the desired signal portions for determination of a noise reference signal are possible. Additionally, although the proportionality factor ω has been described herein as a ratio of a portion of a first signal to a portion of a second signal, a similar proportionality constant determined as a ratio of a portion of a second signal to a portion of a first signal could equally well be utilized in the processor of the present invention. In the latter case, a noise reference signal would generally resemble n′(t)=nλb(t)−ωnλa(t).
- It will also be obvious to one skilled in the art that for most physiological measurements, two wavelengths may be determined which will enable a signal to be measured which is indicative of a quantity of a component about which information is desired. Information about a constituent of any energy absorbing physiological material may be determined by a physiological monitor incorporating a signal processor of the present invention and an adaptive noise canceler by determining wavelengths which are absorbed primarily by the constituent of interest. For most physiological measurements, this is a simple determination.
- Moreover, one skilled in the art will realize that any portion of a patient or a material derived from a patient may be used to take measurements for a physiological monitor incorporating a processor of the present invention and an adaptive noise canceler. Such areas include a digit such as a finger, but are not limited to a finger.
- One, skilled in the art will realize that many different types of physiological monitors may employ a signal processor of the present invention in conjunction with an adaptive noise canceler. Other types of physiological monitors include, but are in not limited to, electron cardiographs, blood pressure monitors, blood gas saturation (other than oxygen saturation) monitors, capnographs, heart rate monitors, respiration monitors, or depth of anesthesia monitors. Additionally, monitors which measure the pressure and quantity of a substance within the body such as a breathalizer, a drug monitor, a cholesterol monitor, a glucose monitor, a carbon dioxide monitor, a glucose monitor, or a carbon monoxide monitor may also employ the above described techniques for removal of undesired signal portions.
- Furthermore, one skilled in the art will realize that the above described techniques of noise removal from a composite signal including noise components can also be performed on signals made up of reflected energy, rather than transmitted energy. One skilled in the art will also realize that a desired portion of a measured signal of any type of energy, including but not limited to sound energy, X-ray energy, gamma ray energy, or light energy can be estimated by the noise removal techniques described above. Thus, one skilled in the art will realize that the processor of the present invention and an adaptive noise canceler can be applied in such monitors as those using ultrasound where a signal is transmitted through a portion of the body and reflected back from within the body back through this portion of the body. Additionally, monitors such as echo cardiographs may also utilize the techniques of the present invention since they too rely on transmission and reflection.
- While the present invention has been described in terms of a physiological monitor, one skilled in the art will realize that the signal processing techniques of the present invention can be applied in many areas, including but not limited to the processing of a physiological signal. The present invention may be applied in any situation where a signal processor comprising a detector receives a first signal which includes a first desired signal portion and a first undesired signal portion and a second signal which includes a second desired signal portion and a second undesired signal portion. The first and second signals propagate through a common medium and the first and second desired signal portions are correlated with one another. Additionally, at least a portion of the first and second undesired signal portions are correlated with one another due to a perturbation of the medium while the first and second signals are propagating through the medium. The processor receives the first and second signals and combines the first and second signals to generate a noise reference signal in which the primary component is derived from the first and second undesired signal portions. Thus, the signal processor of the present invention is readily applicable to numerous signal processing areas.
/***************************************************************************** ************************** APPENDIX A ****************************** ************************* Least Square Lattice ***************************** ************************ Noise Cancelling ****************************/ /* Example for ratiometric approach to noise cancelling */ #define LAMBDA 0.95 void OxiLSL_NC( int reset, int passes, int *signal_1, int *signal_2, int *signal_3, int *target_1, int *target_2) { int i, ii, k, m, n, contraction; static int *s_a, *s_b, *s_c, *out_a, *out_c; static float Delta_sqr, scale, noise_ref; if( reset == TRUE) { s_a = signal_1; s_b = signal_2; s_c = signal_3; out_a = target_1; out_c = target_2; factor = 1.5; scale = 1.0 /4160.0; /* noise canceller initialization at time t=0 */ nc[0].berr = 0.0; nc[0].Gamma = 1.0; for(m=0; m<NC_CELLS; m++) { nc[m].err_a = 0.0; nc[m].err_b = 0.0; nc[m].Roh_a = 0.0; nc[m].Roh_c = 0.0; nc[m].Delta = 0.0; nc[m].Fswsqr = 0.00001; nc[m].Bswsqr = 0.00001; } } /* ====================== END INITIALIZATION =========================*/ for(k=0; k<passes; k++){ contraction = FALSE; for(m=0; m< NC_CELLS; m++) { /* Update delay elements */ nc[m].berr1 = nc[m].berr; nc[m].Bswsqr1 = nc[m].Bswsqr; } noise_ref = factor * log(1.0 − (*s_a) * scale) − log(1.0 − (*s_b) * scale) ; nc[0].err_a = log(1.0 − (*s_b) * scale); nc[0].err_b = log(1.0 − (*s_c) * scale); ++s_a; ++s_b; ++s_c; nc[0].ferr = noise_ref ; nc[0].berr = noise_ref ; nc[0].Fswsqr = LAMBDA * nc[0].Fswsqr + noise_ref * noise_ref; nc[0].Bswsqr = nc[0].Fswsqr; /* Order Update */ for(n=1;( n < NC_CELLS) && (contraction == FALSE); n++) { /* Adaptive Lattice Section */ m = n−1; ii= n−1; nc[m].Delta *= LAMBDA; nc[m].Delta += nc[m].berr1 * nc[m].ferr / nc[m].Gamma ; Delta_sqr = nc[m].Delta * nc[m].Delta; nc[n].fref = −nc[m].Delta / nc[m].Bswsqr1; nc[n].bref = −nc[m].Delta / nc[m].Fswsqr; nc[n].ferr = nc[m].ferr + nc[n].fref * nc[m].berr1; nc[n].berr = nc[m].berr1 + nc[n].bref * nc[m].ferr; nc[n].Fswsqr = nc[m].Fswsqr − Delta_sqr / nc[m].Bswsqr1; nc[n].Bswsqr = nc[m].Bswsqr1 − Delta_sqr / nc[m].Fswsqr; if( (nc[n].Fswsqr + nc[n].Bswsqr) > 0.00001 ∥ (n < 5) ) { nc[n].Gamma = nc[m].Gamma − nc[m].berr1 * nc[m].berr1 / nc[m].Bswsqr1; if(nc[n].Gamma < 0.05) nc[n].Gamma = 0.05; if(nc[n].Gamma > 1.00) nc[n].Gamma = 1.00; /* Joint Process Estimation Section */ nc[m].Roh_a *= LAMBDA; nc[m].Roh_a += nc[m].berr * nc[m].err_a / nc[m].Gamma ; nc[m].k_a = nc[m].Roh_a / nc[m].Bswsqr; nc[n].err_a = nc[m].err_a − nc[m].k_a * nc[m].berr; nc[m].Roh_c *= LAMBDA; nc[m].Roh_c += nc[m].berr * nc[m].err_b / nc[m].Gamma ; nc[m].k_c = nc[m].Roh_c / nc[m].Bswsqr; nc[n].err_b = nc[m].err_b − nc[m].k_c * nc[m].berr; } else { contraction = TRUE; for(i=n; i<NC_CELLS; i++) { nc[i].err_a = 0.0; nc[i].Roh_a = 0.0; nc[i].err_b = 0.0; nc[i].Roh_c = 0.0; nc[i].Delta = 0.0; nc[i].Fswsqr = 0.00001; nc[i].Bswsqr = 0.00001; nc[i].Bswsqr1 = 0.00001; } } } *out_a++ = (int)( (−exp(nc[ii].err_a) +1.0) / scale) ; *out_c++ = (int)( (−exp(nc[ii].err_b) +1.0) / scale) ; } } /********************** Least Square Lattice *************************** ************************* ***************************** *****************************************************************************/ /***************************************************************************** ************************** APPENDIX B ****************************** ************************* Least Square Lattice ***************************** ************************ Noise Cancelling ****************************/ /* Example for constant saturation approach to noise cancelling */ #define LAMBDA 0.95 void OxiLSL_NC( int reset, int passes, int sat_factor, int *signal_1, int *signal_2, int *target_1, int *target_2) { int i, ii, k, m, n, contraction; static int *s_a, *s_b, *out_a, *out_b; static float Delta_sqr, scale, noise_ref; if( reset == TRUE) { s_a = signal_1; s_b = signal_2; out_a = target_1; out_b = target_2; scale = 1.0 /4160.0; /* noise canceller initialization at time t=0 */ nc[0].berr = 0.0; nc[0].Gamma = 1.0; for(m=0; m<NC_CELLS; m++) { nc[m].err_a = 0.0; nc[m].err_b = 0.0; nc[m].Roh_a = 0.0; nc[m].Roh_b = 0.0; nc[m].Delta = 0.0; nc[m].Fswsqr = 0.00001; nc[m].Bswsqr = 0.00001; } } /*===================== END INITIALIZATION ========================*/ for(k=0; k<passes; k++){ contraction = FALSE; for(m=0; m< NC_CELLS; m++) { /* Update delay elements */ nc[m].berr1 = nc[m].berr; nc[m].Bswsqr1 = nc[m].Bswsqr; } noise_ref = sat_factor * log(1.0 − (*s_a) * scale) − log(1.0 − (*s_b) * scale) ; nc[0].err_a = log(1.0 − (*s_a) * scale); nc[0].err_b = log(1.0 − (*s_b) * scale); ++s_a; ++s_b; nc[0].ferr = noise_ref ; nc[0].berr = noise_ref ; nc[0].Fswsqr = LAMBDA * nc[0].Fswsqr + noise_ref * noise_ref; nc[0].Bswsqr = nc[0].Fswsqr; /* Order Update */ for(n=1;( n < NC_CELLS) && (contraction == FALSE) ; n++) { /* Adaptive Lattice Section */ m = n−1; ii= n−1; nc[m].Delta *= LAMBDA; nc[m].Delta += nc[m].berr1 * nc[m].ferr / nc[m].Gamma ; Delta_sqr = nc[m].Delta * nc[m].Delta; nc[n].fref = −nc[m].Delta / nc[m].Bswsqr1; nc[n].bref = −nc[m].Delta / nc[m].Fswsqr; nc[n].ferr = nc[m].ferr + nc[n].fref * nc[m].berr1; nc[n].berr = nc[m].berr1 + nc[n].bref * nc[m].ferr; nc[n].Fswsqr = nc[m].Fswsqr − Delta_sqr / nc[m].Bswsqr1; nc[n].Bswsqr = nc[m].Bswsqr1 − Delta_sqr / nc[m].Fswsqr; if( (nc[n].Fswsqr + nc[n].Bswsqr) > 0.00001 ∥ (n < 5) ) { nc[n].Gamma = nc[m].Gamma − nc[m].berr1 * nc[m].berr1 / nc[m].Bswsqr1; if(nc[n].Gamma < 0.05) nc[n].Gamma = 0.05; if(nc[n].Gamma > 1.00) nc[n].Gamma = 1.00; /* Joint Process Estimation Section */ nc[m].Roh_a *= LAMBDA; nc[m].Roh_a += nc[m].berr * nc[m].err_a / nc[m].Gamma ; nc[m].k_a = nc[m].Roh_a / nc[m].Bswsqr; nc[n].err_a = nc[m].err_a − nc[m].k_a * nc[m].berr; nc[m].Roh_b *= LAMBDA; nc[m].Roh_b += nc[m].berr * nc[m].err_b / nc[m].Gamma ; nc[m].k_b = nc[m].Roh_b / nc[m].Bswsqr; nc[n].err_b = nc[m].err_b − nc[m].k_b * nc[m].berr; } else { contraction = TRUE; for(i=n; i<NC_CELLS; i++) { nc[i].err_a = 0.0; nc[i].Roh_a = 0.0; nc[i].err_b = 0.0; nc[i].Roh_b = 0.0; nc[i].Delta = 0.0; nc[i].Fswsqr = 0.00001; nc[i].Bswsqr = 0.00001; nc[i].Bswsqr1 = 0.00001; } } } *out_a++ = (int)( (−exp(nc[ii].err_a) +1.0) / scale) ; *out_b++ = (int)( (−exp(nc[ii].err_b) +1.0) / scale) ; } } /********************** Least Square Lattice *************************** ************************* ***************************** *****************************************************************************/
Claims (11)
1. A method of determining blood oxygen saturation of pulsing blood, the method comprising:
receiving a plurality of intensity signals from light-sensitive detector over a period of time, wherein the light-sensitive detector detects light of a plurality of wavelengths attenuated by body tissue carrying pulsing blood; and
calculating a representative value of blood oxygen saturation based on an assumption that oxygen saturation of pulsing blood remains relatively constant over a predetermined portion of the period of time.
2. The method of claim 1 , wherein the plurality of intensity signals include motion induced noise.
3. A method of determining blood oxygen saturation of pulsing blood, the method comprising:
receiving a plurality of intensity signals from light-sensitive detector over a period of time, wherein the light-sensitive detector detects light of a plurality of wavelengths attenuated by body tissue carrying pulsing blood; and
calculating a representative value of blood oxygen saturation based on an assumption that oxygen saturation of pulsing blood changes relatively slowly.
4. The method of claim 3 , wherein the calculating comprises use of a self-optimizing filter language.
5. The method of claim 3 , wherein the plurality of intensity signals include motion induced noise.
6. A method of determining blood oxygen saturation comprising:
receiving first and second intensity signals from light-sensitive detector which detects light of at least first and second wavelengths attenuated by body tissue carrying pulsing blood; and
calculating oxygen saturation based upon a principle that the oxygen saturation changes relatively slowly over short periods of time, wherein the calculation occurs during the presence of motion induced noise in the first and second intensity signals.
7. A patient monitoring device which determines an indication of oxygen saturation of pulsing blood, the patient monitoring device comprising:
a light sensitive detector which detects light of a plurality of wavelengths attenuated by body tissue carrying pulsing blood and outputs a plurality of intensity signals over a period of time based on the detected light; and
a signal processing system which calculates a representative value of blood oxygen saturation based on assumptions corresponding to an amount of change in the oxygen saturation of pulsing blood over a predetermined portion of the period of time.
8. The patient monitoring device of claim 7 , wherein the assumptions include an assumption that the oxygen saturation remains relatively constant over the predetermined portion.
9. The patient monitoring device of claim 7 , wherein the assumptions include an assumption that the oxygen saturation remains changes relatively slowly over the predetermined portion.
10. The patient monitoring device of claim 7 , wherein the plurality of intensity signals include motion induced noise.
11. The patient monitoring device of claim 7 , wherein the signal processing system further performs calculations using a self-optimizing filter language.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/839,309 US20040204638A1 (en) | 1991-03-07 | 2004-05-04 | Signal processing apparatus and method |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66606091A | 1991-03-07 | 1991-03-07 | |
US08/249,690 US5482036A (en) | 1991-03-07 | 1994-05-26 | Signal processing apparatus and method |
US08/479,918 US5769785A (en) | 1991-03-07 | 1995-06-07 | Signal processing apparatus and method |
US09/102,131 US6036642A (en) | 1991-03-07 | 1998-06-22 | Signal processing apparatus and method |
US09/441,736 US6206830B1 (en) | 1991-03-07 | 1999-11-17 | Signal processing apparatus and method |
US09/757,444 US6501975B2 (en) | 1991-03-07 | 2001-01-09 | Signal processing apparatus and method |
US10/327,234 US6826419B2 (en) | 1991-03-07 | 2002-12-20 | Signal processing apparatus and method |
US10/839,309 US20040204638A1 (en) | 1991-03-07 | 2004-05-04 | Signal processing apparatus and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/327,234 Continuation US6826419B2 (en) | 1991-03-07 | 2002-12-20 | Signal processing apparatus and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040204638A1 true US20040204638A1 (en) | 2004-10-14 |
Family
ID=24672658
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/249,690 Expired - Lifetime US5482036A (en) | 1991-03-07 | 1994-05-26 | Signal processing apparatus and method |
US08/479,918 Expired - Lifetime US5769785A (en) | 1991-03-07 | 1995-06-07 | Signal processing apparatus and method |
US09/102,131 Ceased US6036642A (en) | 1991-03-07 | 1998-06-22 | Signal processing apparatus and method |
US09/441,736 Expired - Fee Related US6206830B1 (en) | 1991-03-07 | 1999-11-17 | Signal processing apparatus and method |
US09/757,444 Expired - Fee Related US6501975B2 (en) | 1991-03-07 | 2001-01-09 | Signal processing apparatus and method |
US10/095,586 Expired - Fee Related USRE38492E1 (en) | 1991-03-07 | 2002-03-11 | Signal processing apparatus and method |
US10/327,234 Expired - Fee Related US6826419B2 (en) | 1991-03-07 | 2002-12-20 | Signal processing apparatus and method |
US10/839,309 Abandoned US20040204638A1 (en) | 1991-03-07 | 2004-05-04 | Signal processing apparatus and method |
Family Applications Before (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/249,690 Expired - Lifetime US5482036A (en) | 1991-03-07 | 1994-05-26 | Signal processing apparatus and method |
US08/479,918 Expired - Lifetime US5769785A (en) | 1991-03-07 | 1995-06-07 | Signal processing apparatus and method |
US09/102,131 Ceased US6036642A (en) | 1991-03-07 | 1998-06-22 | Signal processing apparatus and method |
US09/441,736 Expired - Fee Related US6206830B1 (en) | 1991-03-07 | 1999-11-17 | Signal processing apparatus and method |
US09/757,444 Expired - Fee Related US6501975B2 (en) | 1991-03-07 | 2001-01-09 | Signal processing apparatus and method |
US10/095,586 Expired - Fee Related USRE38492E1 (en) | 1991-03-07 | 2002-03-11 | Signal processing apparatus and method |
US10/327,234 Expired - Fee Related US6826419B2 (en) | 1991-03-07 | 2002-12-20 | Signal processing apparatus and method |
Country Status (9)
Country | Link |
---|---|
US (8) | US5482036A (en) |
EP (3) | EP1357481A3 (en) |
JP (1) | JP3363150B2 (en) |
AT (1) | ATE184716T1 (en) |
AU (1) | AU658177B2 (en) |
CA (1) | CA2105682C (en) |
DE (1) | DE69229994T2 (en) |
RU (1) | RU2144211C1 (en) |
WO (1) | WO1992015955A1 (en) |
Cited By (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080027299A1 (en) * | 2006-02-20 | 2008-01-31 | Andreas Tobola | Spectral analysis for a more reliable determination of physiological parameters |
US20090216499A1 (en) * | 2006-02-20 | 2009-08-27 | Andreas Tobola | Adaptive filtering for more reliably determining physiological parameters |
US7647084B2 (en) | 2005-08-08 | 2010-01-12 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7650177B2 (en) | 2005-09-29 | 2010-01-19 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US7657296B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Unitary medical sensor assembly and technique for using the same |
US7657295B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7658652B2 (en) | 2006-09-29 | 2010-02-09 | Nellcor Puritan Bennett Llc | Device and method for reducing crosstalk |
US7676253B2 (en) | 2005-09-29 | 2010-03-09 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7680522B2 (en) | 2006-09-29 | 2010-03-16 | Nellcor Puritan Bennett Llc | Method and apparatus for detecting misapplied sensors |
US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
US7689259B2 (en) | 2000-04-17 | 2010-03-30 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with piece-wise function |
US7720516B2 (en) | 1996-10-10 | 2010-05-18 | Nellcor Puritan Bennett Llc | Motion compatible sensor for non-invasive optical blood analysis |
US20100292593A1 (en) * | 2006-02-20 | 2010-11-18 | Andreas Tobola | Spread-spectrum method for determining physiological parameters |
US7869849B2 (en) | 2006-09-26 | 2011-01-11 | Nellcor Puritan Bennett Llc | Opaque, electrically nonconductive region on a medical sensor |
US7881762B2 (en) | 2005-09-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US7880884B2 (en) | 2008-06-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | System and method for coating and shielding electronic sensor components |
US7887345B2 (en) | 2008-06-30 | 2011-02-15 | Nellcor Puritan Bennett Llc | Single use connector for pulse oximetry sensors |
US7890153B2 (en) | 2006-09-28 | 2011-02-15 | Nellcor Puritan Bennett Llc | System and method for mitigating interference in pulse oximetry |
US7894869B2 (en) | 2007-03-09 | 2011-02-22 | Nellcor Puritan Bennett Llc | Multiple configuration medical sensor and technique for using the same |
US7899510B2 (en) | 2005-09-29 | 2011-03-01 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US20110082357A1 (en) * | 2008-05-28 | 2011-04-07 | Neetour Medical Ltd. | Method and apparatus for co2 evaluation |
US20110213226A1 (en) * | 2010-02-28 | 2011-09-01 | Nellcor Puritan Bennett Llc | Motion compensation in a sensor |
US8062221B2 (en) | 2005-09-30 | 2011-11-22 | Nellcor Puritan Bennett Llc | Sensor for tissue gas detection and technique for using the same |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US8070508B2 (en) | 2007-12-31 | 2011-12-06 | Nellcor Puritan Bennett Llc | Method and apparatus for aligning and securing a cable strain relief |
US8073518B2 (en) | 2006-05-02 | 2011-12-06 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US8071935B2 (en) | 2008-06-30 | 2011-12-06 | Nellcor Puritan Bennett Llc | Optical detector with an overmolded faraday shield |
US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
US8092379B2 (en) | 2005-09-29 | 2012-01-10 | Nellcor Puritan Bennett Llc | Method and system for determining when to reposition a physiological sensor |
US8112375B2 (en) | 2008-03-31 | 2012-02-07 | Nellcor Puritan Bennett Llc | Wavelength selection and outlier detection in reduced rank linear models |
US8133176B2 (en) | 1999-04-14 | 2012-03-13 | Tyco Healthcare Group Lp | Method and circuit for indicating quality and accuracy of physiological measurements |
US8145288B2 (en) | 2006-08-22 | 2012-03-27 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US8175671B2 (en) | 2006-09-22 | 2012-05-08 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8190225B2 (en) | 2006-09-22 | 2012-05-29 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8199007B2 (en) | 2007-12-31 | 2012-06-12 | Nellcor Puritan Bennett Llc | Flex circuit snap track for a biometric sensor |
US8216136B2 (en) | 2009-03-05 | 2012-07-10 | Nellcor Puritan Bennett Llc | Systems and methods for monitoring heart rate and blood pressure correlation |
US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
US8224412B2 (en) | 2000-04-17 | 2012-07-17 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with piece-wise function |
US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
US8233954B2 (en) | 2005-09-30 | 2012-07-31 | Nellcor Puritan Bennett Llc | Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same |
US8260391B2 (en) | 2005-09-12 | 2012-09-04 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US8311601B2 (en) | 2009-06-30 | 2012-11-13 | Nellcor Puritan Bennett Llc | Reflectance and/or transmissive pulse oximeter |
US8315685B2 (en) | 2006-09-27 | 2012-11-20 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
US20120296221A1 (en) * | 2010-02-11 | 2012-11-22 | Koninklijke Philips Electronics N.V. | Method and apparatus for determining a respiration signal |
US8346328B2 (en) | 2007-12-21 | 2013-01-01 | Covidien Lp | Medical sensor and technique for using the same |
US8352004B2 (en) | 2007-12-21 | 2013-01-08 | Covidien Lp | Medical sensor and technique for using the same |
US8352009B2 (en) | 2005-09-30 | 2013-01-08 | Covidien Lp | Medical sensor and technique for using the same |
US8352010B2 (en) | 2005-09-30 | 2013-01-08 | Covidien Lp | Folding medical sensor and technique for using the same |
US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
US8366613B2 (en) | 2007-12-26 | 2013-02-05 | Covidien Lp | LED drive circuit for pulse oximetry and method for using same |
US8391941B2 (en) | 2009-07-17 | 2013-03-05 | Covidien Lp | System and method for memory switching for multiple configuration medical sensor |
US8396527B2 (en) | 2006-09-22 | 2013-03-12 | Covidien Lp | Medical sensor for reducing signal artifacts and technique for using the same |
US8417310B2 (en) | 2009-08-10 | 2013-04-09 | Covidien Lp | Digital switching in multi-site sensor |
US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
US8423112B2 (en) | 2008-09-30 | 2013-04-16 | Covidien Lp | Medical sensor and technique for using the same |
US8428675B2 (en) | 2009-08-19 | 2013-04-23 | Covidien Lp | Nanofiber adhesives used in medical devices |
US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
US8442608B2 (en) | 2007-12-28 | 2013-05-14 | Covidien Lp | System and method for estimating physiological parameters by deconvolving artifacts |
US8452366B2 (en) | 2009-03-16 | 2013-05-28 | Covidien Lp | Medical monitoring device with flexible circuitry |
US8452364B2 (en) | 2007-12-28 | 2013-05-28 | Covidien LLP | System and method for attaching a sensor to a patient's skin |
US8483790B2 (en) | 2002-10-18 | 2013-07-09 | Covidien Lp | Non-adhesive oximeter sensor for sensitive skin |
US8505821B2 (en) | 2009-06-30 | 2013-08-13 | Covidien Lp | System and method for providing sensor quality assurance |
US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
US8577434B2 (en) | 2007-12-27 | 2013-11-05 | Covidien Lp | Coaxial LED light sources |
US8634891B2 (en) | 2009-05-20 | 2014-01-21 | Covidien Lp | Method and system for self regulation of sensor component contact pressure |
US8636667B2 (en) | 2009-07-06 | 2014-01-28 | Nellcor Puritan Bennett Ireland | Systems and methods for processing physiological signals in wavelet space |
US8897850B2 (en) | 2007-12-31 | 2014-11-25 | Covidien Lp | Sensor with integrated living hinge and spring |
US8914088B2 (en) | 2008-09-30 | 2014-12-16 | Covidien Lp | Medical sensor and technique for using the same |
US9010634B2 (en) | 2009-06-30 | 2015-04-21 | Covidien Lp | System and method for linking patient data to a patient and providing sensor quality assurance |
WO2015181560A1 (en) * | 2014-05-30 | 2015-12-03 | Huntleigh Technology Limited | Tissue variability compensation apparatus and method |
US9492095B2 (en) | 2009-12-02 | 2016-11-15 | Neetour Medical Ltd. | Hemodynamics-based monitoring and evaluation of a respiratory condition |
US9995611B2 (en) | 2012-03-30 | 2018-06-12 | Icu Medical, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
US10022498B2 (en) | 2011-12-16 | 2018-07-17 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
US10046112B2 (en) | 2013-05-24 | 2018-08-14 | Icu Medical, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
US10166328B2 (en) | 2013-05-29 | 2019-01-01 | Icu Medical, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
US10342917B2 (en) | 2014-02-28 | 2019-07-09 | Icu Medical, Inc. | Infusion system and method which utilizes dual wavelength optical air-in-line detection |
US10430761B2 (en) | 2011-08-19 | 2019-10-01 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
US10463788B2 (en) | 2012-07-31 | 2019-11-05 | Icu Medical, Inc. | Patient care system for critical medications |
US10596316B2 (en) | 2013-05-29 | 2020-03-24 | Icu Medical, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
US10635784B2 (en) | 2007-12-18 | 2020-04-28 | Icu Medical, Inc. | User interface improvements for medical devices |
US10656894B2 (en) | 2017-12-27 | 2020-05-19 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
US11246985B2 (en) | 2016-05-13 | 2022-02-15 | Icu Medical, Inc. | Infusion pump system and method with common line auto flush |
US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
US11324888B2 (en) | 2016-06-10 | 2022-05-10 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
US11344673B2 (en) | 2014-05-29 | 2022-05-31 | Icu Medical, Inc. | Infusion system and pump with configurable closed loop delivery rate catch-up |
US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
US11883361B2 (en) | 2020-07-21 | 2024-01-30 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
Families Citing this family (754)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5490505A (en) | 1991-03-07 | 1996-02-13 | Masimo Corporation | Signal processing apparatus |
CA2105682C (en) * | 1991-03-07 | 2003-09-02 | Mohamed K. Diab | Signal processing apparatus and method |
MX9702434A (en) * | 1991-03-07 | 1998-05-31 | Masimo Corp | Signal processing apparatus. |
US5632272A (en) * | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
US5995855A (en) | 1998-02-11 | 1999-11-30 | Masimo Corporation | Pulse oximetry sensor adapter |
US5638818A (en) * | 1991-03-21 | 1997-06-17 | Masimo Corporation | Low noise optical probe |
US6987994B1 (en) * | 1991-09-03 | 2006-01-17 | Datex-Ohmeda, Inc. | Pulse oximetry SpO2 determination |
US7758503B2 (en) * | 1997-01-27 | 2010-07-20 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
US7376453B1 (en) | 1993-10-06 | 2008-05-20 | Masimo Corporation | Signal processing apparatus |
US6662033B2 (en) | 1994-04-01 | 2003-12-09 | Nellcor Incorporated | Pulse oximeter and sensor optimized for low saturation |
US5421329A (en) | 1994-04-01 | 1995-06-06 | Nellcor, Inc. | Pulse oximeter sensor optimized for low saturation |
US6371921B1 (en) * | 1994-04-15 | 2002-04-16 | Masimo Corporation | System and method of determining whether to recalibrate a blood pressure monitor |
EP1905352B1 (en) | 1994-10-07 | 2014-07-16 | Masimo Corporation | Signal processing method |
AU760205B2 (en) * | 1994-10-07 | 2003-05-08 | Masimo Corporation | Physiological monitor and method of minimizing noise |
US8019400B2 (en) * | 1994-10-07 | 2011-09-13 | Masimo Corporation | Signal processing apparatus |
AU725063B2 (en) * | 1994-10-07 | 2000-10-05 | Masimo Corporation | Physiological monitor and method of minimizing noise |
US5662105A (en) * | 1995-05-17 | 1997-09-02 | Spacelabs Medical, Inc. | System and method for the extractment of physiological signals |
EP0744154A1 (en) * | 1995-05-17 | 1996-11-27 | Spacelabs Medical, Inc. | System and method for the algebraic derivation of physiological signals |
US5758644A (en) * | 1995-06-07 | 1998-06-02 | Masimo Corporation | Manual and automatic probe calibration |
US6931268B1 (en) | 1995-06-07 | 2005-08-16 | Masimo Laboratories, Inc. | Active pulse blood constituent monitoring |
US6517283B2 (en) | 2001-01-16 | 2003-02-11 | Donald Edward Coffey | Cascading chute drainage system |
US5645060A (en) * | 1995-06-14 | 1997-07-08 | Nellcor Puritan Bennett Incorporated | Method and apparatus for removing artifact and noise from pulse oximetry |
US5853364A (en) * | 1995-08-07 | 1998-12-29 | Nellcor Puritan Bennett, Inc. | Method and apparatus for estimating physiological parameters using model-based adaptive filtering |
US5588427A (en) * | 1995-11-20 | 1996-12-31 | Spacelabs Medical, Inc. | Enhancement of physiological signals using fractal analysis |
US5692505A (en) * | 1996-04-25 | 1997-12-02 | Fouts; James Michael | Data processing systems and methods for pulse oximeters |
US6027452A (en) * | 1996-06-26 | 2000-02-22 | Vital Insite, Inc. | Rapid non-invasive blood pressure measuring device |
US5893102A (en) * | 1996-12-06 | 1999-04-06 | Unisys Corporation | Textual database management, storage and retrieval system utilizing word-oriented, dictionary-based data compression/decompression |
US6050950A (en) | 1996-12-18 | 2000-04-18 | Aurora Holdings, Llc | Passive/non-invasive systemic and pulmonary blood pressure measurement |
US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
US9468378B2 (en) | 1997-01-27 | 2016-10-18 | Lawrence A. Lynn | Airway instability detection system and method |
CA2283856C (en) * | 1997-03-21 | 2005-11-22 | Nellcor Puritan Bennett Inc. | Method and apparatus for harmonically filtering data |
US6229856B1 (en) * | 1997-04-14 | 2001-05-08 | Masimo Corporation | Method and apparatus for demodulating signals in a pulse oximetry system |
US6002952A (en) * | 1997-04-14 | 1999-12-14 | Masimo Corporation | Signal processing apparatus and method |
US5873836A (en) * | 1997-07-09 | 1999-02-23 | Bp Sure, Llc | Blood pressure monitoring with improved noise rejection |
US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US20070191697A1 (en) | 2006-02-10 | 2007-08-16 | Lynn Lawrence A | System and method for SPO2 instability detection and quantification |
US5971930A (en) * | 1997-10-17 | 1999-10-26 | Siemens Medical Systems, Inc. | Method and apparatus for removing artifact from physiological signals |
US6525386B1 (en) | 1998-03-10 | 2003-02-25 | Masimo Corporation | Non-protruding optoelectronic lens |
US6094592A (en) * | 1998-05-26 | 2000-07-25 | Nellcor Puritan Bennett, Inc. | Methods and apparatus for estimating a physiological parameter using transforms |
EP1082050B1 (en) | 1998-06-03 | 2011-08-24 | Masimo Corporation | Stereo pulse oximeter |
US6990365B1 (en) * | 1998-07-04 | 2006-01-24 | Edwards Lifesciences | Apparatus for measurement of blood analytes |
WO2000009004A2 (en) | 1998-08-13 | 2000-02-24 | Whitland Research Limited | Optical device |
US7400918B2 (en) * | 1998-07-04 | 2008-07-15 | Edwards Lifesciences | Measurement of blood oxygen saturation |
US7548787B2 (en) | 2005-08-03 | 2009-06-16 | Kamilo Feher | Medical diagnostic and communication system |
US6393311B1 (en) | 1998-10-15 | 2002-05-21 | Ntc Technology Inc. | Method, apparatus and system for removing motion artifacts from measurements of bodily parameters |
US6519486B1 (en) | 1998-10-15 | 2003-02-11 | Ntc Technology Inc. | Method, apparatus and system for removing motion artifacts from measurements of bodily parameters |
US6721585B1 (en) | 1998-10-15 | 2004-04-13 | Sensidyne, Inc. | Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices |
US7991448B2 (en) * | 1998-10-15 | 2011-08-02 | Philips Electronics North America Corporation | Method, apparatus, and system for removing motion artifacts from measurements of bodily parameters |
US7245953B1 (en) | 1999-04-12 | 2007-07-17 | Masimo Corporation | Reusable pulse oximeter probe and disposable bandage apparatii |
USRE41912E1 (en) | 1998-10-15 | 2010-11-02 | Masimo Corporation | Reusable pulse oximeter probe and disposable bandage apparatus |
CA2362357A1 (en) * | 1998-11-09 | 2000-05-18 | Xinde Li | System and method for processing low signal-to-noise ratio signals |
US6463311B1 (en) | 1998-12-30 | 2002-10-08 | Masimo Corporation | Plethysmograph pulse recognition processor |
US6684090B2 (en) | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
US6770028B1 (en) | 1999-01-25 | 2004-08-03 | Masimo Corporation | Dual-mode pulse oximeter |
US20020140675A1 (en) * | 1999-01-25 | 2002-10-03 | Ali Ammar Al | System and method for altering a display mode based on a gravity-responsive sensor |
US6360114B1 (en) | 1999-03-25 | 2002-03-19 | Masimo Corporation | Pulse oximeter probe-off detector |
US9813270B2 (en) | 1999-08-09 | 2017-11-07 | Kamilo Feher | Heart rate sensor and medical diagnostics wireless devices |
US7260369B2 (en) | 2005-08-03 | 2007-08-21 | Kamilo Feher | Location finder, tracker, communication and remote control system |
US9307407B1 (en) | 1999-08-09 | 2016-04-05 | Kamilo Feher | DNA and fingerprint authentication of mobile devices |
US9373251B2 (en) | 1999-08-09 | 2016-06-21 | Kamilo Feher | Base station devices and automobile wireless communication systems |
US6515273B2 (en) * | 1999-08-26 | 2003-02-04 | Masimo Corporation | System for indicating the expiration of the useful operating life of a pulse oximetry sensor |
GB9923069D0 (en) * | 1999-09-29 | 1999-12-01 | Nokia Telecommunications Oy | Estimating an indicator for a communication path |
US6377829B1 (en) | 1999-12-09 | 2002-04-23 | Masimo Corporation | Resposable pulse oximetry sensor |
US6950687B2 (en) | 1999-12-09 | 2005-09-27 | Masimo Corporation | Isolation and communication element for a resposable pulse oximetry sensor |
US6574491B2 (en) | 2000-02-10 | 2003-06-03 | Siemens Medical Systems Inc. | Method and apparatus for detecting a physiological parameter |
JP2001257565A (en) * | 2000-03-10 | 2001-09-21 | Fujitsu Ltd | Method and device for updating reflection coefficient of lattice type filter |
JP4441974B2 (en) * | 2000-03-24 | 2010-03-31 | ソニー株式会社 | Manufacturing method of semiconductor device |
US6430525B1 (en) | 2000-06-05 | 2002-08-06 | Masimo Corporation | Variable mode averager |
US6697656B1 (en) | 2000-06-27 | 2004-02-24 | Masimo Corporation | Pulse oximetry sensor compatible with multiple pulse oximetry systems |
US6889153B2 (en) | 2001-08-09 | 2005-05-03 | Thomas Dietiker | System and method for a self-calibrating non-invasive sensor |
AU2001283371A1 (en) * | 2000-08-15 | 2002-02-25 | The Regents Of The University Of California | Method and apparatus for reducing contamination of an electrical signal |
US6640116B2 (en) * | 2000-08-18 | 2003-10-28 | Masimo Corporation | Optical spectroscopy pathlength measurement system |
EP1309270B1 (en) | 2000-08-18 | 2009-07-01 | Masimo Corporation | Dual-mode pulse oximeter |
AU2001291189A1 (en) | 2000-09-22 | 2002-04-02 | Knobbe, Lim And Buckingham | Method and apparatus for real-time estimation and control of pysiological parameters |
US6434408B1 (en) * | 2000-09-29 | 2002-08-13 | Datex-Ohmeda, Inc. | Pulse oximetry method and system with improved motion correction |
US6505060B1 (en) | 2000-09-29 | 2003-01-07 | Datex-Ohmeda, Inc. | Method and apparatus for determining pulse oximetry differential values |
IL138884A (en) | 2000-10-05 | 2006-07-05 | Conmed Corp | Pulse oximeter and a method of its operation |
AU2002226956A1 (en) | 2000-11-22 | 2002-06-03 | Leap Wireless International, Inc. | Method and system for providing interactive services over a wireless communications network |
US20020093908A1 (en) * | 2000-11-24 | 2002-07-18 | Esion Networks Inc. | Noise/interference suppression system |
US20060195041A1 (en) * | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
US6985764B2 (en) | 2001-05-03 | 2006-01-10 | Masimo Corporation | Flex circuit shielded optical sensor |
US6888633B2 (en) * | 2001-05-16 | 2005-05-03 | X-Rite, Incorporated | Color measurement instrument with modulated illumination |
US20070093721A1 (en) * | 2001-05-17 | 2007-04-26 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
US6850787B2 (en) | 2001-06-29 | 2005-02-01 | Masimo Laboratories, Inc. | Signal component processor |
US6697658B2 (en) * | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
WO2003009478A2 (en) * | 2001-07-17 | 2003-01-30 | Honeywell International Inc. | Dual analog-to-digital converter system for increased dynamic range |
US6754516B2 (en) * | 2001-07-19 | 2004-06-22 | Nellcor Puritan Bennett Incorporated | Nuisance alarm reductions in a physiological monitor |
IL145445A (en) * | 2001-09-13 | 2006-12-31 | Conmed Corp | Signal processing method and device for signal-to-noise improvement |
US7628760B2 (en) * | 2007-02-28 | 2009-12-08 | Semler Scientific, Inc. | Circulation monitoring system and method |
US6564077B2 (en) | 2001-10-10 | 2003-05-13 | Mortara Instrument, Inc. | Method and apparatus for pulse oximetry |
US6748254B2 (en) * | 2001-10-12 | 2004-06-08 | Nellcor Puritan Bennett Incorporated | Stacked adhesive optical sensor |
US20030212312A1 (en) * | 2002-01-07 | 2003-11-13 | Coffin James P. | Low noise patient cable |
US6934570B2 (en) * | 2002-01-08 | 2005-08-23 | Masimo Corporation | Physiological sensor combination |
US7355512B1 (en) * | 2002-01-24 | 2008-04-08 | Masimo Corporation | Parallel alarm processor |
US6822564B2 (en) * | 2002-01-24 | 2004-11-23 | Masimo Corporation | Parallel measurement alarm processor |
WO2003065557A2 (en) * | 2002-01-25 | 2003-08-07 | Masimo Corporation | Power supply rail controller |
US7020507B2 (en) * | 2002-01-31 | 2006-03-28 | Dolphin Medical, Inc. | Separating motion from cardiac signals using second order derivative of the photo-plethysmogram and fast fourier transforms |
DE60332094D1 (en) * | 2002-02-22 | 2010-05-27 | Masimo Corp | ACTIVE PULSE SPECTROPHOTOMETRY |
JP2005535359A (en) * | 2002-02-22 | 2005-11-24 | デイテックス−オーメダ インコーポレイテッド | Monitoring physiological parameters based on fluctuations in photoplethysmographic signals |
US6805673B2 (en) | 2002-02-22 | 2004-10-19 | Datex-Ohmeda, Inc. | Monitoring mayer wave effects based on a photoplethysmographic signal |
US6702752B2 (en) | 2002-02-22 | 2004-03-09 | Datex-Ohmeda, Inc. | Monitoring respiration based on plethysmographic heart rate signal |
US6709402B2 (en) | 2002-02-22 | 2004-03-23 | Datex-Ohmeda, Inc. | Apparatus and method for monitoring respiration with a pulse oximeter |
US6896661B2 (en) * | 2002-02-22 | 2005-05-24 | Datex-Ohmeda, Inc. | Monitoring physiological parameters based on variations in a photoplethysmographic baseline signal |
US7509494B2 (en) * | 2002-03-01 | 2009-03-24 | Masimo Corporation | Interface cable |
KR100455289B1 (en) * | 2002-03-16 | 2004-11-08 | 삼성전자주식회사 | Method of diagnosing using a ray and apparatus thereof |
US6850788B2 (en) | 2002-03-25 | 2005-02-01 | Masimo Corporation | Physiological measurement communications adapter |
US20080200775A1 (en) * | 2007-02-20 | 2008-08-21 | Lynn Lawrence A | Maneuver-based plethysmographic pulse variation detection system and method |
CA2533670A1 (en) * | 2002-07-26 | 2004-02-05 | Obi Aps | Method system and devices for converting venous blood values to arterial blood values |
US7096054B2 (en) * | 2002-08-01 | 2006-08-22 | Masimo Corporation | Low noise optical housing |
US7142901B2 (en) * | 2002-09-25 | 2006-11-28 | Masimo Corporation | Parameter compensated physiological monitor |
US7274955B2 (en) * | 2002-09-25 | 2007-09-25 | Masimo Corporation | Parameter compensated pulse oximeter |
US7096052B2 (en) * | 2002-10-04 | 2006-08-22 | Masimo Corporation | Optical probe including predetermined emission wavelength based on patient type |
AU2003263554A1 (en) * | 2002-10-15 | 2004-05-04 | Koninklijke Philips Electronics N.V. | Method for the presentation of information concerning variations of the perfusion |
US6948761B2 (en) * | 2002-11-01 | 2005-09-27 | The Colonel's International, Inc. | Tonneau cover apparatus |
AU2003295943A1 (en) * | 2002-11-21 | 2004-06-18 | General Hospital Corporation | Apparatus and method for ascertaining and recording electrophysiological signals |
US7027849B2 (en) * | 2002-11-22 | 2006-04-11 | Masimo Laboratories, Inc. | Blood parameter measurement system |
US6970792B1 (en) | 2002-12-04 | 2005-11-29 | Masimo Laboratories, Inc. | Systems and methods for determining blood oxygen saturation values using complex number encoding |
US7919713B2 (en) * | 2007-04-16 | 2011-04-05 | Masimo Corporation | Low noise oximetry cable including conductive cords |
US6954663B2 (en) * | 2003-01-07 | 2005-10-11 | Art Advanced Research Technologies Inc. | Continuous wave optical imaging assuming a scatter-law |
US7006856B2 (en) * | 2003-01-10 | 2006-02-28 | Nellcor Puritan Bennett Incorporated | Signal quality metrics design for qualifying data for a physiological monitor |
US7016715B2 (en) | 2003-01-13 | 2006-03-21 | Nellcorpuritan Bennett Incorporated | Selection of preset filter parameters based on signal quality |
US7225006B2 (en) | 2003-01-23 | 2007-05-29 | Masimo Corporation | Attachment and optical probe |
US6920345B2 (en) | 2003-01-24 | 2005-07-19 | Masimo Corporation | Optical sensor including disposable and reusable elements |
WO2004075746A2 (en) * | 2003-02-27 | 2004-09-10 | Cardiodigital Limited | Method and system for analysing and processing ph0t0plethysmogram signals using wavelet transform |
JP5296312B2 (en) * | 2003-03-12 | 2013-09-25 | イエール ユニバーシティ | Blood volume evaluation method using photoelectric volumetric pulse wave method |
US20050055276A1 (en) * | 2003-06-26 | 2005-03-10 | Kiani Massi E. | Sensor incentive method |
US7025728B2 (en) | 2003-06-30 | 2006-04-11 | Nihon Kohden Corporation | Method for reducing noise, and pulse photometer using the method |
US7455643B1 (en) | 2003-07-07 | 2008-11-25 | Nellcor Puritan Bennett Ireland | Continuous non-invasive blood pressure measurement apparatus and methods providing automatic recalibration |
US7003338B2 (en) | 2003-07-08 | 2006-02-21 | Masimo Corporation | Method and apparatus for reducing coupling between signals |
US7500950B2 (en) | 2003-07-25 | 2009-03-10 | Masimo Corporation | Multipurpose sensor port |
US7254431B2 (en) | 2003-08-28 | 2007-08-07 | Masimo Corporation | Physiological parameter tracking system |
US7254434B2 (en) * | 2003-10-14 | 2007-08-07 | Masimo Corporation | Variable pressure reusable sensor |
US7483729B2 (en) * | 2003-11-05 | 2009-01-27 | Masimo Corporation | Pulse oximeter access apparatus and method |
US7373193B2 (en) * | 2003-11-07 | 2008-05-13 | Masimo Corporation | Pulse oximetry data capture system |
US7242775B2 (en) * | 2003-11-12 | 2007-07-10 | Magiq Technologies, Inc. | Optical pulse calibration for quantum key distribution |
US6968032B2 (en) * | 2003-12-18 | 2005-11-22 | Ge Medical Systems Global Technologies Company, Llc | Systems and methods for filtering images |
US7280858B2 (en) * | 2004-01-05 | 2007-10-09 | Masimo Corporation | Pulse oximetry sensor |
US7163040B2 (en) | 2004-01-13 | 2007-01-16 | Sanford L.P. | Correction tape applicator tip with cylindrical projection |
US7254425B2 (en) * | 2004-01-23 | 2007-08-07 | Abbott Laboratories | Method for detecting artifacts in data |
JP4643153B2 (en) * | 2004-02-06 | 2011-03-02 | 株式会社東芝 | Non-invasive biological information imaging device |
US7371981B2 (en) | 2004-02-20 | 2008-05-13 | Masimo Corporation | Connector switch |
US7120479B2 (en) * | 2004-02-25 | 2006-10-10 | Nellcor Puritan Bennett Inc. | Switch-mode oximeter LED drive with a single inductor |
US7162288B2 (en) * | 2004-02-25 | 2007-01-09 | Nellcor Purtain Bennett Incorporated | Techniques for detecting heart pulses and reducing power consumption in sensors |
US7142142B2 (en) * | 2004-02-25 | 2006-11-28 | Nelicor Puritan Bennett, Inc. | Multi-bit ADC with sigma-delta modulation |
US7190985B2 (en) * | 2004-02-25 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Oximeter ambient light cancellation |
EP1718196B1 (en) * | 2004-02-26 | 2009-04-08 | Diabetes Tools Sweden AB | Metabolic monitoring, a method and apparatus for indicating a health-related condition of a subject |
US7438683B2 (en) * | 2004-03-04 | 2008-10-21 | Masimo Corporation | Application identification sensor |
WO2005086725A2 (en) * | 2004-03-06 | 2005-09-22 | Calisto Medical, Inc. | Methods and devices for non-invasively measuring quantitative information of substances in living organisms |
US7415297B2 (en) * | 2004-03-08 | 2008-08-19 | Masimo Corporation | Physiological parameter system |
US7534212B2 (en) * | 2004-03-08 | 2009-05-19 | Nellcor Puritan Bennett Llc | Pulse oximeter with alternate heart-rate determination |
US7194293B2 (en) * | 2004-03-08 | 2007-03-20 | Nellcor Puritan Bennett Incorporated | Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics |
US7277741B2 (en) * | 2004-03-09 | 2007-10-02 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
WO2005089640A2 (en) * | 2004-03-19 | 2005-09-29 | Masimo Corporation | Low power and personal pulse oximetry systems |
US7758513B2 (en) * | 2004-03-27 | 2010-07-20 | Samsung Electronics Co., Ltd. | Apparatus and method for simultaneously measuring bio signals |
US7292883B2 (en) * | 2004-03-31 | 2007-11-06 | Masimo Corporation | Physiological assessment system |
CA2464029A1 (en) * | 2004-04-08 | 2005-10-08 | Valery Telfort | Non-invasive ventilation monitor |
US7343186B2 (en) | 2004-07-07 | 2008-03-11 | Masimo Laboratories, Inc. | Multi-wavelength physiological monitor |
US9341565B2 (en) * | 2004-07-07 | 2016-05-17 | Masimo Corporation | Multiple-wavelength physiological monitor |
US7937128B2 (en) | 2004-07-09 | 2011-05-03 | Masimo Corporation | Cyanotic infant sensor |
US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
US7976472B2 (en) | 2004-09-07 | 2011-07-12 | Masimo Corporation | Noninvasive hypovolemia monitor |
US20060073719A1 (en) * | 2004-09-29 | 2006-04-06 | Kiani Massi E | Multiple key position plug |
US20060111621A1 (en) * | 2004-11-03 | 2006-05-25 | Andreas Coppi | Musical personal trainer |
US20070048096A1 (en) * | 2004-12-07 | 2007-03-01 | Hubbs Jonathan W | Soil conditioner |
US8932217B2 (en) | 2005-01-13 | 2015-01-13 | Welch Allyn, Inc. | Vital signs monitor |
US20060189871A1 (en) * | 2005-02-18 | 2006-08-24 | Ammar Al-Ali | Portable patient monitor |
US8116839B1 (en) | 2005-02-25 | 2012-02-14 | General Electric Company | System for detecting potential probe malfunction conditions in a pulse oximeter |
US7269537B1 (en) | 2005-02-26 | 2007-09-11 | Duane Loren Mattern | Infrasound sensor with disturbance filtering |
EP1860996B1 (en) | 2005-03-01 | 2018-08-01 | Masimo Laboratories, Inc. | Multiple wavelength sensor drivers |
US7392075B2 (en) * | 2005-03-03 | 2008-06-24 | Nellcor Puritan Bennett Incorporated | Method for enhancing pulse oximetry calculations in the presence of correlated artifacts |
US7937129B2 (en) * | 2005-03-21 | 2011-05-03 | Masimo Corporation | Variable aperture sensor |
JP2008537903A (en) | 2005-04-13 | 2008-10-02 | グルコライト・コーポレーシヨン | Data processing and calibration method for blood glucose monitor based on OCT |
US7403806B2 (en) | 2005-06-28 | 2008-07-22 | General Electric Company | System for prefiltering a plethysmographic signal |
US12014328B2 (en) | 2005-07-13 | 2024-06-18 | Vccb Holdings, Inc. | Medicine bottle cap with electronic embedded curved display |
US10009956B1 (en) | 2017-09-02 | 2018-06-26 | Kamilo Feher | OFDM, 3G and 4G cellular multimode systems and wireless mobile networks |
US7280810B2 (en) | 2005-08-03 | 2007-10-09 | Kamilo Feher | Multimode communication system |
US20070073116A1 (en) * | 2005-08-17 | 2007-03-29 | Kiani Massi E | Patient identification using physiological sensor |
US7725147B2 (en) * | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for removing artifacts from waveforms |
US7725146B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for pre-processing waveforms |
US7486979B2 (en) * | 2005-09-30 | 2009-02-03 | Nellcor Puritan Bennett Llc | Optically aligned pulse oximetry sensor and technique for using the same |
US20070106126A1 (en) | 2005-09-30 | 2007-05-10 | Mannheimer Paul D | Patient monitoring alarm escalation system and method |
US7962188B2 (en) | 2005-10-14 | 2011-06-14 | Masimo Corporation | Robust alarm system |
US7530942B1 (en) | 2005-10-18 | 2009-05-12 | Masimo Corporation | Remote sensing infant warmer |
CN100423688C (en) * | 2005-10-19 | 2008-10-08 | 深圳迈瑞生物医疗电子股份有限公司 | Method and apparatus for inhibiting power frequency common-mode interference |
US20070100220A1 (en) * | 2005-10-28 | 2007-05-03 | Baker Clark R Jr | Adjusting parameters used in pulse oximetry analysis |
US7879355B2 (en) * | 2005-11-08 | 2011-02-01 | Plensat Llc | Method and system for treatment of eating disorders |
US7184809B1 (en) | 2005-11-08 | 2007-02-27 | Woolsthorpe Technologies, Llc | Pulse amplitude indexing method and apparatus |
US7215987B1 (en) * | 2005-11-08 | 2007-05-08 | Woolsthorpe Technologies | Method and apparatus for processing signals reflecting physiological characteristics |
US8233955B2 (en) | 2005-11-29 | 2012-07-31 | Cercacor Laboratories, Inc. | Optical sensor including disposable and reusable elements |
WO2007065015A2 (en) * | 2005-12-03 | 2007-06-07 | Masimo Corporation | Physiological alarm notification system |
US7990382B2 (en) * | 2006-01-03 | 2011-08-02 | Masimo Corporation | Virtual display |
US8182443B1 (en) | 2006-01-17 | 2012-05-22 | Masimo Corporation | Drug administration controller |
US7668579B2 (en) * | 2006-02-10 | 2010-02-23 | Lynn Lawrence A | System and method for the detection of physiologic response to stimulation |
US20070208259A1 (en) * | 2006-03-06 | 2007-09-06 | Mannheimer Paul D | Patient monitoring alarm escalation system and method |
US20070244377A1 (en) * | 2006-03-14 | 2007-10-18 | Cozad Jenny L | Pulse oximeter sleeve |
US8219172B2 (en) | 2006-03-17 | 2012-07-10 | Glt Acquisition Corp. | System and method for creating a stable optical interface |
US8702606B2 (en) * | 2006-03-21 | 2014-04-22 | Covidien Lp | Patient monitoring help video system and method |
US7522948B2 (en) * | 2006-05-02 | 2009-04-21 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US20070260132A1 (en) * | 2006-05-04 | 2007-11-08 | Sterling Bernhard B | Method and apparatus for processing signals reflecting physiological characteristics from multiple sensors |
US8998809B2 (en) | 2006-05-15 | 2015-04-07 | Cercacor Laboratories, Inc. | Systems and methods for calibrating minimally invasive and non-invasive physiological sensor devices |
US7941199B2 (en) | 2006-05-15 | 2011-05-10 | Masimo Laboratories, Inc. | Sepsis monitor |
US9176141B2 (en) | 2006-05-15 | 2015-11-03 | Cercacor Laboratories, Inc. | Physiological monitor calibration system |
US8028701B2 (en) | 2006-05-31 | 2011-10-04 | Masimo Corporation | Respiratory monitoring |
US20070282181A1 (en) * | 2006-06-01 | 2007-12-06 | Carol Findlay | Visual medical sensor indicator |
US10188348B2 (en) | 2006-06-05 | 2019-01-29 | Masimo Corporation | Parameter upgrade system |
WO2007143626A2 (en) | 2006-06-05 | 2007-12-13 | Masimo Laboratories, Inc. | Parameter upgrade system |
US20080039735A1 (en) * | 2006-06-06 | 2008-02-14 | Hickerson Barry L | Respiratory monitor display |
US8380271B2 (en) | 2006-06-15 | 2013-02-19 | Covidien Lp | System and method for generating customizable audible beep tones and alarms |
WO2008002405A2 (en) * | 2006-06-16 | 2008-01-03 | Medtor Llc | System and method for a non-invasive medical sensor |
US20080064965A1 (en) * | 2006-09-08 | 2008-03-13 | Jay Gregory D | Devices and methods for measuring pulsus paradoxus |
US20080064940A1 (en) * | 2006-09-12 | 2008-03-13 | Raridan William B | Sensor cable design for use with spectrophotometric sensors and method of using the same |
US8064975B2 (en) * | 2006-09-20 | 2011-11-22 | Nellcor Puritan Bennett Llc | System and method for probability based determination of estimated oxygen saturation |
USD609193S1 (en) | 2007-10-12 | 2010-02-02 | Masimo Corporation | Connector assembly |
US8315683B2 (en) * | 2006-09-20 | 2012-11-20 | Masimo Corporation | Duo connector patient cable |
USD614305S1 (en) | 2008-02-29 | 2010-04-20 | Masimo Corporation | Connector assembly |
US8118620B2 (en) | 2007-10-12 | 2012-02-21 | Masimo Corporation | Connector assembly with reduced unshielded area |
US8457707B2 (en) | 2006-09-20 | 2013-06-04 | Masimo Corporation | Congenital heart disease monitor |
US9161696B2 (en) | 2006-09-22 | 2015-10-20 | Masimo Corporation | Modular patient monitor |
US8840549B2 (en) * | 2006-09-22 | 2014-09-23 | Masimo Corporation | Modular patient monitor |
US20080103375A1 (en) * | 2006-09-22 | 2008-05-01 | Kiani Massi E | Patient monitor user interface |
US20080076977A1 (en) * | 2006-09-26 | 2008-03-27 | Nellcor Puritan Bennett Inc. | Patient monitoring device snapshot feature system and method |
US8696593B2 (en) | 2006-09-27 | 2014-04-15 | Covidien Lp | Method and system for monitoring intracranial pressure |
US7922665B2 (en) | 2006-09-28 | 2011-04-12 | Nellcor Puritan Bennett Llc | System and method for pulse rate calculation using a scheme for alternate weighting |
US7796403B2 (en) * | 2006-09-28 | 2010-09-14 | Nellcor Puritan Bennett Llc | Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit |
US8068890B2 (en) * | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Pulse oximetry sensor switchover |
US8728059B2 (en) * | 2006-09-29 | 2014-05-20 | Covidien Lp | System and method for assuring validity of monitoring parameter in combination with a therapeutic device |
US20080097175A1 (en) * | 2006-09-29 | 2008-04-24 | Boyce Robin S | System and method for display control of patient monitor |
US8160668B2 (en) * | 2006-09-29 | 2012-04-17 | Nellcor Puritan Bennett Llc | Pathological condition detector using kernel methods and oximeters |
US7706896B2 (en) * | 2006-09-29 | 2010-04-27 | Nellcor Puritan Bennett Llc | User interface and identification in a medical device system and method |
US7698002B2 (en) * | 2006-09-29 | 2010-04-13 | Nellcor Puritan Bennett Llc | Systems and methods for user interface and identification in a medical device |
US20080081956A1 (en) * | 2006-09-29 | 2008-04-03 | Jayesh Shah | System and method for integrating voice with a medical device |
US7925511B2 (en) * | 2006-09-29 | 2011-04-12 | Nellcor Puritan Bennett Llc | System and method for secure voice identification in a medical device |
US20080082338A1 (en) * | 2006-09-29 | 2008-04-03 | O'neil Michael P | Systems and methods for secure voice identification and medical device interface |
US7848891B2 (en) | 2006-09-29 | 2010-12-07 | Nellcor Puritan Bennett Llc | Modulation ratio determination with accommodation of uncertainty |
US8255026B1 (en) | 2006-10-12 | 2012-08-28 | Masimo Corporation, Inc. | Patient monitor capable of monitoring the quality of attached probes and accessories |
US7880626B2 (en) | 2006-10-12 | 2011-02-01 | Masimo Corporation | System and method for monitoring the life of a physiological sensor |
US9192329B2 (en) | 2006-10-12 | 2015-11-24 | Masimo Corporation | Variable mode pulse indicator |
WO2008045538A2 (en) | 2006-10-12 | 2008-04-17 | Masimo Corporation | Perfusion index smoother |
US8265723B1 (en) | 2006-10-12 | 2012-09-11 | Cercacor Laboratories, Inc. | Oximeter probe off indicator defining probe off space |
US20080094228A1 (en) * | 2006-10-12 | 2008-04-24 | Welch James P | Patient monitor using radio frequency identification tags |
US9861305B1 (en) | 2006-10-12 | 2018-01-09 | Masimo Corporation | Method and apparatus for calibration to reduce coupling between signals in a measurement system |
US8600467B2 (en) | 2006-11-29 | 2013-12-03 | Cercacor Laboratories, Inc. | Optical sensor including disposable and reusable elements |
WO2008073855A2 (en) * | 2006-12-09 | 2008-06-19 | Masimo Corporation | Plethysmograph variability processor |
AT504569B1 (en) * | 2006-12-11 | 2009-02-15 | Cnsystems Medizintechnik Gmbh | SIGNAL PROCESSING DEVICE AND DEVICE FOR THE CONTINUOUS, NON-INVASIVE MEASUREMENT OF THE ARTERIAL BLOOD PRESSURE |
CN101621958B (en) * | 2006-12-11 | 2011-05-18 | Cn体系药物技术有限公司 | Device for continuous, non-invasive measurement of arterial blood pressure and uses thereof |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US8652040B2 (en) | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
US8852094B2 (en) | 2006-12-22 | 2014-10-07 | Masimo Corporation | Physiological parameter system |
US7791155B2 (en) * | 2006-12-22 | 2010-09-07 | Masimo Laboratories, Inc. | Detector shield |
US8652060B2 (en) * | 2007-01-20 | 2014-02-18 | Masimo Corporation | Perfusion trend indicator |
US20080200819A1 (en) * | 2007-02-20 | 2008-08-21 | Lynn Lawrence A | Orthostasis detection system and method |
US8710957B2 (en) * | 2007-02-28 | 2014-04-29 | Rf Surgical Systems, Inc. | Method, apparatus and article for detection of transponder tagged objects, for example during surgery |
US20090093687A1 (en) * | 2007-03-08 | 2009-04-09 | Telfort Valery G | Systems and methods for determining a physiological condition using an acoustic monitor |
US20080221426A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | Methods and apparatus for detecting misapplied optical sensors |
US8781544B2 (en) * | 2007-03-27 | 2014-07-15 | Cercacor Laboratories, Inc. | Multiple wavelength optical sensor |
US8374665B2 (en) | 2007-04-21 | 2013-02-12 | Cercacor Laboratories, Inc. | Tissue profile wellness monitor |
US7696877B2 (en) * | 2007-05-01 | 2010-04-13 | Rf Surgical Systems, Inc. | Method, apparatus and article for detection of transponder tagged objects, for example during surgery |
US11607152B2 (en) | 2007-06-12 | 2023-03-21 | Sotera Wireless, Inc. | Optical sensors for use in vital sign monitoring |
US8602997B2 (en) * | 2007-06-12 | 2013-12-10 | Sotera Wireless, Inc. | Body-worn system for measuring continuous non-invasive blood pressure (cNIBP) |
US11330988B2 (en) | 2007-06-12 | 2022-05-17 | Sotera Wireless, Inc. | Body-worn system for measuring continuous non-invasive blood pressure (cNIBP) |
EP2162059B1 (en) * | 2007-06-12 | 2021-01-13 | Sotera Wireless, Inc. | Vital sign monitor and method for measuring blood pressure using optical, electrical, and pressure waveforms |
US20100130875A1 (en) * | 2008-06-18 | 2010-05-27 | Triage Wireless, Inc. | Body-worn system for measuring blood pressure |
US8764671B2 (en) * | 2007-06-28 | 2014-07-01 | Masimo Corporation | Disposable active pulse sensor |
US8048040B2 (en) | 2007-09-13 | 2011-11-01 | Masimo Corporation | Fluid titration system |
WO2009036319A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent emergency patient monitor |
EP2200512A1 (en) | 2007-09-14 | 2010-06-30 | Corventis, Inc. | Adherent device for respiratory monitoring and sleep disordered breathing |
US8684925B2 (en) | 2007-09-14 | 2014-04-01 | Corventis, Inc. | Injectable device for physiological monitoring |
US8116841B2 (en) * | 2007-09-14 | 2012-02-14 | Corventis, Inc. | Adherent device with multiple physiological sensors |
WO2009036334A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent multi-sensor device with empathic monitoring |
US20090076350A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Data Collection in a Multi-Sensor Patient Monitor |
US8897868B2 (en) * | 2007-09-14 | 2014-11-25 | Medtronic, Inc. | Medical device automatic start-up upon contact to patient tissue |
EP2194856B1 (en) * | 2007-09-14 | 2021-09-01 | Medtronic Monitoring, Inc. | Adherent cardiac monitor |
US8374688B2 (en) * | 2007-09-14 | 2013-02-12 | Corventis, Inc. | System and methods for wireless body fluid monitoring |
WO2009036316A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Energy management, tracking and security for adherent patient monitor |
EP2195076A4 (en) * | 2007-09-14 | 2014-12-31 | Corventis Inc | Adherent device for cardiac rhythm management |
US20090076341A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Athletic Monitor |
JP2011501274A (en) | 2007-10-12 | 2011-01-06 | マシモ コーポレイション | System and method for storing, analyzing and retrieving medical data |
US8355766B2 (en) * | 2007-10-12 | 2013-01-15 | Masimo Corporation | Ceramic emitter substrate |
US8310336B2 (en) | 2008-10-10 | 2012-11-13 | Masimo Corporation | Systems and methods for storing, analyzing, retrieving and displaying streaming medical data |
US8251903B2 (en) | 2007-10-25 | 2012-08-28 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
CN107091870B (en) | 2007-12-10 | 2019-10-08 | 安晟信医疗科技控股公司 | Determine measuring device, bio-sensor system and the method for analyte concentration |
US8204567B2 (en) * | 2007-12-13 | 2012-06-19 | Nellcor Puritan Bennett Llc | Signal demodulation |
US20090171167A1 (en) * | 2007-12-27 | 2009-07-02 | Nellcor Puritan Bennett Llc | System And Method For Monitor Alarm Management |
US20090168050A1 (en) * | 2007-12-27 | 2009-07-02 | Nellcor Puritan Bennett Llc | Optical Sensor System And Method |
US20090171176A1 (en) * | 2007-12-28 | 2009-07-02 | Nellcor Puritan Bennett Llc | Snapshot Sensor |
US20090171171A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | Oximetry sensor overmolding location features |
US20090171226A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for evaluating variation in the timing of physiological events |
US20090171166A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | Oximeter with location awareness |
US20090171173A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for reducing motion artifacts in a sensor |
US8979762B2 (en) * | 2008-01-07 | 2015-03-17 | Well Being Digital Limited | Method of determining body parameters during exercise |
US8275553B2 (en) | 2008-02-19 | 2012-09-25 | Nellcor Puritan Bennett Llc | System and method for evaluating physiological parameter data |
US8750953B2 (en) * | 2008-02-19 | 2014-06-10 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
WO2009111542A2 (en) | 2008-03-04 | 2009-09-11 | Glucolight Corporation | Methods and systems for analyte level estimation in optical coherence tomography |
EP2257216B1 (en) * | 2008-03-12 | 2021-04-28 | Medtronic Monitoring, Inc. | Heart failure decompensation prediction based on cardiac rhythm |
US20090247851A1 (en) * | 2008-03-26 | 2009-10-01 | Nellcor Puritan Bennett Llc | Graphical User Interface For Monitor Alarm Management |
US20090247854A1 (en) * | 2008-03-27 | 2009-10-01 | Nellcor Puritan Bennett Llc | Retractable Sensor Cable For A Pulse Oximeter |
US8140272B2 (en) * | 2008-03-27 | 2012-03-20 | Nellcor Puritan Bennett Llc | System and method for unmixing spectroscopic observations with nonnegative matrix factorization |
US20090247850A1 (en) * | 2008-03-28 | 2009-10-01 | Nellcor Puritan Bennett Llc | Manually Powered Oximeter |
US8292809B2 (en) | 2008-03-31 | 2012-10-23 | Nellcor Puritan Bennett Llc | Detecting chemical components from spectroscopic observations |
US8364224B2 (en) * | 2008-03-31 | 2013-01-29 | Covidien Lp | System and method for facilitating sensor and monitor communication |
WO2009146214A1 (en) * | 2008-04-18 | 2009-12-03 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US20090275809A1 (en) * | 2008-05-01 | 2009-11-05 | Starr Life Sciences Corp. | Portable Modular Kiosk Based Physiologic Sensor System with Display and Data Storage for Clinical and Research Applications including Cross Calculating and Cross Checked Physiologic Parameters Based Upon Combined Sensor Input |
US20090275810A1 (en) * | 2008-05-01 | 2009-11-05 | Starr Life Sciences Corp. | Portable modular pc based system for continuous monitoring of blood oxygenation and respiratory parameters |
US20090275844A1 (en) * | 2008-05-02 | 2009-11-05 | Masimo Corporation | Monitor configuration system |
WO2009137524A2 (en) | 2008-05-05 | 2009-11-12 | Masimo Corporation | Pulse oximetry system with electrical decoupling circuitry |
AU2009244200B2 (en) | 2008-05-07 | 2012-10-18 | Lawrence A. Lynn | Medical failure pattern search engine |
CN102014745B (en) * | 2008-05-09 | 2013-06-19 | 皇家飞利浦电子股份有限公司 | Contactless respiration monitoring of patient |
EP2123320A1 (en) * | 2008-05-20 | 2009-11-25 | General Electric Company | Arrangement and method for supervising medical monitor |
US8358212B2 (en) * | 2008-05-27 | 2013-01-22 | Rf Surgical Systems, Inc. | Multi-modal transponder and method and apparatus to detect same |
JP4518189B2 (en) * | 2008-05-28 | 2010-08-04 | ソニー株式会社 | Information processing apparatus and method, program, and recording medium |
WO2009154987A2 (en) * | 2008-05-28 | 2009-12-23 | Rf Surgical Systems, Inc. | Method, apparatus and article for detection of transponder tagged objects, for example during surgery |
EP2285271B1 (en) * | 2008-06-16 | 2011-09-07 | Koninklijke Philips Electronics N.V. | Monitoring a vital parameter of a patient with "in-situ" modulation scheme to avoid interference |
DE102008002741B4 (en) | 2008-06-27 | 2019-07-11 | CiS Forschungsinstitut für Mikrosensorik und Photovoltaik GmbH | Optoelectronic perfusion measuring device for functional circulatory diagnostics |
USD626562S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Triangular saturation pattern detection indicator for a patient monitor display panel |
US20090326347A1 (en) * | 2008-06-30 | 2009-12-31 | Bennett Scharf | Synchronous Light Detection Utilizing CMOS/CCD Sensors For Oximetry Sensing |
US8862194B2 (en) | 2008-06-30 | 2014-10-14 | Covidien Lp | Method for improved oxygen saturation estimation in the presence of noise |
US20090327515A1 (en) * | 2008-06-30 | 2009-12-31 | Thomas Price | Medical Monitor With Network Connectivity |
US8660799B2 (en) | 2008-06-30 | 2014-02-25 | Nellcor Puritan Bennett Ireland | Processing and detecting baseline changes in signals |
US9895068B2 (en) * | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
US8398556B2 (en) | 2008-06-30 | 2013-03-19 | Covidien Lp | Systems and methods for non-invasive continuous blood pressure determination |
US8532932B2 (en) | 2008-06-30 | 2013-09-10 | Nellcor Puritan Bennett Ireland | Consistent signal selection by signal segment selection techniques |
USD626561S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Circular satseconds indicator and triangular saturation pattern detection indicator for a patient monitor display panel |
USD621516S1 (en) | 2008-08-25 | 2010-08-10 | Masimo Laboratories, Inc. | Patient monitoring sensor |
WO2010003134A2 (en) | 2008-07-03 | 2010-01-07 | Masimo Laboratories, Inc. | Protrusion, heat sink, and shielding for improving spectroscopic measurement of blood constituents |
US8385675B2 (en) * | 2008-07-15 | 2013-02-26 | Nellcor Puritan Bennett Ireland | Systems and methods for filtering a signal using a continuous wavelet transform |
US20100016676A1 (en) * | 2008-07-15 | 2010-01-21 | Nellcor Puritan Bennett Ireland | Systems And Methods For Adaptively Filtering Signals |
US8506498B2 (en) | 2008-07-15 | 2013-08-13 | Nellcor Puritan Bennett Ireland | Systems and methods using induced perturbation to determine physiological parameters |
US8370080B2 (en) * | 2008-07-15 | 2013-02-05 | Nellcor Puritan Bennett Ireland | Methods and systems for determining whether to trigger an alarm |
US8805482B2 (en) * | 2008-07-28 | 2014-08-12 | General Electric Conpany | System and method for signal quality indication and false alarm reduction in ECG monitoring systems |
US20100191310A1 (en) * | 2008-07-29 | 2010-07-29 | Corventis, Inc. | Communication-Anchor Loop For Injectable Device |
US8203438B2 (en) | 2008-07-29 | 2012-06-19 | Masimo Corporation | Alarm suspend system |
US8630691B2 (en) | 2008-08-04 | 2014-01-14 | Cercacor Laboratories, Inc. | Multi-stream sensor front ends for noninvasive measurement of blood constituents |
WO2010031070A2 (en) * | 2008-09-15 | 2010-03-18 | Masimo Corporation | Patient monitor including multi-parameter graphical display |
SE532941C2 (en) | 2008-09-15 | 2010-05-18 | Phasein Ab | Gas sampling line for breathing gases |
US20100076319A1 (en) * | 2008-09-25 | 2010-03-25 | Nellcor Puritan Bennett Llc | Pathlength-Corrected Medical Spectroscopy |
US20100076276A1 (en) * | 2008-09-25 | 2010-03-25 | Nellcor Puritan Bennett Llc | Medical Sensor, Display, and Technique For Using The Same |
US9314168B2 (en) | 2008-09-30 | 2016-04-19 | Nellcor Puritan Bennett Ireland | Detecting sleep events using localized blood pressure changes |
US20100081912A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | Ultrasound-Optical Doppler Hemometer and Technique for Using the Same |
US8386000B2 (en) * | 2008-09-30 | 2013-02-26 | Covidien Lp | System and method for photon density wave pulse oximetry and pulse hemometry |
US9301697B2 (en) | 2008-09-30 | 2016-04-05 | Nellcor Puritan Bennett Ireland | Systems and methods for recalibrating a non-invasive blood pressure monitor |
US8410951B2 (en) | 2008-09-30 | 2013-04-02 | Covidien Lp | Detecting a signal quality decrease in a measurement system |
US8433382B2 (en) * | 2008-09-30 | 2013-04-30 | Covidien Lp | Transmission mode photon density wave system and method |
US8532751B2 (en) | 2008-09-30 | 2013-09-10 | Covidien Lp | Laser self-mixing sensors for biological sensing |
US8968193B2 (en) * | 2008-09-30 | 2015-03-03 | Covidien Lp | System and method for enabling a research mode on physiological monitors |
US9687161B2 (en) | 2008-09-30 | 2017-06-27 | Nellcor Puritan Bennett Ireland | Systems and methods for maintaining blood pressure monitor calibration |
US9078609B2 (en) * | 2008-10-02 | 2015-07-14 | Nellcor Puritan Bennett Ireland | Extraction of physiological measurements from a photoplethysmograph (PPG) signal |
US20100088957A1 (en) * | 2008-10-09 | 2010-04-15 | Hubbs Jonathan W | Natural turf with binder |
US8346330B2 (en) | 2008-10-13 | 2013-01-01 | Masimo Corporation | Reflection-detector sensor position indicator |
US8401602B2 (en) | 2008-10-13 | 2013-03-19 | Masimo Corporation | Secondary-emitter sensor position indicator |
US8264342B2 (en) | 2008-10-28 | 2012-09-11 | RF Surgical Systems, Inc | Method and apparatus to detect transponder tagged objects, for example during medical procedures |
US11395594B2 (en) | 2008-10-29 | 2022-07-26 | Flashback Technologies, Inc. | Noninvasive monitoring for fluid resuscitation |
US20110172545A1 (en) * | 2008-10-29 | 2011-07-14 | Gregory Zlatko Grudic | Active Physical Perturbations to Enhance Intelligent Medical Monitoring |
US8512260B2 (en) | 2008-10-29 | 2013-08-20 | The Regents Of The University Of Colorado, A Body Corporate | Statistical, noninvasive measurement of intracranial pressure |
US11395634B2 (en) | 2008-10-29 | 2022-07-26 | Flashback Technologies, Inc. | Estimating physiological states based on changes in CRI |
US11478190B2 (en) | 2008-10-29 | 2022-10-25 | Flashback Technologies, Inc. | Noninvasive hydration monitoring |
US11857293B2 (en) | 2008-10-29 | 2024-01-02 | Flashback Technologies, Inc. | Rapid detection of bleeding before, during, and after fluid resuscitation |
US11382571B2 (en) | 2008-10-29 | 2022-07-12 | Flashback Technologies, Inc. | Noninvasive predictive and/or estimative blood pressure monitoring |
US11406269B2 (en) | 2008-10-29 | 2022-08-09 | Flashback Technologies, Inc. | Rapid detection of bleeding following injury |
WO2010063097A1 (en) * | 2008-12-01 | 2010-06-10 | Nortel Networks Limited | Frequency agile filter using a digital filter and bandstop filtering |
US20090171172A1 (en) * | 2008-12-19 | 2009-07-02 | Nellcor Puritan Bennett Llc | Method and system for pulse gating |
US8771204B2 (en) | 2008-12-30 | 2014-07-08 | Masimo Corporation | Acoustic sensor assembly |
US8588880B2 (en) | 2009-02-16 | 2013-11-19 | Masimo Corporation | Ear sensor |
US20100216639A1 (en) * | 2009-02-20 | 2010-08-26 | Hubbs Jonathon W | Gypsum soil conditioner |
US8788002B2 (en) | 2009-02-25 | 2014-07-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
EP2400884B1 (en) | 2009-02-25 | 2018-03-07 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US9750462B2 (en) | 2009-02-25 | 2017-09-05 | Valencell, Inc. | Monitoring apparatus and methods for measuring physiological and/or environmental conditions |
US10007758B2 (en) | 2009-03-04 | 2018-06-26 | Masimo Corporation | Medical monitoring system |
US10032002B2 (en) | 2009-03-04 | 2018-07-24 | Masimo Corporation | Medical monitoring system |
EP2404253B1 (en) | 2009-03-04 | 2019-09-18 | Masimo Corporation | Medical monitoring system |
US9323894B2 (en) | 2011-08-19 | 2016-04-26 | Masimo Corporation | Health care sanitation monitoring system |
US20100224191A1 (en) * | 2009-03-06 | 2010-09-09 | Cardinal Health 207, Inc. | Automated Oxygen Delivery System |
US8388353B2 (en) | 2009-03-11 | 2013-03-05 | Cercacor Laboratories, Inc. | Magnetic connector |
US20100234718A1 (en) * | 2009-03-12 | 2010-09-16 | Anand Sampath | Open architecture medical communication system |
US20100240972A1 (en) * | 2009-03-20 | 2010-09-23 | Nellcor Puritan Bennett Llc | Slider Spot Check Pulse Oximeter |
US8897847B2 (en) | 2009-03-23 | 2014-11-25 | Masimo Corporation | Digit gauge for noninvasive optical sensor |
US20100249550A1 (en) * | 2009-03-25 | 2010-09-30 | Neilcor Puritan Bennett LLC | Method And Apparatus For Optical Filtering Of A Broadband Emitter In A Medical Sensor |
US8478538B2 (en) | 2009-05-07 | 2013-07-02 | Nellcor Puritan Bennett Ireland | Selection of signal regions for parameter extraction |
US8989831B2 (en) | 2009-05-19 | 2015-03-24 | Masimo Corporation | Disposable components for reusable physiological sensor |
US11896350B2 (en) | 2009-05-20 | 2024-02-13 | Sotera Wireless, Inc. | Cable system for generating signals for detecting motion and measuring vital signs |
US8180440B2 (en) | 2009-05-20 | 2012-05-15 | Sotera Wireless, Inc. | Alarm system that processes both motion and vital signs using specific heuristic rules and thresholds |
US8571619B2 (en) | 2009-05-20 | 2013-10-29 | Masimo Corporation | Hemoglobin display and patient treatment |
US11589754B2 (en) * | 2009-05-20 | 2023-02-28 | Sotera Wireless, Inc. | Blood pressure-monitoring system with alarm/alert system that accounts for patient motion |
US8346332B2 (en) * | 2009-06-10 | 2013-01-01 | Medtronic, Inc. | Absolute calibrated tissue oxygen saturation and total hemoglobin volume fraction |
WO2010144649A1 (en) * | 2009-06-10 | 2010-12-16 | Medtronic, Inc. | Shock reduction using absolute calibrated tissue oxygen saturation and total hemoglobin volume fraction |
EP2440116B1 (en) * | 2009-06-10 | 2018-02-28 | Medtronic, Inc. | Device and method for monitoring of absolute oxygen saturation and tissue hemoglobin concentration |
US8352008B2 (en) * | 2009-06-10 | 2013-01-08 | Medtronic, Inc. | Active noise cancellation in an optical sensor signal |
EP2440285B1 (en) * | 2009-06-10 | 2021-08-04 | Medtronic, Inc. | Tissue oxygenation monitoring in heart failure |
US8418524B2 (en) | 2009-06-12 | 2013-04-16 | Masimo Corporation | Non-invasive sensor calibration device |
US8437824B2 (en) * | 2009-06-17 | 2013-05-07 | Sotera Wireless, Inc. | Body-worn pulse oximeter |
US8290730B2 (en) | 2009-06-30 | 2012-10-16 | Nellcor Puritan Bennett Ireland | Systems and methods for assessing measurements in physiological monitoring devices |
US20100331631A1 (en) * | 2009-06-30 | 2010-12-30 | Nellcor Puritan Bennett Llc | Oxygen saturation ear sensor design that optimizes both attachment method and signal quality |
US8670811B2 (en) * | 2009-06-30 | 2014-03-11 | Masimo Corporation | Pulse oximetry system for adjusting medical ventilation |
US9198582B2 (en) | 2009-06-30 | 2015-12-01 | Nellcor Puritan Bennett Ireland | Determining a characteristic physiological parameter |
US20110208015A1 (en) | 2009-07-20 | 2011-08-25 | Masimo Corporation | Wireless patient monitoring system |
US20110040197A1 (en) * | 2009-07-20 | 2011-02-17 | Masimo Corporation | Wireless patient monitoring system |
US20110021941A1 (en) * | 2009-07-23 | 2011-01-27 | Nellcor Puritan Bennett Ireland | Systems and methods for respiration monitoring |
US20110021892A1 (en) * | 2009-07-23 | 2011-01-27 | Nellcor Puritan Bennett Ireland | Systems and methods for respiration monitoring |
US8471713B2 (en) | 2009-07-24 | 2013-06-25 | Cercacor Laboratories, Inc. | Interference detector for patient monitor |
US20110028806A1 (en) * | 2009-07-29 | 2011-02-03 | Sean Merritt | Reflectance calibration of fluorescence-based glucose measurements |
US8473020B2 (en) | 2009-07-29 | 2013-06-25 | Cercacor Laboratories, Inc. | Non-invasive physiological sensor cover |
US20110028809A1 (en) * | 2009-07-29 | 2011-02-03 | Masimo Corporation | Patient monitor ambient display device |
US8494786B2 (en) | 2009-07-30 | 2013-07-23 | Covidien Lp | Exponential sampling of red and infrared signals |
US8478376B2 (en) * | 2009-07-30 | 2013-07-02 | Nellcor Puritan Bennett Ireland | Systems and methods for determining physiological information using selective transform data |
US8628477B2 (en) | 2009-07-31 | 2014-01-14 | Nellcor Puritan Bennett Ireland | Systems and methods for non-invasive determination of blood pressure |
US20110029865A1 (en) * | 2009-07-31 | 2011-02-03 | Nellcor Puritan Bennett Llc | Control Interface For A Medical Monitor |
US20110087081A1 (en) * | 2009-08-03 | 2011-04-14 | Kiani Massi Joe E | Personalized physiological monitor |
US8494606B2 (en) * | 2009-08-19 | 2013-07-23 | Covidien Lp | Photoplethysmography with controlled application of sensor pressure |
US8688183B2 (en) | 2009-09-03 | 2014-04-01 | Ceracor Laboratories, Inc. | Emitter driver for noninvasive patient monitor |
US8521245B2 (en) * | 2009-09-11 | 2013-08-27 | Medtronic, Inc. | Method and apparatus for post-shock evaluation using tissue oxygenation measurements |
US11253169B2 (en) | 2009-09-14 | 2022-02-22 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US20110172498A1 (en) | 2009-09-14 | 2011-07-14 | Olsen Gregory A | Spot check monitor credit system |
US20110066043A1 (en) * | 2009-09-14 | 2011-03-17 | Matt Banet | System for measuring vital signs during hemodialysis |
US8740807B2 (en) * | 2009-09-14 | 2014-06-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US12121364B2 (en) | 2009-09-14 | 2024-10-22 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US9579039B2 (en) | 2011-01-10 | 2017-02-28 | Masimo Corporation | Non-invasive intravascular volume index monitor |
US8527038B2 (en) * | 2009-09-15 | 2013-09-03 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US10806351B2 (en) * | 2009-09-15 | 2020-10-20 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US20110066044A1 (en) * | 2009-09-15 | 2011-03-17 | Jim Moon | Body-worn vital sign monitor |
US8321004B2 (en) * | 2009-09-15 | 2012-11-27 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8364250B2 (en) * | 2009-09-15 | 2013-01-29 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US10420476B2 (en) * | 2009-09-15 | 2019-09-24 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US20110137297A1 (en) | 2009-09-17 | 2011-06-09 | Kiani Massi Joe E | Pharmacological management system |
WO2011035070A1 (en) * | 2009-09-17 | 2011-03-24 | Masimo Laboratories, Inc. | Improving analyte monitoring using one or more accelerometers |
US8494604B2 (en) * | 2009-09-21 | 2013-07-23 | Covidien Lp | Wavelength-division multiplexing in a multi-wavelength photon density wave system |
US8788001B2 (en) * | 2009-09-21 | 2014-07-22 | Covidien Lp | Time-division multiplexing in a multi-wavelength photon density wave system |
US9220440B2 (en) | 2009-09-21 | 2015-12-29 | Nellcor Puritan Bennett Ireland | Determining a characteristic respiration rate |
US8704666B2 (en) * | 2009-09-21 | 2014-04-22 | Covidien Lp | Medical device interface customization systems and methods |
US8798704B2 (en) * | 2009-09-24 | 2014-08-05 | Covidien Lp | Photoacoustic spectroscopy method and system to discern sepsis from shock |
US8571618B1 (en) | 2009-09-28 | 2013-10-29 | Cercacor Laboratories, Inc. | Adaptive calibration system for spectrophotometric measurements |
US9066660B2 (en) | 2009-09-29 | 2015-06-30 | Nellcor Puritan Bennett Ireland | Systems and methods for high-pass filtering a photoplethysmograph signal |
US8515511B2 (en) | 2009-09-29 | 2013-08-20 | Covidien Lp | Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same |
US9554739B2 (en) | 2009-09-29 | 2017-01-31 | Covidien Lp | Smart cable for coupling a medical sensor to an electronic patient monitor |
US8376955B2 (en) * | 2009-09-29 | 2013-02-19 | Covidien Lp | Spectroscopic method and system for assessing tissue temperature |
US8463347B2 (en) | 2009-09-30 | 2013-06-11 | Nellcor Puritan Bennett Ireland | Systems and methods for normalizing a plethysmograph signal for improved feature analysis |
US20110077484A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Ireland | Systems And Methods For Identifying Non-Corrupted Signal Segments For Use In Determining Physiological Parameters |
US20110074342A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Wireless electricity for electronic devices |
US20110077470A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Patient Monitor Symmetry Control |
US20110082711A1 (en) | 2009-10-06 | 2011-04-07 | Masimo Laboratories, Inc. | Personal digital assistant or organizer for monitoring glucose levels |
WO2011047216A2 (en) | 2009-10-15 | 2011-04-21 | Masimo Corporation | Physiological acoustic monitoring system |
US9066680B1 (en) | 2009-10-15 | 2015-06-30 | Masimo Corporation | System for determining confidence in respiratory rate measurements |
WO2011047211A1 (en) | 2009-10-15 | 2011-04-21 | Masimo Corporation | Pulse oximetry system with low noise cable hub |
US8790268B2 (en) | 2009-10-15 | 2014-07-29 | Masimo Corporation | Bidirectional physiological information display |
US10463340B2 (en) | 2009-10-15 | 2019-11-05 | Masimo Corporation | Acoustic respiratory monitoring systems and methods |
US8755535B2 (en) | 2009-10-15 | 2014-06-17 | Masimo Corporation | Acoustic respiratory monitoring sensor having multiple sensing elements |
US9724016B1 (en) | 2009-10-16 | 2017-08-08 | Masimo Corp. | Respiration processor |
US8790259B2 (en) | 2009-10-22 | 2014-07-29 | Corventis, Inc. | Method and apparatus for remote detection and monitoring of functional chronotropic incompetence |
US20110118561A1 (en) | 2009-11-13 | 2011-05-19 | Masimo Corporation | Remote control for a medical monitoring device |
US9226686B2 (en) * | 2009-11-23 | 2016-01-05 | Rf Surgical Systems, Inc. | Method and apparatus to account for transponder tagged objects used during medical procedures |
US9839381B1 (en) | 2009-11-24 | 2017-12-12 | Cercacor Laboratories, Inc. | Physiological measurement system with automatic wavelength adjustment |
DE112010004682T5 (en) | 2009-12-04 | 2013-03-28 | Masimo Corporation | Calibration for multi-level physiological monitors |
DE102009047660A1 (en) * | 2009-12-08 | 2011-06-09 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Method for compensating variation of light intensity of light beam during optical measurement, involves supplying light beam signal to adaptive filter, and evaluating filter output signal based on optical characteristics of measuring medium |
US9451897B2 (en) * | 2009-12-14 | 2016-09-27 | Medtronic Monitoring, Inc. | Body adherent patch with electronics for physiologic monitoring |
US9153112B1 (en) | 2009-12-21 | 2015-10-06 | Masimo Corporation | Modular patient monitor |
GB2490817A (en) | 2010-01-19 | 2012-11-14 | Masimo Corp | Wellness analysis system |
JP2013521054A (en) | 2010-03-01 | 2013-06-10 | マシモ コーポレイション | Adaptive alarm system |
WO2011112524A1 (en) | 2010-03-08 | 2011-09-15 | Masimo Corporation | Reprocessing of a physiological sensor |
US20110224498A1 (en) * | 2010-03-10 | 2011-09-15 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
EP2549926A1 (en) * | 2010-03-23 | 2013-01-30 | Koninklijke Philips Electronics N.V. | Interference reduction in monitoring a vital parameter of a patient |
US9307928B1 (en) | 2010-03-30 | 2016-04-12 | Masimo Corporation | Plethysmographic respiration processor |
US9451887B2 (en) | 2010-03-31 | 2016-09-27 | Nellcor Puritan Bennett Ireland | Systems and methods for measuring electromechanical delay of the heart |
US8965498B2 (en) | 2010-04-05 | 2015-02-24 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
US8979765B2 (en) | 2010-04-19 | 2015-03-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9173593B2 (en) | 2010-04-19 | 2015-11-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9339209B2 (en) | 2010-04-19 | 2016-05-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9173594B2 (en) | 2010-04-19 | 2015-11-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8747330B2 (en) | 2010-04-19 | 2014-06-10 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8888700B2 (en) | 2010-04-19 | 2014-11-18 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8898037B2 (en) | 2010-04-28 | 2014-11-25 | Nellcor Puritan Bennett Ireland | Systems and methods for signal monitoring using Lissajous figures |
US8712494B1 (en) | 2010-05-03 | 2014-04-29 | Masimo Corporation | Reflective non-invasive sensor |
US9138180B1 (en) | 2010-05-03 | 2015-09-22 | Masimo Corporation | Sensor adapter cable |
US7884933B1 (en) | 2010-05-05 | 2011-02-08 | Revolutionary Business Concepts, Inc. | Apparatus and method for determining analyte concentrations |
US8666468B1 (en) | 2010-05-06 | 2014-03-04 | Masimo Corporation | Patient monitor for determining microcirculation state |
US9326712B1 (en) | 2010-06-02 | 2016-05-03 | Masimo Corporation | Opticoustic sensor |
US8740792B1 (en) | 2010-07-12 | 2014-06-03 | Masimo Corporation | Patient monitor capable of accounting for environmental conditions |
US9408542B1 (en) | 2010-07-22 | 2016-08-09 | Masimo Corporation | Non-invasive blood pressure measurement system |
US8930145B2 (en) | 2010-07-28 | 2015-01-06 | Covidien Lp | Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring |
US9649054B2 (en) | 2010-08-26 | 2017-05-16 | Cercacor Laboratories, Inc. | Blood pressure measurement method |
WO2012050847A2 (en) | 2010-09-28 | 2012-04-19 | Masimo Corporation | Depth of consciousness monitor including oximeter |
US9775545B2 (en) | 2010-09-28 | 2017-10-03 | Masimo Corporation | Magnetic electrical connector for patient monitors |
US9211095B1 (en) | 2010-10-13 | 2015-12-15 | Masimo Corporation | Physiological measurement logic engine |
US8723677B1 (en) | 2010-10-20 | 2014-05-13 | Masimo Corporation | Patient safety system with automatically adjusting bed |
US8825428B2 (en) | 2010-11-30 | 2014-09-02 | Neilcor Puritan Bennett Ireland | Methods and systems for recalibrating a blood pressure monitor with memory |
US9259160B2 (en) | 2010-12-01 | 2016-02-16 | Nellcor Puritan Bennett Ireland | Systems and methods for determining when to measure a physiological parameter |
US20120226117A1 (en) | 2010-12-01 | 2012-09-06 | Lamego Marcelo M | Handheld processing device including medical applications for minimally and non invasive glucose measurements |
US9357934B2 (en) | 2010-12-01 | 2016-06-07 | Nellcor Puritan Bennett Ireland | Systems and methods for physiological event marking |
US10722130B2 (en) | 2010-12-28 | 2020-07-28 | Sotera Wireless, Inc. | Body-worn system for continuous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure |
US8888701B2 (en) | 2011-01-27 | 2014-11-18 | Valencell, Inc. | Apparatus and methods for monitoring physiological data during environmental interference |
EP2673721A1 (en) | 2011-02-13 | 2013-12-18 | Masimo Corporation | Medical characterization system |
EP2675348B1 (en) | 2011-02-18 | 2019-11-06 | Sotera Wireless, Inc. | Modular wrist-worn processor for patient monitoring |
SG10201601161YA (en) | 2011-02-18 | 2016-03-30 | Sotera Wireless Inc | Optical sensor for measuring physiological properties |
US9066666B2 (en) | 2011-02-25 | 2015-06-30 | Cercacor Laboratories, Inc. | Patient monitor for monitoring microcirculation |
US8830449B1 (en) | 2011-04-18 | 2014-09-09 | Cercacor Laboratories, Inc. | Blood analysis system |
US9095316B2 (en) | 2011-04-20 | 2015-08-04 | Masimo Corporation | System for generating alarms based on alarm patterns |
US9622692B2 (en) | 2011-05-16 | 2017-04-18 | Masimo Corporation | Personal health device |
US9109902B1 (en) | 2011-06-13 | 2015-08-18 | Impact Sports Technologies, Inc. | Monitoring device with a pedometer |
US9532722B2 (en) | 2011-06-21 | 2017-01-03 | Masimo Corporation | Patient monitoring system |
US9986919B2 (en) | 2011-06-21 | 2018-06-05 | Masimo Corporation | Patient monitoring system |
US9245668B1 (en) | 2011-06-29 | 2016-01-26 | Cercacor Laboratories, Inc. | Low noise cable providing communication between electronic sensor components and patient monitor |
US11439329B2 (en) | 2011-07-13 | 2022-09-13 | Masimo Corporation | Multiple measurement mode in a physiological sensor |
US20130023775A1 (en) | 2011-07-20 | 2013-01-24 | Cercacor Laboratories, Inc. | Magnetic Reusable Sensor |
CA2871608C (en) | 2011-07-22 | 2020-07-07 | Flashback Technologies, Inc. | Hemodynamic reserve monitor and hemodialysis control |
US9192351B1 (en) | 2011-07-22 | 2015-11-24 | Masimo Corporation | Acoustic respiratory monitoring sensor with probe-off detection |
WO2013016007A2 (en) | 2011-07-25 | 2013-01-31 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
RU2466493C1 (en) * | 2011-07-26 | 2012-11-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ставропольский государственный аграрный университет" | Method to generate reference voltage |
US8755872B1 (en) | 2011-07-28 | 2014-06-17 | Masimo Corporation | Patient monitoring system for indicating an abnormal condition |
EP2739207B1 (en) | 2011-08-02 | 2017-07-19 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
US9782077B2 (en) | 2011-08-17 | 2017-10-10 | Masimo Corporation | Modulated physiological sensor |
JP5837785B2 (en) | 2011-09-13 | 2015-12-24 | 日本光電工業株式会社 | Biological signal measuring device |
US9693709B2 (en) | 2011-09-23 | 2017-07-04 | Nellcot Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9119597B2 (en) | 2011-09-23 | 2015-09-01 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9402554B2 (en) | 2011-09-23 | 2016-08-02 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9675274B2 (en) | 2011-09-23 | 2017-06-13 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9808188B1 (en) | 2011-10-13 | 2017-11-07 | Masimo Corporation | Robust fractional saturation determination |
EP2765909B1 (en) | 2011-10-13 | 2019-06-26 | Masimo Corporation | Physiological acoustic monitoring system |
WO2013056160A2 (en) | 2011-10-13 | 2013-04-18 | Masimo Corporation | Medical monitoring hub |
US9943269B2 (en) | 2011-10-13 | 2018-04-17 | Masimo Corporation | System for displaying medical monitoring data |
US9778079B1 (en) | 2011-10-27 | 2017-10-03 | Masimo Corporation | Physiological monitor gauge panel |
US9693736B2 (en) | 2011-11-30 | 2017-07-04 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information using historical distribution |
US9060695B2 (en) | 2011-11-30 | 2015-06-23 | Covidien Lp | Systems and methods for determining differential pulse transit time from the phase difference of two analog plethysmographs |
US9445759B1 (en) | 2011-12-22 | 2016-09-20 | Cercacor Laboratories, Inc. | Blood glucose calibration system |
US9392945B2 (en) | 2012-01-04 | 2016-07-19 | Masimo Corporation | Automated CCHD screening and detection |
US12004881B2 (en) | 2012-01-04 | 2024-06-11 | Masimo Corporation | Automated condition screening and detection |
US11172890B2 (en) | 2012-01-04 | 2021-11-16 | Masimo Corporation | Automated condition screening and detection |
CN107260142B (en) | 2012-01-16 | 2020-10-20 | 瓦伦赛尔公司 | Reduction of physiological index errors using inertial frequency |
CN104168828A (en) | 2012-01-16 | 2014-11-26 | 瓦伦赛尔公司 | Physiological metric estimation rise and fall limiting |
JP6179064B2 (en) * | 2012-01-25 | 2017-08-16 | セイコーエプソン株式会社 | Pulse wave measuring device and signal processing device |
JP6102055B2 (en) * | 2012-01-25 | 2017-03-29 | セイコーエプソン株式会社 | Pulse wave measuring device and signal processing device |
US9267572B2 (en) | 2012-02-08 | 2016-02-23 | Masimo Corporation | Cable tether system |
US10149616B2 (en) | 2012-02-09 | 2018-12-11 | Masimo Corporation | Wireless patient monitoring device |
US10307111B2 (en) | 2012-02-09 | 2019-06-04 | Masimo Corporation | Patient position detection system |
US9480435B2 (en) | 2012-02-09 | 2016-11-01 | Masimo Corporation | Configurable patient monitoring system |
KR101910982B1 (en) * | 2012-02-13 | 2019-01-04 | 삼성전자주식회사 | Method and apparatus for eliminating motion artifact of biosignal using personalized biosignal pattern |
US9195385B2 (en) | 2012-03-25 | 2015-11-24 | Masimo Corporation | Physiological monitor touchscreen interface |
US9131881B2 (en) | 2012-04-17 | 2015-09-15 | Masimo Corporation | Hypersaturation index |
US9833146B2 (en) | 2012-04-17 | 2017-12-05 | Covidien Lp | Surgical system and method of use of the same |
US8644413B2 (en) | 2012-05-29 | 2014-02-04 | Magnolia Broadband Inc. | Implementing blind tuning in hybrid MIMO RF beamforming systems |
US8837650B2 (en) | 2012-05-29 | 2014-09-16 | Magnolia Broadband Inc. | System and method for discrete gain control in hybrid MIMO RF beamforming for multi layer MIMO base station |
US8811522B2 (en) | 2012-05-29 | 2014-08-19 | Magnolia Broadband Inc. | Mitigating interferences for a multi-layer MIMO system augmented by radio distribution network |
US8861635B2 (en) | 2012-05-29 | 2014-10-14 | Magnolia Broadband Inc. | Setting radio frequency (RF) beamformer antenna weights per data-stream in a multiple-input-multiple-output (MIMO) system |
US8767862B2 (en) | 2012-05-29 | 2014-07-01 | Magnolia Broadband Inc. | Beamformer phase optimization for a multi-layer MIMO system augmented by radio distribution network |
US8971452B2 (en) | 2012-05-29 | 2015-03-03 | Magnolia Broadband Inc. | Using 3G/4G baseband signals for tuning beamformers in hybrid MIMO RDN systems |
US8842765B2 (en) | 2012-05-29 | 2014-09-23 | Magnolia Broadband Inc. | Beamformer configurable for connecting a variable number of antennas and radio circuits |
US8619927B2 (en) | 2012-05-29 | 2013-12-31 | Magnolia Broadband Inc. | System and method for discrete gain control in hybrid MIMO/RF beamforming |
US10542903B2 (en) | 2012-06-07 | 2020-01-28 | Masimo Corporation | Depth of consciousness monitor |
US9154204B2 (en) | 2012-06-11 | 2015-10-06 | Magnolia Broadband Inc. | Implementing transmit RDN architectures in uplink MIMO systems |
US9697928B2 (en) | 2012-08-01 | 2017-07-04 | Masimo Corporation | Automated assembly sensor cable |
US10827961B1 (en) | 2012-08-29 | 2020-11-10 | Masimo Corporation | Physiological measurement calibration |
US9877650B2 (en) | 2012-09-20 | 2018-01-30 | Masimo Corporation | Physiological monitor with mobile computing device connectivity |
US9955937B2 (en) | 2012-09-20 | 2018-05-01 | Masimo Corporation | Acoustic patient sensor coupler |
US9749232B2 (en) | 2012-09-20 | 2017-08-29 | Masimo Corporation | Intelligent medical network edge router |
US9717458B2 (en) | 2012-10-20 | 2017-08-01 | Masimo Corporation | Magnetic-flap optical sensor |
US9560996B2 (en) | 2012-10-30 | 2017-02-07 | Masimo Corporation | Universal medical system |
US9787568B2 (en) | 2012-11-05 | 2017-10-10 | Cercacor Laboratories, Inc. | Physiological test credit method |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
US9750461B1 (en) | 2013-01-02 | 2017-09-05 | Masimo Corporation | Acoustic respiratory monitoring sensor with probe-off detection |
WO2014109982A2 (en) | 2013-01-09 | 2014-07-17 | Valencell Inc. | Cadence detection based on inertial harmonics |
US9724025B1 (en) | 2013-01-16 | 2017-08-08 | Masimo Corporation | Active-pulse blood analysis system |
WO2014116924A1 (en) | 2013-01-28 | 2014-07-31 | Valencell, Inc. | Physiological monitoring devices having sensing elements decoupled from body motion |
US8797969B1 (en) | 2013-02-08 | 2014-08-05 | Magnolia Broadband Inc. | Implementing multi user multiple input multiple output (MU MIMO) base station using single-user (SU) MIMO co-located base stations |
US9343808B2 (en) | 2013-02-08 | 2016-05-17 | Magnotod Llc | Multi-beam MIMO time division duplex base station using subset of radios |
US8774150B1 (en) | 2013-02-13 | 2014-07-08 | Magnolia Broadband Inc. | System and method for reducing side-lobe contamination effects in Wi-Fi access points |
US20140226740A1 (en) | 2013-02-13 | 2014-08-14 | Magnolia Broadband Inc. | Multi-beam co-channel wi-fi access point |
US9155110B2 (en) | 2013-03-27 | 2015-10-06 | Magnolia Broadband Inc. | System and method for co-located and co-channel Wi-Fi access points |
US8989103B2 (en) | 2013-02-13 | 2015-03-24 | Magnolia Broadband Inc. | Method and system for selective attenuation of preamble reception in co-located WI FI access points |
US9750442B2 (en) | 2013-03-09 | 2017-09-05 | Masimo Corporation | Physiological status monitor |
US9965946B2 (en) | 2013-03-13 | 2018-05-08 | Masimo Corporation | Systems and methods for monitoring a patient health network |
US10441181B1 (en) | 2013-03-13 | 2019-10-15 | Masimo Corporation | Acoustic pulse and respiration monitoring system |
US9986952B2 (en) | 2013-03-14 | 2018-06-05 | Masimo Corporation | Heart sound simulator |
WO2014158820A1 (en) | 2013-03-14 | 2014-10-02 | Cercacor Laboratories, Inc. | Patient monitor as a minimally invasive glucometer |
US9936917B2 (en) | 2013-03-14 | 2018-04-10 | Masimo Laboratories, Inc. | Patient monitor placement indicator |
WO2014159132A1 (en) | 2013-03-14 | 2014-10-02 | Cercacor Laboratories, Inc. | Systems and methods for testing patient monitors |
US10456038B2 (en) | 2013-03-15 | 2019-10-29 | Cercacor Laboratories, Inc. | Cloud-based physiological monitoring system |
WO2014149781A1 (en) | 2013-03-15 | 2014-09-25 | Cercacor Laboratories, Inc. | Cloud-based physiological monitoring system |
US20140275878A1 (en) * | 2013-03-15 | 2014-09-18 | Covidien Lp | Methods and systems for equalizing physiological signals |
US9100968B2 (en) | 2013-05-09 | 2015-08-04 | Magnolia Broadband Inc. | Method and system for digital cancellation scheme with multi-beam |
EP3003150A1 (en) | 2013-06-06 | 2016-04-13 | Koninklijke Philips N.V. | Use of a barrier contact medium for chemo-chemo-optical sensors in transcutaneous applications |
US9425882B2 (en) | 2013-06-28 | 2016-08-23 | Magnolia Broadband Inc. | Wi-Fi radio distribution network stations and method of operating Wi-Fi RDN stations |
US8995416B2 (en) | 2013-07-10 | 2015-03-31 | Magnolia Broadband Inc. | System and method for simultaneous co-channel access of neighboring access points |
US9891079B2 (en) | 2013-07-17 | 2018-02-13 | Masimo Corporation | Pulser with double-bearing position encoder for non-invasive physiological monitoring |
US8824596B1 (en) | 2013-07-31 | 2014-09-02 | Magnolia Broadband Inc. | System and method for uplink transmissions in time division MIMO RDN architecture |
US10555678B2 (en) | 2013-08-05 | 2020-02-11 | Masimo Corporation | Blood pressure monitor with valve-chamber assembly |
US9497781B2 (en) | 2013-08-13 | 2016-11-15 | Magnolia Broadband Inc. | System and method for co-located and co-channel Wi-Fi access points |
WO2015038683A2 (en) | 2013-09-12 | 2015-03-19 | Cercacor Laboratories, Inc. | Medical device management system |
US9060362B2 (en) | 2013-09-12 | 2015-06-16 | Magnolia Broadband Inc. | Method and system for accessing an occupied Wi-Fi channel by a client using a nulling scheme |
US9088898B2 (en) | 2013-09-12 | 2015-07-21 | Magnolia Broadband Inc. | System and method for cooperative scheduling for co-located access points |
US9830424B2 (en) | 2013-09-18 | 2017-11-28 | Hill-Rom Services, Inc. | Bed/room/patient association systems and methods |
US11147518B1 (en) | 2013-10-07 | 2021-10-19 | Masimo Corporation | Regional oximetry signal processor |
JP6484230B2 (en) | 2013-10-07 | 2019-03-13 | マシモ・コーポレイション | Local oximetry sensor |
US10828007B1 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Acoustic sensor with attachment portion |
US10832818B2 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Alarm notification system |
US10022068B2 (en) | 2013-10-28 | 2018-07-17 | Covidien Lp | Systems and methods for detecting held breath events |
US9172454B2 (en) | 2013-11-01 | 2015-10-27 | Magnolia Broadband Inc. | Method and system for calibrating a transceiver array |
US8891598B1 (en) | 2013-11-19 | 2014-11-18 | Magnolia Broadband Inc. | Transmitter and receiver calibration for obtaining the channel reciprocity for time division duplex MIMO systems |
US8942134B1 (en) | 2013-11-20 | 2015-01-27 | Magnolia Broadband Inc. | System and method for selective registration in a multi-beam system |
US8929322B1 (en) * | 2013-11-20 | 2015-01-06 | Magnolia Broadband Inc. | System and method for side lobe suppression using controlled signal cancellation |
US9014066B1 (en) | 2013-11-26 | 2015-04-21 | Magnolia Broadband Inc. | System and method for transmit and receive antenna patterns calibration for time division duplex (TDD) systems |
US9294177B2 (en) | 2013-11-26 | 2016-03-22 | Magnolia Broadband Inc. | System and method for transmit and receive antenna patterns calibration for time division duplex (TDD) systems |
US9042276B1 (en) | 2013-12-05 | 2015-05-26 | Magnolia Broadband Inc. | Multiple co-located multi-user-MIMO access points |
US10279247B2 (en) | 2013-12-13 | 2019-05-07 | Masimo Corporation | Avatar-incentive healthcare therapy |
US10086138B1 (en) | 2014-01-28 | 2018-10-02 | Masimo Corporation | Autonomous drug delivery system |
US11259745B2 (en) | 2014-01-28 | 2022-03-01 | Masimo Corporation | Autonomous drug delivery system |
US10532174B2 (en) | 2014-02-21 | 2020-01-14 | Masimo Corporation | Assistive capnography device |
EP3153093B1 (en) | 2014-02-28 | 2019-04-03 | Valencell, Inc. | Method and apparatus for generating assessments using physical activity and biometric parameters |
US9100154B1 (en) | 2014-03-19 | 2015-08-04 | Magnolia Broadband Inc. | Method and system for explicit AP-to-AP sounding in an 802.11 network |
US9172446B2 (en) | 2014-03-19 | 2015-10-27 | Magnolia Broadband Inc. | Method and system for supporting sparse explicit sounding by implicit data |
US9271176B2 (en) | 2014-03-28 | 2016-02-23 | Magnolia Broadband Inc. | System and method for backhaul based sounding feedback |
AU2014389444B2 (en) | 2014-03-31 | 2019-07-25 | Covidien Lp | Method, apparatus and article for detection of transponder tagged objects, for example during surgery |
US10339269B2 (en) | 2014-03-31 | 2019-07-02 | Covidien Lp | Hand-held spherical antenna system to detect transponder tagged objects, for example during surgery |
US9924897B1 (en) | 2014-06-12 | 2018-03-27 | Masimo Corporation | Heated reprocessing of physiological sensors |
US10123729B2 (en) | 2014-06-13 | 2018-11-13 | Nanthealth, Inc. | Alarm fatigue management systems and methods |
US10231670B2 (en) | 2014-06-19 | 2019-03-19 | Masimo Corporation | Proximity sensor in pulse oximeter |
US9179849B1 (en) | 2014-07-25 | 2015-11-10 | Impact Sports Technologies, Inc. | Mobile plethysmographic device |
US20160029898A1 (en) | 2014-07-30 | 2016-02-04 | Valencell, Inc. | Physiological Monitoring Devices and Methods Using Optical Sensors |
EP3199100A1 (en) | 2014-08-06 | 2017-08-02 | Valencell, Inc. | Earbud with a physiological information sensor module |
US10111591B2 (en) | 2014-08-26 | 2018-10-30 | Nanthealth, Inc. | Real-time monitoring systems and methods in a healthcare environment |
US10231657B2 (en) | 2014-09-04 | 2019-03-19 | Masimo Corporation | Total hemoglobin screening sensor |
US10383520B2 (en) | 2014-09-18 | 2019-08-20 | Masimo Semiconductor, Inc. | Enhanced visible near-infrared photodiode and non-invasive physiological sensor |
US9794653B2 (en) | 2014-09-27 | 2017-10-17 | Valencell, Inc. | Methods and apparatus for improving signal quality in wearable biometric monitoring devices |
WO2016057553A1 (en) | 2014-10-07 | 2016-04-14 | Masimo Corporation | Modular physiological sensors |
EP3203912B1 (en) | 2014-10-10 | 2021-03-10 | Medtor LLC | System and method for a non-invasive medical sensor |
EP3234822B1 (en) | 2014-12-18 | 2019-02-20 | Draeger Medical Systems, Inc. | Alarm routing optimization strategies in a targeted alarm system |
KR102575058B1 (en) | 2015-01-23 | 2023-09-05 | 마시모 스웨덴 에이비 | Nasal/Oral Cannula Systems and Manufacturing |
MX2017010045A (en) | 2015-02-06 | 2018-04-10 | Masimo Corp | Connector assembly with pogo pins for use with medical sensors. |
USD755392S1 (en) | 2015-02-06 | 2016-05-03 | Masimo Corporation | Pulse oximetry sensor |
AU2016215031B2 (en) | 2015-02-06 | 2020-01-16 | Masimo Corporation | Fold flex circuit for optical probes |
US10568553B2 (en) | 2015-02-06 | 2020-02-25 | Masimo Corporation | Soft boot pulse oximetry sensor |
FR3032606B1 (en) * | 2015-02-17 | 2019-12-13 | Bioserenity | METHOD OF NON-INVASIVE MEASUREMENT OF A PHYSIOLOGICAL PARAMETER USING A CONFOCAL SPECTROSCOPIC MEASUREMENT DEVICE |
US9690963B2 (en) | 2015-03-02 | 2017-06-27 | Covidien Lp | Hand-held dual spherical antenna system |
USD775331S1 (en) | 2015-03-02 | 2016-12-27 | Covidien Lp | Hand-held antenna system |
US10524738B2 (en) | 2015-05-04 | 2020-01-07 | Cercacor Laboratories, Inc. | Noninvasive sensor system with visual infographic display |
WO2016191307A1 (en) | 2015-05-22 | 2016-12-01 | Cercacor Laboratories, Inc. | Non-invasive optical physiological differential pathlength sensor |
US10470692B2 (en) * | 2015-06-12 | 2019-11-12 | ChroniSense Medical Ltd. | System for performing pulse oximetry |
US11464457B2 (en) | 2015-06-12 | 2022-10-11 | ChroniSense Medical Ltd. | Determining an early warning score based on wearable device measurements |
US11160461B2 (en) | 2015-06-12 | 2021-11-02 | ChroniSense Medical Ltd. | Blood pressure measurement using a wearable device |
US11160459B2 (en) | 2015-06-12 | 2021-11-02 | ChroniSense Medical Ltd. | Monitoring health status of people suffering from chronic diseases |
US10952638B2 (en) | 2015-06-12 | 2021-03-23 | ChroniSense Medical Ltd. | System and method for monitoring respiratory rate and oxygen saturation |
US11712190B2 (en) | 2015-06-12 | 2023-08-01 | ChroniSense Medical Ltd. | Wearable device electrocardiogram |
US10687742B2 (en) | 2015-06-12 | 2020-06-23 | ChroniSense Medical Ltd. | Using invariant factors for pulse oximetry |
US10448871B2 (en) | 2015-07-02 | 2019-10-22 | Masimo Corporation | Advanced pulse oximetry sensor |
CA2994172A1 (en) | 2015-08-11 | 2017-02-16 | Masimo Corporation | Medical monitoring analysis and replay including indicia responsive to light attenuated by body tissue |
US10448844B2 (en) | 2015-08-31 | 2019-10-22 | Masimo Corporation | Systems and methods for patient fall detection |
US11504066B1 (en) | 2015-09-04 | 2022-11-22 | Cercacor Laboratories, Inc. | Low-noise sensor system |
EP3344127A4 (en) | 2015-10-23 | 2018-07-25 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
US11679579B2 (en) | 2015-12-17 | 2023-06-20 | Masimo Corporation | Varnish-coated release liner |
US10537285B2 (en) | 2016-03-04 | 2020-01-21 | Masimo Corporation | Nose sensor |
US10993662B2 (en) | 2016-03-04 | 2021-05-04 | Masimo Corporation | Nose sensor |
US11000235B2 (en) | 2016-03-14 | 2021-05-11 | ChroniSense Medical Ltd. | Monitoring procedure for early warning of cardiac episodes |
US11191484B2 (en) | 2016-04-29 | 2021-12-07 | Masimo Corporation | Optical sensor tape |
WO2018009612A1 (en) | 2016-07-06 | 2018-01-11 | Patient Doctor Technologies, Inc. | Secure and zero knowledge data sharing for cloud applications |
US10617302B2 (en) | 2016-07-07 | 2020-04-14 | Masimo Corporation | Wearable pulse oximeter and respiration monitor |
WO2018009736A1 (en) | 2016-07-08 | 2018-01-11 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
US10751004B2 (en) | 2016-07-08 | 2020-08-25 | Edwards Lifesciences Corporation | Predictive weighting of hypotension profiling parameters |
US11076813B2 (en) * | 2016-07-22 | 2021-08-03 | Edwards Lifesciences Corporation | Mean arterial pressure (MAP) derived prediction of future hypotension |
WO2018071715A1 (en) | 2016-10-13 | 2018-04-19 | Masimo Corporation | Systems and methods for patient fall detection |
US11504058B1 (en) | 2016-12-02 | 2022-11-22 | Masimo Corporation | Multi-site noninvasive measurement of a physiological parameter |
US10750984B2 (en) | 2016-12-22 | 2020-08-25 | Cercacor Laboratories, Inc. | Methods and devices for detecting intensity of light with translucent detector |
US10721785B2 (en) | 2017-01-18 | 2020-07-21 | Masimo Corporation | Patient-worn wireless physiological sensor with pairing functionality |
WO2018156648A1 (en) | 2017-02-24 | 2018-08-30 | Masimo Corporation | Managing dynamic licenses for physiological parameters in a patient monitoring environment |
US10327713B2 (en) | 2017-02-24 | 2019-06-25 | Masimo Corporation | Modular multi-parameter patient monitoring device |
US10388120B2 (en) | 2017-02-24 | 2019-08-20 | Masimo Corporation | Localized projection of audible noises in medical settings |
US11086609B2 (en) | 2017-02-24 | 2021-08-10 | Masimo Corporation | Medical monitoring hub |
WO2018156809A1 (en) | 2017-02-24 | 2018-08-30 | Masimo Corporation | Augmented reality system for displaying patient data |
CN111010865B (en) | 2017-02-24 | 2023-07-25 | 梅西莫股份有限公司 | System for displaying medical monitoring data |
WO2018165618A1 (en) | 2017-03-10 | 2018-09-13 | Masimo Corporation | Pneumonia screener |
EP3382423A1 (en) * | 2017-03-27 | 2018-10-03 | Koninklijke Philips N.V. | Methods and systems for filtering ultrasound image clutter |
WO2018194992A1 (en) | 2017-04-18 | 2018-10-25 | Masimo Corporation | Nose sensor |
US10918281B2 (en) | 2017-04-26 | 2021-02-16 | Masimo Corporation | Medical monitoring device having multiple configurations |
USD835283S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
EP3614909B1 (en) | 2017-04-28 | 2024-04-03 | Masimo Corporation | Spot check measurement system |
USD835284S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
USD835285S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
USD835282S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
WO2018208616A1 (en) | 2017-05-08 | 2018-11-15 | Masimo Corporation | System for pairing a medical system to a network controller by use of a dongle |
US11026604B2 (en) | 2017-07-13 | 2021-06-08 | Cercacor Laboratories, Inc. | Medical monitoring device for harmonizing physiological measurements |
USD906970S1 (en) | 2017-08-15 | 2021-01-05 | Masimo Corporation | Connector |
USD890708S1 (en) | 2017-08-15 | 2020-07-21 | Masimo Corporation | Connector |
US10505311B2 (en) | 2017-08-15 | 2019-12-10 | Masimo Corporation | Water resistant connector for noninvasive patient monitor |
USD880477S1 (en) | 2017-08-15 | 2020-04-07 | Masimo Corporation | Connector |
US11045163B2 (en) | 2017-09-19 | 2021-06-29 | Ausculsciences, Inc. | Method of detecting noise in auscultatory sound signals of a coronary-artery-disease detection system |
EP3675713B1 (en) | 2017-10-19 | 2024-09-18 | Masimo Corporation | Display arrangement for medical monitoring system |
USD925597S1 (en) | 2017-10-31 | 2021-07-20 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
KR20200083539A (en) | 2017-10-31 | 2020-07-08 | 마시모 코오퍼레이션 | System for displaying oxygen status indication |
RU2682474C1 (en) * | 2018-01-16 | 2019-03-19 | Непубличное акционерное общество "Институт кардиологической техники" (ИНКАРТ) | Finger photoplethysographic system device for continuous non-invasive measurement of arterial pressure |
US11766198B2 (en) | 2018-02-02 | 2023-09-26 | Cercacor Laboratories, Inc. | Limb-worn patient monitoring device |
US11998298B2 (en) | 2018-02-26 | 2024-06-04 | Biointellisense, Inc. | System and method for a wearable vital signs monitor |
WO2019169026A1 (en) | 2018-03-01 | 2019-09-06 | Masimo Corporation | Autonomous drug delivery system |
US10668882B2 (en) * | 2018-03-30 | 2020-06-02 | Veoneer Us Inc. | Mechanical transfer function cancellation |
WO2019204368A1 (en) | 2018-04-19 | 2019-10-24 | Masimo Corporation | Mobile patient alarm display |
US11883129B2 (en) | 2018-04-24 | 2024-01-30 | Cercacor Laboratories, Inc. | Easy insert finger sensor for transmission based spectroscopy sensor |
EP3801207A1 (en) | 2018-06-06 | 2021-04-14 | Masimo Corporation | Opioid overdose monitoring |
US12097043B2 (en) | 2018-06-06 | 2024-09-24 | Masimo Corporation | Locating a locally stored medication |
US10779098B2 (en) | 2018-07-10 | 2020-09-15 | Masimo Corporation | Patient monitor alarm speaker analyzer |
US11872156B2 (en) | 2018-08-22 | 2024-01-16 | Masimo Corporation | Core body temperature measurement |
US11389093B2 (en) | 2018-10-11 | 2022-07-19 | Masimo Corporation | Low noise oximetry cable |
USD1041511S1 (en) | 2018-10-11 | 2024-09-10 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
USD916135S1 (en) | 2018-10-11 | 2021-04-13 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
US11406286B2 (en) | 2018-10-11 | 2022-08-09 | Masimo Corporation | Patient monitoring device with improved user interface |
USD999246S1 (en) | 2018-10-11 | 2023-09-19 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
USD917550S1 (en) | 2018-10-11 | 2021-04-27 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
US11445948B2 (en) | 2018-10-11 | 2022-09-20 | Masimo Corporation | Patient connector assembly with vertical detents |
USD998630S1 (en) | 2018-10-11 | 2023-09-12 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
USD917564S1 (en) | 2018-10-11 | 2021-04-27 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD998631S1 (en) | 2018-10-11 | 2023-09-12 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
USD897098S1 (en) | 2018-10-12 | 2020-09-29 | Masimo Corporation | Card holder set |
US11464410B2 (en) | 2018-10-12 | 2022-10-11 | Masimo Corporation | Medical systems and methods |
CN113170298A (en) | 2018-10-12 | 2021-07-23 | 迈心诺公司 | System for transmitting sensor data using dual communication scheme |
US12004869B2 (en) | 2018-11-05 | 2024-06-11 | Masimo Corporation | System to monitor and manage patient hydration via plethysmograph variablity index in response to the passive leg raising |
US11986289B2 (en) | 2018-11-27 | 2024-05-21 | Willow Laboratories, Inc. | Assembly for medical monitoring device with multiple physiological sensors |
US11684296B2 (en) | 2018-12-21 | 2023-06-27 | Cercacor Laboratories, Inc. | Noninvasive physiological sensor |
US11918386B2 (en) | 2018-12-26 | 2024-03-05 | Flashback Technologies, Inc. | Device-based maneuver and activity state-based physiologic status monitoring |
US12066426B1 (en) | 2019-01-16 | 2024-08-20 | Masimo Corporation | Pulsed micro-chip laser for malaria detection |
EP3920791B1 (en) | 2019-02-07 | 2024-10-30 | Masimo Corporation | Combining multiple qeeg features to estimate drug-independent sedation level using machine learning |
US11911325B2 (en) | 2019-02-26 | 2024-02-27 | Hill-Rom Services, Inc. | Bed interface for manual location |
US20210022628A1 (en) | 2019-04-17 | 2021-01-28 | Masimo Corporation | Patient monitoring systems, devices, and methods |
USD985498S1 (en) | 2019-08-16 | 2023-05-09 | Masimo Corporation | Connector |
USD917704S1 (en) | 2019-08-16 | 2021-04-27 | Masimo Corporation | Patient monitor |
USD919094S1 (en) | 2019-08-16 | 2021-05-11 | Masimo Corporation | Blood pressure device |
USD921202S1 (en) | 2019-08-16 | 2021-06-01 | Masimo Corporation | Holder for a blood pressure device |
USD919100S1 (en) | 2019-08-16 | 2021-05-11 | Masimo Corporation | Holder for a patient monitor |
US11832940B2 (en) | 2019-08-27 | 2023-12-05 | Cercacor Laboratories, Inc. | Non-invasive medical monitoring device for blood analyte measurements |
US12131661B2 (en) | 2019-10-03 | 2024-10-29 | Willow Laboratories, Inc. | Personalized health coaching system |
WO2021077019A1 (en) | 2019-10-18 | 2021-04-22 | Masimo Corporation | Display layout and interactive objects for patient monitoring |
USD927699S1 (en) | 2019-10-18 | 2021-08-10 | Masimo Corporation | Electrode pad |
KR20220115927A (en) | 2019-10-25 | 2022-08-19 | 세르카코르 래버러토리즈, 인크. | Indicator compounds, devices comprising indicator compounds, and methods of making and using the same |
CA3167295A1 (en) | 2020-01-13 | 2021-07-22 | Masimo Corporation | Wearable device with physiological parameters monitoring |
US12128213B2 (en) | 2020-01-30 | 2024-10-29 | Willow Laboratories, Inc. | Method of operating redundant staggered disease management systems |
US11721105B2 (en) | 2020-02-13 | 2023-08-08 | Masimo Corporation | System and method for monitoring clinical activities |
US11879960B2 (en) | 2020-02-13 | 2024-01-23 | Masimo Corporation | System and method for monitoring clinical activities |
US12048534B2 (en) | 2020-03-04 | 2024-07-30 | Willow Laboratories, Inc. | Systems and methods for securing a tissue site to a sensor |
WO2021189002A1 (en) | 2020-03-20 | 2021-09-23 | Masimo Corporation | Wearable device for noninvasive body temperature measurement |
US11620464B2 (en) | 2020-03-31 | 2023-04-04 | Covidien Lp | In-vivo introducible antenna for detection of RF tags |
USD933232S1 (en) | 2020-05-11 | 2021-10-12 | Masimo Corporation | Blood pressure monitor |
US12127838B2 (en) | 2020-04-22 | 2024-10-29 | Willow Laboratories, Inc. | Self-contained minimal action invasive blood constituent system |
USD979516S1 (en) | 2020-05-11 | 2023-02-28 | Masimo Corporation | Connector |
US12029844B2 (en) | 2020-06-25 | 2024-07-09 | Willow Laboratories, Inc. | Combination spirometer-inhaler |
USD980091S1 (en) | 2020-07-27 | 2023-03-07 | Masimo Corporation | Wearable temperature measurement device |
USD974193S1 (en) | 2020-07-27 | 2023-01-03 | Masimo Corporation | Wearable temperature measurement device |
US12082926B2 (en) | 2020-08-04 | 2024-09-10 | Masimo Corporation | Optical sensor with multiple detectors or multiple emitters |
US11986067B2 (en) | 2020-08-19 | 2024-05-21 | Masimo Corporation | Strap for a wearable device |
USD946596S1 (en) | 2020-09-30 | 2022-03-22 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD946597S1 (en) | 2020-09-30 | 2022-03-22 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD946598S1 (en) | 2020-09-30 | 2022-03-22 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD997365S1 (en) | 2021-06-24 | 2023-08-29 | Masimo Corporation | Physiological nose sensor |
USD1036293S1 (en) | 2021-08-17 | 2024-07-23 | Masimo Corporation | Straps for a wearable device |
US12126683B2 (en) | 2021-08-31 | 2024-10-22 | Masimo Corporation | Privacy switch for mobile communications device |
USD1000975S1 (en) | 2021-09-22 | 2023-10-10 | Masimo Corporation | Wearable temperature measurement device |
USD1048571S1 (en) | 2021-10-07 | 2024-10-22 | Masimo Corporation | Bite block |
USD1048908S1 (en) | 2022-10-04 | 2024-10-29 | Masimo Corporation | Wearable sensor |
USD1042596S1 (en) | 2022-12-12 | 2024-09-17 | Masimo Corporation | Monitoring camera |
CN118216932B (en) * | 2024-05-24 | 2024-07-26 | 小舟科技有限公司 | Electroencephalogram region filtering method and device based on abnormal wave signal intensity distribution prediction |
Citations (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3638640A (en) * | 1967-11-01 | 1972-02-01 | Robert F Shaw | Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths |
US3647299A (en) * | 1970-04-20 | 1972-03-07 | American Optical Corp | Oximeter |
US4086915A (en) * | 1975-04-30 | 1978-05-02 | Harvey I. Kofsky | Ear oximetry process and apparatus |
US4095117A (en) * | 1975-06-30 | 1978-06-13 | Medicor Muvek | Circuit for defining the dye dilution curves in vivo and in vitro for calculating the cardiac blood flowrate value per minute |
US4243935A (en) * | 1979-05-18 | 1981-01-06 | The United States Of America As Represented By The Secretary Of The Navy | Adaptive detector |
US4266554A (en) * | 1978-06-22 | 1981-05-12 | Minolta Camera Kabushiki Kaisha | Digital oximeter |
US4446871A (en) * | 1980-01-25 | 1984-05-08 | Minolta Kabushiki Kaisha | Optical analyzer for measuring a construction ratio between components in the living tissue |
US4519396A (en) * | 1979-03-30 | 1985-05-28 | American Home Products Corporation (Del.) | Fetal heart rate monitor apparatus and method for combining electrically and mechanically derived cardiographic signals |
US4537200A (en) * | 1983-07-07 | 1985-08-27 | The Board Of Trustees Of The Leland Stanford Junior University | ECG enhancement by adaptive cancellation of electrosurgical interference |
US4586513A (en) * | 1982-02-19 | 1986-05-06 | Minolta Camera Kabushiki Kaisha | Noninvasive device for photoelectrically measuring the property of arterial blood |
US4649505A (en) * | 1984-07-02 | 1987-03-10 | General Electric Company | Two-input crosstalk-resistant adaptive noise canceller |
US4653498A (en) * | 1982-09-13 | 1987-03-31 | Nellcor Incorporated | Pulse oximeter monitor |
US4723294A (en) * | 1985-12-06 | 1988-02-02 | Nec Corporation | Noise canceling system |
US4751931A (en) * | 1986-09-22 | 1988-06-21 | Allegheny-Singer Research Institute | Method and apparatus for determining his-purkinje activity |
US4773422A (en) * | 1987-04-30 | 1988-09-27 | Nonin Medical, Inc. | Single channel pulse oximeter |
US4799493A (en) * | 1987-03-13 | 1989-01-24 | Cardiac Pacemakers, Inc. | Dual channel coherent fibrillation detection system |
US4800495A (en) * | 1986-08-18 | 1989-01-24 | Physio-Control Corporation | Method and apparatus for processing signals used in oximetry |
US4802486A (en) * | 1985-04-01 | 1989-02-07 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4807631A (en) * | 1987-10-09 | 1989-02-28 | Critikon, Inc. | Pulse oximetry system |
US4819752A (en) * | 1987-10-02 | 1989-04-11 | Datascope Corp. | Blood constituent measuring device and method |
US4819646A (en) * | 1986-08-18 | 1989-04-11 | Physio-Control Corporation | Feedback-controlled method and apparatus for processing signals used in oximetry |
US4824242A (en) * | 1986-09-26 | 1989-04-25 | Sensormedics Corporation | Non-invasive oximeter and method |
US4848901A (en) * | 1987-10-08 | 1989-07-18 | Critikon, Inc. | Pulse oximeter sensor control system |
US4858199A (en) * | 1988-09-06 | 1989-08-15 | Mobile Oil Corporation | Method and apparatus for cancelling nonstationary sinusoidal noise from seismic data |
US4859056A (en) * | 1986-08-18 | 1989-08-22 | Physio-Control Corporation | Multiple-pulse method and apparatus for use in oximetry |
US4860759A (en) * | 1987-09-08 | 1989-08-29 | Criticare Systems, Inc. | Vital signs monitor |
US4863265A (en) * | 1987-10-16 | 1989-09-05 | Mine Safety Appliances Company | Apparatus and method for measuring blood constituents |
US4892101A (en) * | 1986-08-18 | 1990-01-09 | Physio-Control Corporation | Method and apparatus for offsetting baseline portion of oximeter signal |
US4907594A (en) * | 1987-07-18 | 1990-03-13 | Nicolay Gmbh | Method for the determination of the saturation of the blood of a living organism with oxygen and electronic circuit for performing this method |
US4911167A (en) * | 1985-06-07 | 1990-03-27 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4913150A (en) * | 1986-08-18 | 1990-04-03 | Physio-Control Corporation | Method and apparatus for the automatic calibration of signals employed in oximetry |
US4927264A (en) * | 1987-12-02 | 1990-05-22 | Omron Tateisi Electronics Co. | Non-invasive measuring method and apparatus of blood constituents |
US4928692A (en) * | 1985-04-01 | 1990-05-29 | Goodman David E | Method and apparatus for detecting optical pulses |
US4934372A (en) * | 1985-04-01 | 1990-06-19 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4942877A (en) * | 1986-09-05 | 1990-07-24 | Minolta Camera Kabushiki Kaisha | Device for measuring oxygen saturation degree in arterial blood |
US4948248A (en) * | 1988-07-22 | 1990-08-14 | Invivo Research Inc. | Blood constituent measuring device and method |
US4949710A (en) * | 1988-10-06 | 1990-08-21 | Protocol Systems, Inc. | Method of artifact rejection for noninvasive blood-pressure measurement by prediction and adjustment of blood-pressure data |
US4951680A (en) * | 1987-09-30 | 1990-08-28 | National Research Development Corporation | Fetal monitoring during labor |
US5042499A (en) * | 1988-09-30 | 1991-08-27 | Frank Thomas H | Noninvasive electrocardiographic method of real time signal processing for obtaining and displaying instantaneous fetal heart rate and fetal heart rate beat-to-beat variability |
US5337744A (en) * | 1993-07-14 | 1994-08-16 | Masimo Corporation | Low noise finger cot probe |
US5431170A (en) * | 1990-05-26 | 1995-07-11 | Mathews; Geoffrey R. | Pulse responsive device |
US5482036A (en) * | 1991-03-07 | 1996-01-09 | Masimo Corporation | Signal processing apparatus and method |
US5490505A (en) * | 1991-03-07 | 1996-02-13 | Masimo Corporation | Signal processing apparatus |
US5494032A (en) * | 1991-07-12 | 1996-02-27 | Sandia Corporation | Oximeter for reliable clinical determination of blood oxygen saturation in a fetus |
US5632272A (en) * | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
US5638818A (en) * | 1991-03-21 | 1997-06-17 | Masimo Corporation | Low noise optical probe |
US5638816A (en) * | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
US5645440A (en) * | 1995-10-16 | 1997-07-08 | Masimo Corporation | Patient cable connector |
USD393830S (en) * | 1995-10-16 | 1998-04-28 | Masimo Corporation | Patient cable connector |
US5743262A (en) * | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
US5760910A (en) * | 1995-06-07 | 1998-06-02 | Masimo Corporation | Optical filter for spectroscopic measurement and method of producing the optical filter |
US5758644A (en) * | 1995-06-07 | 1998-06-02 | Masimo Corporation | Manual and automatic probe calibration |
US5890929A (en) * | 1996-06-19 | 1999-04-06 | Masimo Corporation | Shielded medical connector |
US5919134A (en) * | 1997-04-14 | 1999-07-06 | Masimo Corp. | Method and apparatus for demodulating signals in a pulse oximetry system |
US6067462A (en) * | 1997-04-14 | 2000-05-23 | Masimo Corporation | Signal processing apparatus and method |
US6184521B1 (en) * | 1998-01-06 | 2001-02-06 | Masimo Corporation | Photodiode detector with integrated noise shielding |
US6229856B1 (en) * | 1997-04-14 | 2001-05-08 | Masimo Corporation | Method and apparatus for demodulating signals in a pulse oximetry system |
US6349228B1 (en) * | 1998-02-11 | 2002-02-19 | Masimo Corporation | Pulse oximetry sensor adapter |
US6360114B1 (en) * | 1999-03-25 | 2002-03-19 | Masimo Corporation | Pulse oximeter probe-off detector |
US6371921B1 (en) * | 1994-04-15 | 2002-04-16 | Masimo Corporation | System and method of determining whether to recalibrate a blood pressure monitor |
US6377829B1 (en) * | 1999-12-09 | 2002-04-23 | Masimo Corporation | Resposable pulse oximetry sensor |
US6388240B2 (en) * | 1999-08-26 | 2002-05-14 | Masimo Corporation | Shielded optical probe and method having a longevity indication |
US6430525B1 (en) * | 2000-06-05 | 2002-08-06 | Masimo Corporation | Variable mode averager |
US6515273B2 (en) * | 1999-08-26 | 2003-02-04 | Masimo Corporation | System for indicating the expiration of the useful operating life of a pulse oximetry sensor |
US6525386B1 (en) * | 1998-03-10 | 2003-02-25 | Masimo Corporation | Non-protruding optoelectronic lens |
US6526300B1 (en) * | 1999-06-18 | 2003-02-25 | Masimo Corporation | Pulse oximeter probe-off detection system |
US6542764B1 (en) * | 1999-12-01 | 2003-04-01 | Masimo Corporation | Pulse oximeter monitor for expressing the urgency of the patient's condition |
US6541756B2 (en) * | 1991-03-21 | 2003-04-01 | Masimo Corporation | Shielded optical probe having an electrical connector |
US6584336B1 (en) * | 1999-01-25 | 2003-06-24 | Masimo Corporation | Universal/upgrading pulse oximeter |
US6606511B1 (en) * | 1999-01-07 | 2003-08-12 | Masimo Corporation | Pulse oximetry pulse indicator |
US6684090B2 (en) * | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
US6697658B2 (en) * | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
US6697656B1 (en) * | 2000-06-27 | 2004-02-24 | Masimo Corporation | Pulse oximetry sensor compatible with multiple pulse oximetry systems |
US6714804B2 (en) * | 1998-06-03 | 2004-03-30 | Masimo Corporation | Stereo pulse oximeter |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3704706A (en) * | 1969-10-23 | 1972-12-05 | Univ Drexel | Heart rate and respiratory monitor |
US3991277A (en) | 1973-02-15 | 1976-11-09 | Yoshimutsu Hirata | Frequency division multiplex system using comb filters |
JPS5725217B2 (en) | 1974-10-14 | 1982-05-28 | ||
US4038536A (en) * | 1976-03-29 | 1977-07-26 | Rockwell International Corporation | Adaptive recursive least mean square error filter |
US4063551A (en) * | 1976-04-06 | 1977-12-20 | Unisen, Inc. | Blood pulse sensor and readout |
JPS5493890A (en) | 1977-12-30 | 1979-07-25 | Minolta Camera Kk | Eyeeground oximeter |
US4238746A (en) | 1978-03-20 | 1980-12-09 | The United States Of America As Represented By The Secretary Of The Navy | Adaptive line enhancer |
US4407290A (en) * | 1981-04-01 | 1983-10-04 | Biox Technology, Inc. | Blood constituent measuring device and method |
DE3328862A1 (en) * | 1982-09-16 | 1985-02-28 | Siemens AG, 1000 Berlin und 8000 München | Tissue photometry method and device, in particular for quantatively determining the blood oxygen saturation from photometric measurements |
DE3323862A1 (en) | 1983-06-29 | 1985-01-03 | Affeld, Klaus, Dr. Dipl.-Ing., 1000 Berlin | SAFETY DRIVE FOR AN ARTIFICIAL HEART |
US4714341A (en) | 1984-02-23 | 1987-12-22 | Minolta Camera Kabushiki Kaisha | Multi-wavelength oximeter having a means for disregarding a poor signal |
GB2166326B (en) * | 1984-10-29 | 1988-04-27 | Hazeltine Corp | Lms adaptive loop module |
US4617589A (en) | 1984-12-17 | 1986-10-14 | Rca Corporation | Adaptive frame comb filter system |
US4781200A (en) | 1985-10-04 | 1988-11-01 | Baker Donald A | Ambulatory non-invasive automatic fetal monitoring system |
US5259381A (en) | 1986-08-18 | 1993-11-09 | Physio-Control Corporation | Apparatus for the automatic calibration of signals employed in oximetry |
US4869253A (en) * | 1986-08-18 | 1989-09-26 | Physio-Control Corporation | Method and apparatus for indicating perfusion and oxygen saturation trends in oximetry |
US4867571A (en) * | 1986-09-26 | 1989-09-19 | Sensormedics Corporation | Wave form filter pulse detector and method for modulated signal |
US4793361A (en) * | 1987-03-13 | 1988-12-27 | Cardiac Pacemakers, Inc. | Dual channel P-wave detection in surface electrocardiographs |
GB8719333D0 (en) * | 1987-08-14 | 1987-09-23 | Swansea University College Of | Motion artefact rejection system |
US4960126A (en) | 1988-01-15 | 1990-10-02 | Criticare Systems, Inc. | ECG synchronized pulse oximeter |
US4883353A (en) * | 1988-02-11 | 1989-11-28 | Puritan-Bennett Corporation | Pulse oximeter |
US4869254A (en) * | 1988-03-30 | 1989-09-26 | Nellcor Incorporated | Method and apparatus for calculating arterial oxygen saturation |
EP0341327B1 (en) * | 1988-05-09 | 1993-09-15 | Hewlett-Packard GmbH | A method for processing signals, particularly for oximetric measurements on living human tissue |
US4883356A (en) | 1988-09-13 | 1989-11-28 | The Perkin-Elmer Corporation | Spectrometer detector mounting assembly |
JPH06103257B2 (en) * | 1988-12-19 | 1994-12-14 | 大塚電子株式会社 | Method and apparatus for measuring absorption coefficient of substance using light scattering |
US4956867A (en) * | 1989-04-20 | 1990-09-11 | Massachusetts Institute Of Technology | Adaptive beamforming for noise reduction |
GB2235288B (en) * | 1989-07-27 | 1993-02-10 | Nat Res Dev | Oximeters |
US5273036A (en) * | 1991-04-03 | 1993-12-28 | Ppg Industries, Inc. | Apparatus and method for monitoring respiration |
US5246002A (en) | 1992-02-11 | 1993-09-21 | Physio-Control Corporation | Noise insensitive pulse transmittance oximeter |
EP0760223A1 (en) | 1995-08-31 | 1997-03-05 | Hewlett-Packard GmbH | Apparatus for monitoring, in particular pulse oximeter |
EP0761159B1 (en) | 1995-08-31 | 1999-09-29 | Hewlett-Packard Company | Apparatus for medical monitoring, in particular pulse oximeter |
US5842981A (en) | 1996-07-17 | 1998-12-01 | Criticare Systems, Inc. | Direct to digital oximeter |
-
1992
- 1992-03-05 CA CA002105682A patent/CA2105682C/en not_active Expired - Lifetime
- 1992-03-05 EP EP03015656A patent/EP1357481A3/en not_active Withdrawn
- 1992-03-05 AU AU15369/92A patent/AU658177B2/en not_active Expired
- 1992-03-05 WO PCT/US1992/001895 patent/WO1992015955A1/en active IP Right Grant
- 1992-03-05 JP JP50745192A patent/JP3363150B2/en not_active Expired - Lifetime
- 1992-03-05 AT AT92907861T patent/ATE184716T1/en not_active IP Right Cessation
- 1992-03-05 EP EP92907861A patent/EP0574509B1/en not_active Expired - Lifetime
- 1992-03-05 EP EP99103974A patent/EP0930045A3/en not_active Withdrawn
- 1992-03-05 DE DE69229994T patent/DE69229994T2/en not_active Expired - Lifetime
- 1992-03-05 RU RU93058616A patent/RU2144211C1/en active
-
1994
- 1994-05-26 US US08/249,690 patent/US5482036A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/479,918 patent/US5769785A/en not_active Expired - Lifetime
-
1998
- 1998-06-22 US US09/102,131 patent/US6036642A/en not_active Ceased
-
1999
- 1999-11-17 US US09/441,736 patent/US6206830B1/en not_active Expired - Fee Related
-
2001
- 2001-01-09 US US09/757,444 patent/US6501975B2/en not_active Expired - Fee Related
-
2002
- 2002-03-11 US US10/095,586 patent/USRE38492E1/en not_active Expired - Fee Related
- 2002-12-20 US US10/327,234 patent/US6826419B2/en not_active Expired - Fee Related
-
2004
- 2004-05-04 US US10/839,309 patent/US20040204638A1/en not_active Abandoned
Patent Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3638640A (en) * | 1967-11-01 | 1972-02-01 | Robert F Shaw | Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths |
US3647299A (en) * | 1970-04-20 | 1972-03-07 | American Optical Corp | Oximeter |
US4086915A (en) * | 1975-04-30 | 1978-05-02 | Harvey I. Kofsky | Ear oximetry process and apparatus |
US4095117A (en) * | 1975-06-30 | 1978-06-13 | Medicor Muvek | Circuit for defining the dye dilution curves in vivo and in vitro for calculating the cardiac blood flowrate value per minute |
US4266554A (en) * | 1978-06-22 | 1981-05-12 | Minolta Camera Kabushiki Kaisha | Digital oximeter |
US4519396A (en) * | 1979-03-30 | 1985-05-28 | American Home Products Corporation (Del.) | Fetal heart rate monitor apparatus and method for combining electrically and mechanically derived cardiographic signals |
US4243935A (en) * | 1979-05-18 | 1981-01-06 | The United States Of America As Represented By The Secretary Of The Navy | Adaptive detector |
US4446871A (en) * | 1980-01-25 | 1984-05-08 | Minolta Kabushiki Kaisha | Optical analyzer for measuring a construction ratio between components in the living tissue |
US4694833A (en) * | 1982-02-19 | 1987-09-22 | Minolta Camera Kabushiki Kaisha | Noninvasive device for photoelectrically measuring the property of arterial blood |
US4586513A (en) * | 1982-02-19 | 1986-05-06 | Minolta Camera Kabushiki Kaisha | Noninvasive device for photoelectrically measuring the property of arterial blood |
US4653498A (en) * | 1982-09-13 | 1987-03-31 | Nellcor Incorporated | Pulse oximeter monitor |
US4653498B1 (en) * | 1982-09-13 | 1989-04-18 | ||
US4537200A (en) * | 1983-07-07 | 1985-08-27 | The Board Of Trustees Of The Leland Stanford Junior University | ECG enhancement by adaptive cancellation of electrosurgical interference |
US4649505A (en) * | 1984-07-02 | 1987-03-10 | General Electric Company | Two-input crosstalk-resistant adaptive noise canceller |
US4802486A (en) * | 1985-04-01 | 1989-02-07 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4934372A (en) * | 1985-04-01 | 1990-06-19 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4928692A (en) * | 1985-04-01 | 1990-05-29 | Goodman David E | Method and apparatus for detecting optical pulses |
US4911167A (en) * | 1985-06-07 | 1990-03-27 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4723294A (en) * | 1985-12-06 | 1988-02-02 | Nec Corporation | Noise canceling system |
US4800495A (en) * | 1986-08-18 | 1989-01-24 | Physio-Control Corporation | Method and apparatus for processing signals used in oximetry |
US4913150A (en) * | 1986-08-18 | 1990-04-03 | Physio-Control Corporation | Method and apparatus for the automatic calibration of signals employed in oximetry |
US4819646A (en) * | 1986-08-18 | 1989-04-11 | Physio-Control Corporation | Feedback-controlled method and apparatus for processing signals used in oximetry |
US4859056A (en) * | 1986-08-18 | 1989-08-22 | Physio-Control Corporation | Multiple-pulse method and apparatus for use in oximetry |
US4892101A (en) * | 1986-08-18 | 1990-01-09 | Physio-Control Corporation | Method and apparatus for offsetting baseline portion of oximeter signal |
US4942877A (en) * | 1986-09-05 | 1990-07-24 | Minolta Camera Kabushiki Kaisha | Device for measuring oxygen saturation degree in arterial blood |
US4751931A (en) * | 1986-09-22 | 1988-06-21 | Allegheny-Singer Research Institute | Method and apparatus for determining his-purkinje activity |
US4824242A (en) * | 1986-09-26 | 1989-04-25 | Sensormedics Corporation | Non-invasive oximeter and method |
US4799493A (en) * | 1987-03-13 | 1989-01-24 | Cardiac Pacemakers, Inc. | Dual channel coherent fibrillation detection system |
US4773422A (en) * | 1987-04-30 | 1988-09-27 | Nonin Medical, Inc. | Single channel pulse oximeter |
US4907594A (en) * | 1987-07-18 | 1990-03-13 | Nicolay Gmbh | Method for the determination of the saturation of the blood of a living organism with oxygen and electronic circuit for performing this method |
US4860759A (en) * | 1987-09-08 | 1989-08-29 | Criticare Systems, Inc. | Vital signs monitor |
US4951680A (en) * | 1987-09-30 | 1990-08-28 | National Research Development Corporation | Fetal monitoring during labor |
US4819752A (en) * | 1987-10-02 | 1989-04-11 | Datascope Corp. | Blood constituent measuring device and method |
US4848901A (en) * | 1987-10-08 | 1989-07-18 | Critikon, Inc. | Pulse oximeter sensor control system |
US4807631A (en) * | 1987-10-09 | 1989-02-28 | Critikon, Inc. | Pulse oximetry system |
US4863265A (en) * | 1987-10-16 | 1989-09-05 | Mine Safety Appliances Company | Apparatus and method for measuring blood constituents |
US4927264A (en) * | 1987-12-02 | 1990-05-22 | Omron Tateisi Electronics Co. | Non-invasive measuring method and apparatus of blood constituents |
US4948248A (en) * | 1988-07-22 | 1990-08-14 | Invivo Research Inc. | Blood constituent measuring device and method |
US4858199A (en) * | 1988-09-06 | 1989-08-15 | Mobile Oil Corporation | Method and apparatus for cancelling nonstationary sinusoidal noise from seismic data |
US5042499A (en) * | 1988-09-30 | 1991-08-27 | Frank Thomas H | Noninvasive electrocardiographic method of real time signal processing for obtaining and displaying instantaneous fetal heart rate and fetal heart rate beat-to-beat variability |
US4949710A (en) * | 1988-10-06 | 1990-08-21 | Protocol Systems, Inc. | Method of artifact rejection for noninvasive blood-pressure measurement by prediction and adjustment of blood-pressure data |
US5431170A (en) * | 1990-05-26 | 1995-07-11 | Mathews; Geoffrey R. | Pulse responsive device |
US5769785A (en) * | 1991-03-07 | 1998-06-23 | Masimo Corporation | Signal processing apparatus and method |
US5482036A (en) * | 1991-03-07 | 1996-01-09 | Masimo Corporation | Signal processing apparatus and method |
US5490505A (en) * | 1991-03-07 | 1996-02-13 | Masimo Corporation | Signal processing apparatus |
US6206830B1 (en) * | 1991-03-07 | 2001-03-27 | Masimo Corporation | Signal processing apparatus and method |
US5632272A (en) * | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
US6236872B1 (en) * | 1991-03-07 | 2001-05-22 | Masimo Corporation | Signal processing apparatus |
US6081735A (en) * | 1991-03-07 | 2000-06-27 | Masimo Corporation | Signal processing apparatus |
US6263222B1 (en) * | 1991-03-07 | 2001-07-17 | Masimo Corporation | Signal processing apparatus |
USRE38492E1 (en) * | 1991-03-07 | 2004-04-06 | Masimo Corporation | Signal processing apparatus and method |
US6036642A (en) * | 1991-03-07 | 2000-03-14 | Masimo Corporation | Signal processing apparatus and method |
USRE38476E1 (en) * | 1991-03-07 | 2004-03-30 | Masimo Corporation | Signal processing apparatus |
US5638818A (en) * | 1991-03-21 | 1997-06-17 | Masimo Corporation | Low noise optical probe |
US6088607A (en) * | 1991-03-21 | 2000-07-11 | Masimo Corporation | Low noise optical probe |
US5782757A (en) * | 1991-03-21 | 1998-07-21 | Masimo Corporation | Low-noise optical probes |
US6256523B1 (en) * | 1991-03-21 | 2001-07-03 | Masimo Corporation | Low-noise optical probes |
US6541756B2 (en) * | 1991-03-21 | 2003-04-01 | Masimo Corporation | Shielded optical probe having an electrical connector |
US5494032A (en) * | 1991-07-12 | 1996-02-27 | Sandia Corporation | Oximeter for reliable clinical determination of blood oxygen saturation in a fetus |
US5337744A (en) * | 1993-07-14 | 1994-08-16 | Masimo Corporation | Low noise finger cot probe |
US6371921B1 (en) * | 1994-04-15 | 2002-04-16 | Masimo Corporation | System and method of determining whether to recalibrate a blood pressure monitor |
US5743262A (en) * | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
US5758644A (en) * | 1995-06-07 | 1998-06-02 | Masimo Corporation | Manual and automatic probe calibration |
US6397091B2 (en) * | 1995-06-07 | 2002-05-28 | Masimo Corporation | Manual and automatic probe calibration |
US5638816A (en) * | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
US6011986A (en) * | 1995-06-07 | 2000-01-04 | Masimo Corporation | Manual and automatic probe calibration |
US6110522A (en) * | 1995-06-07 | 2000-08-29 | Masimo Laboratories | Blood glucose monitoring system |
US5940182A (en) * | 1995-06-07 | 1999-08-17 | Masimo Corporation | Optical filter for spectroscopic measurement and method of producing the optical filter |
US6678543B2 (en) * | 1995-06-07 | 2004-01-13 | Masimo Corporation | Optical probe and positioning wrap |
US6278522B1 (en) * | 1995-06-07 | 2001-08-21 | Masimo Laboratories | Optical filter for spectroscopic measurement and method of producing the optical filter |
US5760910A (en) * | 1995-06-07 | 1998-06-02 | Masimo Corporation | Optical filter for spectroscopic measurement and method of producing the optical filter |
US5860919A (en) * | 1995-06-07 | 1999-01-19 | Masimo Corporation | Active pulse blood constituent monitoring method |
US5645440A (en) * | 1995-10-16 | 1997-07-08 | Masimo Corporation | Patient cable connector |
USD393830S (en) * | 1995-10-16 | 1998-04-28 | Masimo Corporation | Patient cable connector |
US6280213B1 (en) * | 1995-10-16 | 2001-08-28 | Masimo Corporation | Patient cable connector |
US5934925A (en) * | 1995-10-16 | 1999-08-10 | Masimo Corporation | Patient cable connector |
US5890929A (en) * | 1996-06-19 | 1999-04-06 | Masimo Corporation | Shielded medical connector |
US6699194B1 (en) * | 1997-04-14 | 2004-03-02 | Masimo Corporation | Signal processing apparatus and method |
US6229856B1 (en) * | 1997-04-14 | 2001-05-08 | Masimo Corporation | Method and apparatus for demodulating signals in a pulse oximetry system |
US6067462A (en) * | 1997-04-14 | 2000-05-23 | Masimo Corporation | Signal processing apparatus and method |
US5919134A (en) * | 1997-04-14 | 1999-07-06 | Masimo Corp. | Method and apparatus for demodulating signals in a pulse oximetry system |
US6184521B1 (en) * | 1998-01-06 | 2001-02-06 | Masimo Corporation | Photodiode detector with integrated noise shielding |
US6597933B2 (en) * | 1998-02-11 | 2003-07-22 | Masimo Corporation | Pulse oximetry sensor adapter |
US6349228B1 (en) * | 1998-02-11 | 2002-02-19 | Masimo Corporation | Pulse oximetry sensor adapter |
US6525386B1 (en) * | 1998-03-10 | 2003-02-25 | Masimo Corporation | Non-protruding optoelectronic lens |
US6714804B2 (en) * | 1998-06-03 | 2004-03-30 | Masimo Corporation | Stereo pulse oximeter |
US6606511B1 (en) * | 1999-01-07 | 2003-08-12 | Masimo Corporation | Pulse oximetry pulse indicator |
US6684090B2 (en) * | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
US6584336B1 (en) * | 1999-01-25 | 2003-06-24 | Masimo Corporation | Universal/upgrading pulse oximeter |
US6360114B1 (en) * | 1999-03-25 | 2002-03-19 | Masimo Corporation | Pulse oximeter probe-off detector |
US6526300B1 (en) * | 1999-06-18 | 2003-02-25 | Masimo Corporation | Pulse oximeter probe-off detection system |
US6388240B2 (en) * | 1999-08-26 | 2002-05-14 | Masimo Corporation | Shielded optical probe and method having a longevity indication |
US6580086B1 (en) * | 1999-08-26 | 2003-06-17 | Masimo Corporation | Shielded optical probe and method |
US6515273B2 (en) * | 1999-08-26 | 2003-02-04 | Masimo Corporation | System for indicating the expiration of the useful operating life of a pulse oximetry sensor |
US6542764B1 (en) * | 1999-12-01 | 2003-04-01 | Masimo Corporation | Pulse oximeter monitor for expressing the urgency of the patient's condition |
US6377829B1 (en) * | 1999-12-09 | 2002-04-23 | Masimo Corporation | Resposable pulse oximetry sensor |
US6725075B2 (en) * | 1999-12-09 | 2004-04-20 | Masimo Corporation | Resposable pulse oximetry sensor |
US6430525B1 (en) * | 2000-06-05 | 2002-08-06 | Masimo Corporation | Variable mode averager |
US6697656B1 (en) * | 2000-06-27 | 2004-02-24 | Masimo Corporation | Pulse oximetry sensor compatible with multiple pulse oximetry systems |
US6697658B2 (en) * | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
Cited By (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8649839B2 (en) | 1996-10-10 | 2014-02-11 | Covidien Lp | Motion compatible sensor for non-invasive optical blood analysis |
US7720516B2 (en) | 1996-10-10 | 2010-05-18 | Nellcor Puritan Bennett Llc | Motion compatible sensor for non-invasive optical blood analysis |
US8133176B2 (en) | 1999-04-14 | 2012-03-13 | Tyco Healthcare Group Lp | Method and circuit for indicating quality and accuracy of physiological measurements |
US8224412B2 (en) | 2000-04-17 | 2012-07-17 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with piece-wise function |
US8078246B2 (en) | 2000-04-17 | 2011-12-13 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with piece-wise function |
US7689259B2 (en) | 2000-04-17 | 2010-03-30 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with piece-wise function |
US8483790B2 (en) | 2002-10-18 | 2013-07-09 | Covidien Lp | Non-adhesive oximeter sensor for sensitive skin |
US7657295B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7738937B2 (en) | 2005-08-08 | 2010-06-15 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8311602B2 (en) | 2005-08-08 | 2012-11-13 | Nellcor Puritan Bennett Llc | Compliant diaphragm medical sensor and technique for using the same |
US7684843B2 (en) | 2005-08-08 | 2010-03-23 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7657296B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Unitary medical sensor assembly and technique for using the same |
US8528185B2 (en) | 2005-08-08 | 2013-09-10 | Covidien Lp | Bi-stable medical sensor and technique for using the same |
US7693559B2 (en) | 2005-08-08 | 2010-04-06 | Nellcor Puritan Bennett Llc | Medical sensor having a deformable region and technique for using the same |
US7647084B2 (en) | 2005-08-08 | 2010-01-12 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7657294B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Compliant diaphragm medical sensor and technique for using the same |
US8260391B2 (en) | 2005-09-12 | 2012-09-04 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US7729736B2 (en) | 2005-09-29 | 2010-06-01 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7650177B2 (en) | 2005-09-29 | 2010-01-19 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US8092379B2 (en) | 2005-09-29 | 2012-01-10 | Nellcor Puritan Bennett Llc | Method and system for determining when to reposition a physiological sensor |
US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US7899510B2 (en) | 2005-09-29 | 2011-03-01 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8600469B2 (en) | 2005-09-29 | 2013-12-03 | Covidien Lp | Medical sensor and technique for using the same |
US7676253B2 (en) | 2005-09-29 | 2010-03-09 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8965473B2 (en) | 2005-09-29 | 2015-02-24 | Covidien Lp | Medical sensor for reducing motion artifacts and technique for using the same |
US8060171B2 (en) | 2005-09-29 | 2011-11-15 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8062221B2 (en) | 2005-09-30 | 2011-11-22 | Nellcor Puritan Bennett Llc | Sensor for tissue gas detection and technique for using the same |
US8352010B2 (en) | 2005-09-30 | 2013-01-08 | Covidien Lp | Folding medical sensor and technique for using the same |
US8233954B2 (en) | 2005-09-30 | 2012-07-31 | Nellcor Puritan Bennett Llc | Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same |
US8352009B2 (en) | 2005-09-30 | 2013-01-08 | Covidien Lp | Medical sensor and technique for using the same |
US7881762B2 (en) | 2005-09-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US8398557B2 (en) * | 2006-02-20 | 2013-03-19 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Spread-spectrum method for determining physiological parameters |
US8676542B2 (en) * | 2006-02-20 | 2014-03-18 | Fraunhofer-Gesellschaft zur Foederung der Angewandten Forshung e.V. | Adaptive filtering for more reliably determining physiological parameters |
EP1909189A2 (en) * | 2006-02-20 | 2008-04-09 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Spectral analysis for more reliable determination of vital parameters |
US20090216499A1 (en) * | 2006-02-20 | 2009-08-27 | Andreas Tobola | Adaptive filtering for more reliably determining physiological parameters |
US20080027299A1 (en) * | 2006-02-20 | 2008-01-31 | Andreas Tobola | Spectral analysis for a more reliable determination of physiological parameters |
US8295901B2 (en) | 2006-02-20 | 2012-10-23 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Spectral analysis for a more reliable determination of physiological parameters |
US20100292593A1 (en) * | 2006-02-20 | 2010-11-18 | Andreas Tobola | Spread-spectrum method for determining physiological parameters |
US8073518B2 (en) | 2006-05-02 | 2011-12-06 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US8437826B2 (en) | 2006-05-02 | 2013-05-07 | Covidien Lp | Clip-style medical sensor and technique for using the same |
US8577436B2 (en) | 2006-08-22 | 2013-11-05 | Covidien Lp | Medical sensor for reducing signal artifacts and technique for using the same |
US8145288B2 (en) | 2006-08-22 | 2012-03-27 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
US8396527B2 (en) | 2006-09-22 | 2013-03-12 | Covidien Lp | Medical sensor for reducing signal artifacts and technique for using the same |
US8175671B2 (en) | 2006-09-22 | 2012-05-08 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8190225B2 (en) | 2006-09-22 | 2012-05-29 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8190224B2 (en) | 2006-09-22 | 2012-05-29 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8195264B2 (en) | 2006-09-22 | 2012-06-05 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US7869849B2 (en) | 2006-09-26 | 2011-01-11 | Nellcor Puritan Bennett Llc | Opaque, electrically nonconductive region on a medical sensor |
US8315685B2 (en) | 2006-09-27 | 2012-11-20 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
US8660626B2 (en) | 2006-09-28 | 2014-02-25 | Covidien Lp | System and method for mitigating interference in pulse oximetry |
US7890153B2 (en) | 2006-09-28 | 2011-02-15 | Nellcor Puritan Bennett Llc | System and method for mitigating interference in pulse oximetry |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US7794266B2 (en) | 2006-09-29 | 2010-09-14 | Nellcor Puritan Bennett Llc | Device and method for reducing crosstalk |
US7680522B2 (en) | 2006-09-29 | 2010-03-16 | Nellcor Puritan Bennett Llc | Method and apparatus for detecting misapplied sensors |
US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US7658652B2 (en) | 2006-09-29 | 2010-02-09 | Nellcor Puritan Bennett Llc | Device and method for reducing crosstalk |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US7894869B2 (en) | 2007-03-09 | 2011-02-22 | Nellcor Puritan Bennett Llc | Multiple configuration medical sensor and technique for using the same |
US10635784B2 (en) | 2007-12-18 | 2020-04-28 | Icu Medical, Inc. | User interface improvements for medical devices |
US8346328B2 (en) | 2007-12-21 | 2013-01-01 | Covidien Lp | Medical sensor and technique for using the same |
US8352004B2 (en) | 2007-12-21 | 2013-01-08 | Covidien Lp | Medical sensor and technique for using the same |
US8366613B2 (en) | 2007-12-26 | 2013-02-05 | Covidien Lp | LED drive circuit for pulse oximetry and method for using same |
US8577434B2 (en) | 2007-12-27 | 2013-11-05 | Covidien Lp | Coaxial LED light sources |
US8452364B2 (en) | 2007-12-28 | 2013-05-28 | Covidien LLP | System and method for attaching a sensor to a patient's skin |
US8442608B2 (en) | 2007-12-28 | 2013-05-14 | Covidien Lp | System and method for estimating physiological parameters by deconvolving artifacts |
US8897850B2 (en) | 2007-12-31 | 2014-11-25 | Covidien Lp | Sensor with integrated living hinge and spring |
US8070508B2 (en) | 2007-12-31 | 2011-12-06 | Nellcor Puritan Bennett Llc | Method and apparatus for aligning and securing a cable strain relief |
US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
US8199007B2 (en) | 2007-12-31 | 2012-06-12 | Nellcor Puritan Bennett Llc | Flex circuit snap track for a biometric sensor |
US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
US8112375B2 (en) | 2008-03-31 | 2012-02-07 | Nellcor Puritan Bennett Llc | Wavelength selection and outlier detection in reduced rank linear models |
US20110082357A1 (en) * | 2008-05-28 | 2011-04-07 | Neetour Medical Ltd. | Method and apparatus for co2 evaluation |
US8071935B2 (en) | 2008-06-30 | 2011-12-06 | Nellcor Puritan Bennett Llc | Optical detector with an overmolded faraday shield |
US7880884B2 (en) | 2008-06-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | System and method for coating and shielding electronic sensor components |
US7887345B2 (en) | 2008-06-30 | 2011-02-15 | Nellcor Puritan Bennett Llc | Single use connector for pulse oximetry sensors |
US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
US8423112B2 (en) | 2008-09-30 | 2013-04-16 | Covidien Lp | Medical sensor and technique for using the same |
US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
US8914088B2 (en) | 2008-09-30 | 2014-12-16 | Covidien Lp | Medical sensor and technique for using the same |
US8932219B2 (en) | 2009-03-05 | 2015-01-13 | Nellcor Puritan Bennett Ireland | Systems and methods for monitoring heart rate and blood pressure correlation |
US8216136B2 (en) | 2009-03-05 | 2012-07-10 | Nellcor Puritan Bennett Llc | Systems and methods for monitoring heart rate and blood pressure correlation |
US8452366B2 (en) | 2009-03-16 | 2013-05-28 | Covidien Lp | Medical monitoring device with flexible circuitry |
US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
US8634891B2 (en) | 2009-05-20 | 2014-01-21 | Covidien Lp | Method and system for self regulation of sensor component contact pressure |
US9010634B2 (en) | 2009-06-30 | 2015-04-21 | Covidien Lp | System and method for linking patient data to a patient and providing sensor quality assurance |
US8311601B2 (en) | 2009-06-30 | 2012-11-13 | Nellcor Puritan Bennett Llc | Reflectance and/or transmissive pulse oximeter |
US8505821B2 (en) | 2009-06-30 | 2013-08-13 | Covidien Lp | System and method for providing sensor quality assurance |
US8636667B2 (en) | 2009-07-06 | 2014-01-28 | Nellcor Puritan Bennett Ireland | Systems and methods for processing physiological signals in wavelet space |
US8391941B2 (en) | 2009-07-17 | 2013-03-05 | Covidien Lp | System and method for memory switching for multiple configuration medical sensor |
US8417310B2 (en) | 2009-08-10 | 2013-04-09 | Covidien Lp | Digital switching in multi-site sensor |
US8428675B2 (en) | 2009-08-19 | 2013-04-23 | Covidien Lp | Nanofiber adhesives used in medical devices |
US9492095B2 (en) | 2009-12-02 | 2016-11-15 | Neetour Medical Ltd. | Hemodynamics-based monitoring and evaluation of a respiratory condition |
US9675282B2 (en) * | 2010-02-11 | 2017-06-13 | Koninklijke Philips N.V. | Method and apparatus for determining a respiration signal |
US20120296221A1 (en) * | 2010-02-11 | 2012-11-22 | Koninklijke Philips Electronics N.V. | Method and apparatus for determining a respiration signal |
US20110213226A1 (en) * | 2010-02-28 | 2011-09-01 | Nellcor Puritan Bennett Llc | Motion compensation in a sensor |
US8483788B2 (en) | 2010-02-28 | 2013-07-09 | Covidien Lp | Motion compensation in a sensor |
US11599854B2 (en) | 2011-08-19 | 2023-03-07 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
US10430761B2 (en) | 2011-08-19 | 2019-10-01 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
US11972395B2 (en) | 2011-08-19 | 2024-04-30 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
US11004035B2 (en) | 2011-08-19 | 2021-05-11 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
US10022498B2 (en) | 2011-12-16 | 2018-07-17 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
US11376361B2 (en) | 2011-12-16 | 2022-07-05 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
US9995611B2 (en) | 2012-03-30 | 2018-06-12 | Icu Medical, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
US10578474B2 (en) | 2012-03-30 | 2020-03-03 | Icu Medical, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
US11933650B2 (en) | 2012-03-30 | 2024-03-19 | Icu Medical, Inc. | Air detection system and method for detecting air in a pump of an infusion system |
US10463788B2 (en) | 2012-07-31 | 2019-11-05 | Icu Medical, Inc. | Patient care system for critical medications |
US11623042B2 (en) | 2012-07-31 | 2023-04-11 | Icu Medical, Inc. | Patient care system for critical medications |
US12048831B2 (en) | 2013-05-24 | 2024-07-30 | Icu Medical, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
US10046112B2 (en) | 2013-05-24 | 2018-08-14 | Icu Medical, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
US10874793B2 (en) | 2013-05-24 | 2020-12-29 | Icu Medical, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
US10166328B2 (en) | 2013-05-29 | 2019-01-01 | Icu Medical, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
US10596316B2 (en) | 2013-05-29 | 2020-03-24 | Icu Medical, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
US12059551B2 (en) | 2013-05-29 | 2024-08-13 | Icu Medical, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
US11596737B2 (en) | 2013-05-29 | 2023-03-07 | Icu Medical, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
US11433177B2 (en) | 2013-05-29 | 2022-09-06 | Icu Medical, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
US12083310B2 (en) | 2014-02-28 | 2024-09-10 | Icu Medical, Inc. | Infusion system and method which utilizes dual wavelength optical air-in-line detection |
US10342917B2 (en) | 2014-02-28 | 2019-07-09 | Icu Medical, Inc. | Infusion system and method which utilizes dual wavelength optical air-in-line detection |
US11344673B2 (en) | 2014-05-29 | 2022-05-31 | Icu Medical, Inc. | Infusion system and pump with configurable closed loop delivery rate catch-up |
WO2015181560A1 (en) * | 2014-05-30 | 2015-12-03 | Huntleigh Technology Limited | Tissue variability compensation apparatus and method |
US10390717B2 (en) | 2014-05-30 | 2019-08-27 | Huntleigh Technology Limited | Tissue variability compensation apparatus and method |
US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
US12115337B2 (en) | 2015-03-02 | 2024-10-15 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
US11246985B2 (en) | 2016-05-13 | 2022-02-15 | Icu Medical, Inc. | Infusion pump system and method with common line auto flush |
US11324888B2 (en) | 2016-06-10 | 2022-05-10 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
US12076531B2 (en) | 2016-06-10 | 2024-09-03 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
US11029911B2 (en) | 2017-12-27 | 2021-06-08 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
US11868161B2 (en) | 2017-12-27 | 2024-01-09 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
US10656894B2 (en) | 2017-12-27 | 2020-05-19 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
US11883361B2 (en) | 2020-07-21 | 2024-01-30 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
Also Published As
Publication number | Publication date |
---|---|
US6501975B2 (en) | 2002-12-31 |
CA2105682A1 (en) | 1992-09-08 |
AU658177B2 (en) | 1995-04-06 |
US5769785A (en) | 1998-06-23 |
EP0574509A1 (en) | 1993-12-22 |
US20010029326A1 (en) | 2001-10-11 |
DE69229994T2 (en) | 2000-04-27 |
EP1357481A3 (en) | 2005-04-27 |
DE69229994D1 (en) | 1999-10-21 |
ATE184716T1 (en) | 1999-10-15 |
US6826419B2 (en) | 2004-11-30 |
EP0574509A4 (en) | 1996-07-31 |
US5482036A (en) | 1996-01-09 |
US6036642A (en) | 2000-03-14 |
CA2105682C (en) | 2003-09-02 |
EP1357481A2 (en) | 2003-10-29 |
EP0930045A3 (en) | 1999-10-27 |
WO1992015955A1 (en) | 1992-09-17 |
AU1536992A (en) | 1992-10-06 |
EP0930045A2 (en) | 1999-07-21 |
US6206830B1 (en) | 2001-03-27 |
US20030097049A1 (en) | 2003-05-22 |
JP3363150B2 (en) | 2003-01-08 |
USRE38492E1 (en) | 2004-04-06 |
JPH06507485A (en) | 1994-08-25 |
EP0574509B1 (en) | 1999-09-15 |
RU2144211C1 (en) | 2000-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6826419B2 (en) | Signal processing apparatus and method | |
US7469157B2 (en) | Signal processing apparatus | |
US8046042B2 (en) | Signal processing apparatus | |
US8128572B2 (en) | Signal processing apparatus | |
US8560034B1 (en) | Signal processing apparatus | |
US7376453B1 (en) | Signal processing apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |